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Summary
Visual perception is highly variable across healthy individuals and increasing evidence
suggests that this inter-individual variation could be due to differences at the genetic,
neurochemical, structural and neurophysiological level. Specifically, variation in the GAD1
gene (responsible for synthesising the majority of cortical GABA) has been associated with
differences in the level of the inhibitory neurotransmitter GABA. In addition, differences in
GABA and cortical structural parameters (surface area and thickness) have been shown to
predict differences in neural gamma oscillations. However, these findings have not been
replicated in large independent studies. Hence, Chapter 3 and 4 of this thesis combines the
non-invasive neuroimaging tools MRI, MRS and MEG with genetic data to investigate the
relationship between variations in genes, GABA, structure and gamma oscillations in the
visual cortex of a large cohort of healthy individuals.
Group differences in GABA, structure and gamma oscillations have also been reported
between psychiatric populations (schizophrenia and bipolar disorder) and healthy individuals.
However, differences in the direction of effect (increase or decrease) and no group
differences have been found. Thus, Chapter 5 aims to further study these inconsistent
findings by exploring group differences in GABA, structure and gamma oscillations between
a healthy group and a schizoaffective bipolar disorder group.
Lastly, inter- individual variation is also present in auditory perception but has received much
less attention into the factors driving this variation. As in the visual system, similar links
between neurochemical, structural and neurophysiological measures could be present in the
auditory domain. Chapter 6 investigates the association between auditory gamma oscillations
and auditory structural parameters in a healthy cohort.
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1Chapter 1 - General Introduction
1.1 Rationale
Vision and hearing are two of our most important senses, which enable us to perceive the
environment and guide our behavioural responses. The visual and auditory system process
relatively independent external stimuli and provide us with rich sources of information about
objects in our surroundings. For example, the visual system processes light waves, so that we
can perceive colour, depth, and motion and recognise familiar objects and faces. In contrast,
the auditory system analyses the pattern of sound waves (changes in air pressure). This
enables us to localise sound, recognise familiar sounds and voices, and to communicate via
speech. The two systems can also work in conjunction with one another, such as in motion
perception, which allows us to assess the speed of moving objects. In order to carry out these
sensory functions, the visual and auditory systems are highly specialised and organised
structures, showing both similarities and dissimilarities with one another. Small differences in
the structure and chemical composition of these two systems may lead to subtle differences in
visual and auditory perception in healthy individuals. Larger differences may lead to
clinically measurable altered perception and behaviour. This thesis uses neuroimaging and
genetic information to investigate individual differences in the visual and auditory cortex of
healthy individuals and group differences between healthy individuals and a psychiatric
population.
The introduction of modern brain imaging techniques has greatly improved our
understanding of the structural and functional specialisation of the human brain in vivo.
Different imaging techniques have particular methodological advantages that enable us to
2build an intricate picture of the brain. The high field strength of magnetic resonance imaging
(MRI) scanners allows detailed structural information to be obtained, while the high spatial
resolution of functional magnetic resonance imaging (fMRI) means that the precise location
of changes in regional blood flow (an indirect measure of neuronal activity) in response to
stimulation can be identified. Electroencephalography (EEG) and magnetoencephalography
(MEG) directly measure neural activity and have high temporal resolution, providing detailed
information about the time course of neuronal activity, while magnetic resonance
spectroscopy (MRS) can determine the concentration of specific brain metabolites.
Importantly, different imaging modalities show correlational relationships between measures
that can be translated to behavioural responses. This suggests that functionally relevant
measures are being obtained. For example, in the visual cortex, a functional measure of
neural inhibitory activity (gamma oscillations) correlates with an inhibitory chemical
neurotransmitter measure (GABA concentration) (Muthukumaraswamy et al., 2010) and
behavioural measures of inhibition (Edden et al., 2009, Yoon et al., 2010).
Neuroimaging measures also show inter-individual variability, meaning that the measure
obtained at a single time point is different between individuals. Little is known about the
reasons for this variability and whether it has any perceptual consequences. Normally, studies
consider this variability a confound and remove it by averaging participant data. However,
increasing evidence suggests inter-individual variability may be of particular importance for
explaining variability in our perception and behaviour. In particular, structural MRI studies
have shown the importance of inter-individual differences in human brain structure in relation
to behaviours. For example, differences in grey matter volume and the integrity of white
matter have been shown to reflect differences in working memory, numerical processing and
empathy (Banissy et al., 2012, Krause et al., 2014, Soto et al., 2014). Thus, investigating
3what underlies individual variability in our neuroimaging data is important, as it may help us
explain differences in perception and behaviour in health and disease.
This thesis focuses on investigating inter-individual variability in gamma oscillatory activity
(a functional imaging measure) in the human visual and auditory cortex. Several key studies
have driven this context, as they have shown individual variability in gamma band
oscillations in both the human visual (Hoogenboom et al., 2006, Muthukumaraswamy et al.,
2010) and auditory cortex (Arrondo et al., 2009, Artieda et al., 2004). Gamma oscillations are
high frequency oscillations (30-100Hz) and understanding their underlying  driving factors is
of particular interest as they have been implicated in cognitive and sensory processing (Ward,
2003). Importantly, gamma oscillations are thought to be generated via the balance of
reciprocal connections between cortical inhibitory and excitatory neurons (Buzsaki and
Wang, 2012). Given that these oscillations rely on the cortical inhibitory/excitatory balance
of neuronal assemblies, it is reasonable to suggest that inter-individual differences in gamma
measures may reflect underlying inter-individual differences in GABAergic and
glutamatergic neurochemical measures and/or the cortical structural architecture. Indeed, in
the visual cortex individual differences in gamma peak frequency have been found to
positively correlate with baseline visual MRS GABA concentrations (Muthukumaraswamy et
al., 2009) and visual cortical surface area (Schwarzkopf et al., 2012). However, these studies
had small sample sizes and have failed to be replicated (Cousijn et al., 2014, Perry et al.,
2013, Robson, 2012). Thus, one of the aims of this thesis is to investigate whether individual
differences in visual gamma peak frequency measured using MEG can be explained by MRS
measured occipital GABA concentration and/or structural properties of the visual cortex in a
large independent sample. In contrast to the visual system, whether differences in structural
or neurochemical properties of the auditory cortex can explain inter-individual variability in
4auditory gamma oscillations is not clear, and to our knowledge has not been investigated.
Therefore, this thesis also explores whether differences in the structural properties of the
auditory cortex could explain inter-individual differences in auditory gamma oscillations.
Importantly, the non-invasive nature of neuroimaging allows us to explore the neurobiology
of the human brain in both the healthy and diseased state. This has been particularly
important in the field of psychiatry, as psychiatric disorders are poorly understood at the
molecular and cellular level, which impedes the development of new drug targets. Currently,
antipsychotics that primarily act through blockade of D2-type dopamine receptors are the
only approved treatment for schizophrenia. However, many patients are unresponsive to these
medications and they do not treat the negative and cognitive symptoms associated with the
disorder (Miyamoto et al., 2012). Similarly, in bipolar disorder no effective treatments are
available for the cognitive symptoms and up to 37% of patients relapse within the first year
even with mood stabilising treatment (Gitlin et al., 1995). Thus, alternative neurochemical
theories are needed as new drug targets to improve the treatment of these disorders.
Due to their implication in cognitive function, gamma oscillations have been studied in a
range of psychiatric populations such as bipolar disorder and schizophrenia. Group
differences between patient populations and healthy controls have been reported in a range of
cortical areas (O'Donnell et al., 2004, Williams and Boksa, 2010). Although the majority of
studies report reductions in gamma band measures, the results have not been consistent, with
increases and even no difference being reported (Riečanský et al., 2010, Uhlhaas et al.,
2006). In conjunction, altered GABAergic function in schizophrenia and bipolar disorder has
been supported via MRS measured in vivo GABA levels. However, these findings are also
inconsistent across cortical regions, with increases (Brady et al., 2013, Kegeles et al., 2012)
5decreases (Rowland et al., 2013, Yoon et al., 2010) and no group differences (Kaufman et al.,
2009, Tayoshi et al., 2010) being reported. Therefore, another aim of this thesis is to build
upon this literature by further investigating gamma oscillations and GABA levels in a
psychiatric population that have both mood and psychotic episodes, known as schizoaffective
bipolar disorder. Further understanding how gamma oscillations and GABA levels are
perturbed in psychiatric disorders will help unravel the underlying neuronal networks and
biology involved in these disorders.
One potential reason for confounding results may be that psychiatric populations are
biologically heterogeneous groups, as they are classified into diagnostic categories based on
their symptomology rather than their neurobiology. Hence, a psychiatric population may not
be biologically specific enough, meaning that it is hard to identify reliable neuroimaging
measures. In addition, imaging measures do not provide cellular resolution, such as
differentiation between different types of neurons. This may be particularly relevant to help
us understand the complex neurobiology of psychiatric disorders. Importantly, the new field
of genetic imaging has allowed us to investigate more biologically specific pathways by
grouping individuals based on their genetic make-up. This means that we can investigate how
genes involved in a specific system such as enzymes, receptors or transporters influence
downstream imaging measures and lead to the clinical and behavioural phenotype. Thus,
differences in genetic make-up can also be applied to investigate specific individual
differences in neuroimaging and behavioural data. For the context of this thesis, how genetic
variants involved in cortical GABAergic signalling and schizophrenia risk-associated alleles
influence downstream variation in neuroimaging measures of inhibition (gamma and GABA)
was investigated. Overall, by linking imaging techniques with genetic information we can
6learn more about individual and group differences in brain structure, chemical composition
and function and relate these to behavioural changes in both health and disease.
This introductory chapter is divided into the following sections to provide a detailed
background into the context and main components of this thesis:
1.2 The Anatomy and Microcircuitry of the Visual and Auditory System
1.3 Gamma Oscillations in the Visual and Auditory System
1.4 Gamma Oscillations and GABA in Psychiatric Disorders
1.5 Genetic Imaging
1.5.1 Impact of Genetic Variation on Gamma Frequency and GABA
1.6 Outline of Thesis Chapters
1.2 The Anatomy and Microcircuitry of the Visual and Auditory System
The visual system is one of the most studied sensory modalities, with much of our knowledge
of its anatomy and function originating from studies in the cat and macaque monkey (Hubel
and Wiesel, 1962, Lund, 1988). The neural pathway of the visual system begins at the retinal
ganglion cells that project from the retina, via the optic nerve to the optic chiasm and the
optic tract. At the optic chiasm, the optic nerve from both eyes meet and cross over, meaning
that the left visual field is viewed by the right hemisphere and the right visual field is viewed
by the left hemisphere (Figure 1). The majority of optic tract axons form synaptic
connections within the major relay station of the brain, at the lateral geniculate nucleus
(LGN) of the thalamus. The LGN is made up of 6 layers and neurons from this nucleus
project via the optic radiation to the primary visual cortex (V1, striate cortex) via two main
pathways: the magnocellular and parvocellular pathway. The magnocellular pathway
7originates from layers 1 and 2 of the LGN and projects to layer 4Cα of V1. The parvocellular
pathway begins across layers 3, 4, 5 and 6 of the LGN and projects to layers 4A and 4Cβ of
V1. V1 also provides strong feedback connections to the LGN.
Figure 1.1: Illustration of the main pathways in the visual system. The left visual field
(purple) is represented in the right hemisphere and the right visual field (blue) is represented
in the left hemisphere. Image from (Hannula et al., 2005).
As in the LGN, V1 is made up of 6 cortical layers, with layer 4 being split into 4A, 4B and
4C (4Cα and 4Cβ). Layer 1 lies under the pia matter and contains mainly axons and dendrites
from cells in deeper layers. Interneurons make up about 15% of visual cortical neurons and
make local connections within the cortex. Excitatory neurons (spiny stellate cells and
pyramidal cells) make up 85% of visual cortical neurons; spiny stellate cells are found in
layer 4C and make local connections whereas pyramidal cells are widespread in V1 and send
axons within and outside of V1 (Callaway, 1998).
8Figure 1.2: Laminar structure and cell types in the visual cortex. Image taken from “The
Principles of Neuroscience” (Figure 27-10) (Kandel et al., 2000).
The laminar and cell specific arrangement of V1 is a fundamental feature of the visual system
that translates into functional organisation from the sensory periphery up to V1. This allows
for topographic organisation, whereby neighbouring cells in V1 receive input from
corresponding points of neighbouring cells in the LGN and retina. This provides V1 with a
retinotopic map of the visual scene. In addition, functional specialisation can be found
between the parvocellular and magnocellular pathways. The magnocellular pathway is
involved in the perception of movement, depth and contrast whereas the parvocellular
pathway is primarily involved in the perception of colour (Liu et al., 2006). Within V1 itself,
functional organisation is present horizontally and vertically, in which neurons with similar
response properties are spatially grouped together. Neighbouring neurons have been found to
have similar selectivity to the orientation and spatial frequency of a visual stimulus and a
preferred eye input (ocular dominance) (Martinez et al., 2005). Following considerable
processing in V1, the visual signal is sent to subcortical areas and the extrastriate cortex, V2,
V3, V4 and V5. These visual cortical areas are involved in higher level processing of the
visual stimulus and are specialised for representing certain aspects of the visual stimulus: V2
9for low level stimulus processing, V3 for depth perception, V4 for colour and V5 for motion
(Grill-Spector and Malach, 2004).
In comparison, the auditory system is less well studied but shares corresponding components
with the visual system. Sound waves are transduced to neural signals by hair cells in the
cochlea, and sent along the auditory nerve via spiral ganglion cells to the ventral cochlear
nucleus and dorsal cochlear nucleus in the medulla. Multiple efferent pathways are present
from these nuclei but the main pathway continues to the superior olive on both sides of the
brainstem. This bilateral innervation enables sound to be heard in both ears. Projections from
the superior olive ascend to the inferior colliculus in the midbrain and synapse on the medial
geniculate nucleus (MGN) of the thalamus. Lastly, afferent neurons from the MGN project to
the primary auditory cortex (A1), located on the superior temporal gyrus in the temporal lobe.
Information from A1 is then sent to the association area, located adjacently to A1, for
processing of the more complex parameters of the stimulus.
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Figure 1.3: The main pathways in the auditory system. Image taken from “Neuroscience:
Exploring the Brain” (Figure 11.18) (Bear et al., 2007).
Thus, both sensory systems share analogous anatomic components; a receptor organ, sensory
receptors, ganglion projection cells, thalamic relay station, primary sensory cortex and
association areas. However, the auditory modality contains many more cortico-thalamic
pathways, suggesting that processing in the midbrain is an important part of auditory
perception.
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Figure 1.4: The main components of the visual and auditory cortex.
The microcircuitry of A1 is also similar to that of V1, with 6 cortical layers and local
connections between layers formed by interneurons and cortico-cortical connections from
pyramidal cells (Winer and JA, 1992). One of the main differences between the two sensory
cortices is the different functional organisation of A1. The auditory system does have a
topographic map, in which hair cells along the cochlear respond to different sound
frequencies that is maintained across subthalamic nuclei. However, this frequency
representation (tonotopy) does not seem to be as well defined in A1 (Castro and Kandler,
2010). In addition, the response properties of A1 neurons to certain parameters of acoustic
stimuli (frequency, duration and amplitude) are not as straightforward. Although clusters of
neurons do show sensitivity to a particular frequency, the response properties are generally
less sharply tuned and not spatially organised. It has been hypothesised that this difference
may be due to the increased processing at lower levels, such as in the inferior colliculus and
12
that A1 may be involved in more complex processing. For example, A1 neurons are
preferentially driven by stimuli with spectral and temporal complexity rather than simple pure
tones (Wang et al., 2005). Thus, the auditory cortex is not a simple translation from the visual
cortex. Auditory processing involves more processing at lower levels and A1 may in fact, not
be organised for simple sound parameters but for higher order parameters comparable to the
inferior temporal cortex of the visual system (King and Nelken, 2009).
1.3 Gamma Oscillations in the Visual and Auditory System
EEG and MEG are widely used to noninvasively measure cortical neural oscillations
(synchronous activity of large groups of neurons). Importantly, two main types of oscillatory
activity can be measured: evoked and induced. Evoked activity is time and phase-locked to
the stimulus, occurring about 70-120ms after stimulus onset. Induced activity is time-locked
but not phase-locked to the stimulus and occurs 200ms onwards from stimulus onset (Pantev,
1995). Another type of activity, called the steady-state response (SSR), which is considered
an evoked response can also be measured via EEG and MEG. The SSR is produced in
response to a repeated sensory stimulus in which populations of neurons are entrained to the
stimulus at the frequency of stimulation (Herrmann, 2001).
As well as being classed into evoked or induced activity, neural oscillations are divided into
several categories, based on their frequency bands; delta (1-4Hz), theta (4-8Hz) alpha (8-
12Hz), beta (12-30Hz) and gamma (30-100Hz). Each frequency band has their own
specialised function and are differentially modulated (Pfurtscheller and Lopes da Silva,
1999). Oscillations in the lower frequency bands are thought to reflect long-range
synchronisation across brain areas whereas higher frequency oscillations reflect
synchronisation in local networks (Schnitzler and Gross, 2005). Gamma oscillations can be
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measured from a wide range of brain regions, including the prefrontal cortex and sensory
regions.
Modelling and neurophysiological studies have shown that gamma oscillations are generated
via reciprocally connected interneuron and pyramidal cell assemblies (Buzsaki and Wang,
2012, Whittington et al., 2011). Interneurons can be classed into three main types of
GABAergic neurons: parvalbumin, calretinin and somatostatin (Gonchar et al., 2007).
Parvalbumin (PV) expressing interneurons make up half of the GABAergic interneurons in
the cortex and it is these neurons that are specifically essential for the generation of gamma
oscillations. The main model to explain gamma oscillatory generation and maintenance is the
pyramidal-interneuron network gamma (PING) model (Gonzalez-Burgos and Lewis, 2012).
In this model, parvalbumin expressing interneurons are recruited by phasic glutamatergic
input from pyramidal cells (primarily via NMDA receptors) and provide fast-spiking
feedback inhibition to pyramidal cells (primarily via GABAA receptors).
Figure 1.5: The PING model showing the reciprocal connectivity between pyramidal and
parvalbumin positive cells. Image taken from (Gonzalez-Burgos and Lewis, 2012).
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Optogenetic studies in mice support the model and have shown that in vivo, PV positive
interneurons are essential for driving cortical gamma oscillations (Cardin et al., 2009, Sohal
et al., 2009). Computational models have been used to manipulate the parameters of the
PING model and have shown that gamma oscillations are intricately modulated, both
excitatory and inhibitory input and output can alter the response (Spencer, 2009).
Gamma oscillations are significantly enhanced by sensory input and are modality specific;
visual stimuli create large increases in the primary visual cortex and auditory stimuli generate
increases in the temporal cortex (Jefferys et al., 1996). In the human visual cortex, gamma
oscillations can be optimally induced using square-wave, high-contrast gratings (Adjamian et
al., 2004, Hoogenboom et al., 2006, Muthukumaraswamy et al., 2010) that closely resemble
those measured invasively in the macaque (Hall et al., 2005). Thus, a square-wave, high
contrast grating is used in this thesis to induce visual gamma activity. This type of visual
stimulus produces both an early evoked and a later sustained response, which have been
localised to V1 (Hoogenboom et al., 2006, Perry et al., 2011).
15
Figure 1.6: Visually induced gamma oscillations located to the primary visual cortex in the
human (a+b) which are comparable to the local field potential obtained from the macaque
monkey (c+d). Image taken from (Hall et al., 2005).
Within the sustained response, two main measures are typically extracted from the above
time-frequency spectra; peak gamma frequency and power. These two measures can be
modulated by stimulus parameters including contrast (Ray and Maunsell, 2010), orientation
(Koelewijn et al., 2011), spatial frequency (Adjamian et al., 2004), motion (Swettenham et
al., 2009) and size (Perry et al., 2013). These findings imply that sustained visual gamma
oscillatory activity has a role in encoding the stimulus properties of a visual stimulus to aid
perception. An important aspect of visually induced gamma oscillations is that individuals
show inter-individual variability in peak gamma frequency and power that is stable over time
(Muthukumaraswamy et al., 2010). The factors underlying this variability are unknown, but
may represent underlying differences in the chemical or structural properties of V1. Peak
gamma frequency has been shown to positively correlate with resting occipital GABA
concentration (Muthukumaraswamy et al., 2009), V1 surface area (Schwarzkopf et al., 2012)
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and V1 thickness (Gaetz et al., 2012, Muthukumaraswamy et al., 2010). Similarly, the exact
significance of the variability is also unknown but may translate to differences in behavioural
measures of the visual system (Edden et al., 2009). Pharmaco-MEG work further supports the
involvement of GABAergic signalling in visually induced gamma measures, as modulation of
GABAA receptors alters gamma responses (Campbell et al., 2014, Saxena et al., 2013).
However, recent work in a larger cohort suggests that these quantitative inhibitory measures
are not correlated and that the main driving factor between the previously correlated occipital
GABA and gamma peak frequency is age (Robson, 2012). Hence, this thesis aimed to
explore this finding in a large homogeneous cohort.
In the auditory cortex, steady-state responses (SSRs) can be obtained with trains of clicks
(Galambos et al., 1981) or amplitude-modulated tones (Picton et al., 1987). Interestingly, if
the auditory cortex is driven with auditory stimuli over a range of frequencies, SSRs show a
main peak at 40Hz and a secondary peak between 80 to 120Hz (Galambos et al., 1981, Lins
et al., 1995), while higher or lower frequencies produce smaller amplitudes. The cause of this
specific increased response around 40Hz is still debated; one theory suggests they are the
result of phase summation from middle latency responses whereas others believe it is due to
the preferential working frequency of the auditory network (Pastor et al., 2002). Support for
the latter theory has recently been shown, whereby following delivery of click trains at
various frequencies, 40Hz produces the largest increase in regional cerebral blood flow in
auditory areas (Pastor et al., 2002), suggesting increased cortical synaptic activity at 40Hz.
Using MEG and fMRI, ASSRs have been localised to the superior temporal gyrus of the
auditory cortex (Herdman et al., 2003). Significantly, not only is A1 activated to 40Hz
auditory stimuli but a network of regions involving a cortico-cerebellar-thalamic loop are
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specifically activated at 40Hz (Pastor et al., 2008). These findings further enforce the
importance of cortico-thalamic processing in auditory processing.
The majority of auditory SSRs studies specifically drive the cortex at 40Hz as they are
interested in the power of the response at that frequency. However, one study has shown the
importance of using a stimulus that drives the auditory cortex simultaneously over a range of
frequencies. This method has identified inter-individual differences in gamma oscillations in
the human auditory cortex (Artieda et al., 2004). Using an amplitude-modulated tone, which
increased in frequency from 1 to 120Hz (chirp), individuals were found to have two peak
frequency responses. The strongest peak response across individuals ranged between 20 to
65Hz and the second weaker peak response ranged between 80 to 120Hz (Figure 1.7).
Figure 1.7: The auditory steady-state response obtained from an amplitude-modulated tone
that increases in frequency from 1 to 120Hz. Image taken from (Artieda et al., 2004).
As in the visual modality, the factors underlying the auditory individual differences are still
unknown. The chemical composition of A1 may play an important part, as increasing
inhibition with a GABAAR agonist increases the amplitude of the ASSR in rats (Vohs et al.,
18
2010). Interestingly, the peak gamma frequency has also been related to behavioural
responses. Lower peak frequencies to the amplitude-modulated tone were associated with
multiple sclerosis (MS) patients with a cognitive impairment compared to MS patients with
higher cognitive abilities or healthy controls (Arrondo et al., 2009).
This thesis aims to increase our understanding of individual gamma differences in the
auditory response by using an auditory chirp in a healthy population and seeing if they can be
explained by structural properties of the primary auditory cortex. In addition, peak gamma
frequencies in the auditory cortex will be compared with peak frequencies obtained from the
visual cortex to determine if there is a relationship between the two measures.
1.4 Gamma Oscillations and GABA in Psychiatric Disorders
Schizophrenia and bipolar disorder are two of the most common and debilitating psychiatric
disorders, with prevalence rates of about 1% (Regier et al., 1993) and 3.5% (Merikangas et
al., 2007) respectively. These psychiatric disorders have been classed as separate diseases
since the 19th century, known as the Kraepelin dichotomy. This dichotomy distinguishes
between the two disorders based on their differential symptom patterns. Schizophrenia
individuals show positive symptoms (hallucinations, delusions, and disordered thoughts),
negative symptoms (lack of interest and emotional flatness) and cognitive symptoms
(problems with attention, working memory and executive functioning). Bipolar disorder is
characterised by extreme mood changes, including manic (e.g. feeling euphoric, restlessness,
racing thoughts) and depressive episodes (e.g. feeling worthless, lack of interest, fatigue).
Bipolar individuals can also show symptoms of psychosis (hallucinations and delusions) and
cognitive difficulties that are similar to those experienced by schizophrenia individuals.
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Initially, sensory processing deficits were not considered a major clinical feature of
schizophrenia or bipolar disorder. This is due to the more evident presentation of thought
disorder, delusions and/or mood episodes. However, following substantial evidence,
disturbances in visual and auditory processing are now accepted as core deficits in
schizophrenia (Iliadou et al., 2013, Javitt, 2009) and are increasingly being recognised as
deficits associated with bipolar disorder (O'Bryan et al., 2014). In terms of visual processing,
behavioural deficits are evident in the discrimination of orientation, motion, contrast and
object size (Chen, 2011, Chen et al., 2006, O'Bryan et al., 2014). In auditory processing,
deficits can be found in the ability to discriminate tones by pitch (Javitt et al., 2000) and
duration (Todd et al., 2003). Importantly, these low level processing deficits may lead to
higher level cognitive impairments.
Neuroimaging studies have further added to the importance of these sensory two systems in
psychiatric disorders, by identifying structural and neurophysiological abnormalities
(Hirayasu et al., 2000). Due to their implication in cognition and sensory perception, gamma
band oscillatory measures have been studied in a range of cortical regions in schizophrenia
and bipolar disorder (O'Donnell et al., 2004, Williams and Boksa, 2010). Studies
investigating group differences in the gamma band can compare several different measures
including evoked power, induced power, phase locking and peak frequency. The methods of
analysis for these measures are explained in the methods section (Chapter 2) of this thesis.
Both disorders show alterations in evoked, induced and steady-state gamma band activity
compared to healthy individuals in response to a variety of tasks (Uhlhaas and Singer, 2010).
In schizophrenia individuals, gamma oscillatory activity is often reduced in response to basic
sensory stimuli using EEG and MEG. For example, in the visual domain an oddball task
using letters as stimuli (individuals have to count rare target stimuli) found no evoked gamma
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power (25-45Hz) or reduced gamma phase locking over the occipital cortex in schizophrenia
patients (Spencer et al., 2008a). Similarly, using an illusory square (individuals identify if an
illusory square is present or absent) schizophrenia individuals show reduced visual evoked
gamma phase locking (Spencer et al., 2003) and reduced gamma frequency (Spencer et al.,
2004). Evoked visual gamma activity is also altered in more demanding visual tasks such as a
backward masking task, where reduced  gamma power (30-40Hz) has been found across EEG
electrodes (Wynn et al., 2005). In addition, induced visual high gamma frequency oscillations
(60-120Hz) in response to mooney faces are reduced in schizophrenia (Grützner et al., 2013).
In the auditory domain, most studies have investigated auditory gamma steady-state
responses in schizophrenia and have identified decreases in power and frequency in the
gamma range (O'Donnell et al., 2013).
In contrast, gamma measures in bipolar disorder have been less extensively studied but
disturbances have also been identified. Bipolar individuals show reduced gamma power at
both high and low gamma frequencies and reduced phase locking in auditory steady-state
responses (O'Donnell et al., 2004, Oda et al., 2012, Rass et al., 2010). Altered higher level
processing in the visual domain has also been identified in response to an implicit emotional
face task (identify gender) (Liu et al., 2014).
Importantly, these disturbances in gamma oscillatory activity suggest an altered excitatory/
inhibitory cortical balance. This coincides with the wealth of evidence implicating altered
GABAergic and glutamatergic dysfunction in schizophrenia and bipolar disorder. One of the
most widely replicated findings of altered GABAergic function in schizophrenia and bipolar
disorder originate from post-mortem studies, in which glutamic acid decarboxylase 1 (GAD1)
mRNA levels are decreased across multiple cortical regions, including sensory areas
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(Gonzalez-Burgos et al., 2010, Hashimoto et al., 2008, Thompson et al., 2009). The GAD1
gene encodes the GAD67 enzyme, which is responsible for the majority of GABA synthesis
via the catalysis of glutamate (Asada et al., 1997). Significantly, GAD1 mRNA reductions
have primarily been found in the subclass of parvalbumin expressing interneurons, which are
critical for producing gamma oscillations. Further evidence for altered GABAergic signalling
in major mental disorders has been shown by MRS GABA imaging studies (Brady et al.,
2013, Yoon et al., 2010). One specific theory suggests that dysfunction of parvalbumin
neurons is due to a hypofunction of N-methyl-D-aspartate (NMDA) receptors (Nakazawa et
al., 2012). NMDA receptor hypofunction has been a major hypothesis in the pathophysiology
of schizophrenia (Poels et al., 2014) and is supported by genetic evidence showing lowered
expression of NMDA receptor subunit mRNA (Weickert et al., 2013). Also, NMDA receptor
blockade via ketamine administration induces the positive, negative and cognitive symptoms
observed in schizophrenia (Krystal et al., 1994, Lahti et al., 2001). Therefore, disrupted
GABAergic and glutamatergic signalling may lead to an inability to synchronise cortical
activity such as gamma oscillations, leading to the symptoms observed in schizophrenia and
bipolar disorder.
Although the majority of studies demonstrate reduced gamma oscillatory activity in
schizophrenia and bipolar disorder, which is supported by reduced in vivo GABA levels,
increases and/or no group differences in these measures have also been reported (Kegeles et
al., 2012, Spencer et al., 2008a, Uhlhaas et al., 2006). These findings could be due to a
number of reasons including different regions studied, different stimuli and the heterogeneity
of psychiatric populations. This thesis aims to explore gamma oscillatory activity and GABA
concentration in the visual cortex of a subgroup of bipolar individuals, known as
schizoaffective bipolar disorder (SABP). SABP individuals display episodes of mania and
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depression but also psychotic symptoms. Hence, exploring the neurophysiology and
neurobiology in this subtype may help us learn about specific alterations in psychosis and aid
us to differentiate between schizophrenia and bipolar disorder. In addition, genetic evidence
implies a specific influence of GABAAR genes in the SABP phenotype that is not applicable
to the wider bipolar phenotype (Craddock et al., 2010). The SABP group may therefore also
present a more biologically homogenous group in which to investigate how altered GABAAR
function affects gamma oscillations.
1.5 Genetic Imaging
A gene is a stretch of deoxyribonucleic acid (DNA) that codes proteins. Proteins carry out
most processes in cells and affect how a cell processes and responds to stimuli. This means
that variations in our DNA may affect the expression or function of a protein, leading to
downstream functional changes in a single cell or cell assembly. In order for DNA to work
efficiently it has a specific structure, consisting of nucleotides, which they themselves are
made up of a phosphate, a sugar (deoxyribose) and one of four chemical bases: adenine (A),
guanine (G), cytosine (C) and thymine (T). These chemical bases pair up in a particular way,
so that A is always paired with T and C is always paired with G.
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Figure 1.8: The structure of DNA. Image taken from the National Human Genome Research
Institute: http://www.genome.gov/.
Variations in chemical base pairs are common and include insertions, deletions, duplications
and single nucleotide polymorphisms (SNPs). SNPs are the most common type of genetic
variation (~10 million SNPs in the human genome) and to be classified as a SNP, must occur
in at least 1% of the population. They are defined as a change in a single base pair (e.g. a C
base substituted for a T base) and may have protective effects or be associated with risk for
certain disorders.
Figure 1.9: An example of a SNP in a region of DNA. Image taken from
http://www.farma.ku.dk/index.php/Personlig-medicinering-af-type/11444/0/.
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Genetics has been a major research area in neuropsychiatric illness, as genes are thought to
play a major role in the predisposition of schizophrenia and bipolar disorder. This is primarily
due to twin studies that have shown high heritability estimates of 81% and 75% in these
disorders respectively (Sullivan et al., 2012). These twin studies estimate heritability based
on the idea that monozygotic twins share 100% of their genes and dizygotic twins share 50%
of their genes. Therefore, differences between monozygotic and dizygotic twin pairs are
interpreted as being due to genetic differences. To identify the particular genes associated
with these disorders, genome-wide association studies (GWAS) have been employed, in
which genetic variation is compared between cases with the disease and matched controls. A
GWAS can provide large amounts of genetic information as they can analyse the entire
genome (more than 500,000 SNPs) using chip-based genotyping (Lawrence et al., 2005).
These large studies have revealed that schizophrenia and bipolar disorder are complex genetic
disorders, with a considerable genetic overlap (Cardno and Owen, 2014). Importantly, not
only one but multiple genetic variants, together with environmental interactions predispose
individuals to these disorders (Purcell et al., 2009). Thus, schizophrenia and bipolar disorder
are known as polygenic illnesses, with each ‘risk’ SNP increasing the susceptibility to a
disorder by a small fraction. To date, variants involved in calcium neuronal signalling,
neuronal development and signal transduction have been implicated (Consortium, 2011,
Group, 2011, Ripke et al., 2013).
The new field of genetic imaging has rapidly expanded over the past decade and is being used
to understand how these genetic variants are influencing downstream biological functions,
which may lead to clinical phenotypes. In psychiatric genetic imaging, genetic and brain
imaging data are combined to study psychiatric illness. The approach aims to understand
more about the biological effects of genes by using a quantitative imaging measure as an
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intermediate phenotype (endophenotype) that lies in between the genetic and clinical
phenotype pathway (Flint and Munafò, 2007). Although the imaging endophenotype cannot
explain the effects of variants at a cellular level it can identify effects at a functional circuit
level. The idea is that the endophenotype lies closer to the genetic variant, so is more
sensitive to the consequential biological effects than the clinical phenotype. In principle, the
endophenotype is also less genetically complex than the clinical phenotype and so should
reduce the sample size needed to identify specific genetic effects. In order to be accepted as
an endophenotype, the measure must meet certain criteria: be stable over time, heritable and
occur in the patient and unaffected family member more frequently than in the general
population (Gottesman and Gould, 2003).
Figure 1.10: The concept of genetic imaging to help link genes with microcircuitry and
behaviour.
At present, two main genetic imaging approaches that use endophenotypes exist: a candidate
gene approach and a GWAS approach (Amos et al., 2011). A candidate gene approach
investigates the effect of a specific SNP on an imaging measure and the SNP is chosen based
on a biological hypothesis from prior knowledge. The advantage of this approach is that it has
high statistical power but it does not discover new genes that may be involved in the disorder
and is vulnerable to false positive findings. In comparison, a GWAS approach is unbiased
and investigates the influence of the entire genome on the imaging measure. A GWAS can
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identify new genes that may be implicated in the disease even if their function is unknown.
However, this method has low statistical power due to the number of independent tests and
requires large sample sizes. To combat the issue of low statistical power in GWAS but still
test the effect of multiple SNPs, a new approach using polygenic risk scores has been
implemented. This method pools together the effects of common genetic risk variants with
small effects and weights them by their effect size (Dudbridge, 2013).
So far, candidate gene approaches have been the main method used in genetic imaging and
have produced some promising results implicating variants in the COMT, BDNF, CACNA1C
gene on functional measures (Prathikanti and Weinberger, 2005). For example, individuals
with a risk variant in the CACNA1C gene (important for calcium signalling) which has been
strongly associated with bipolar disorder, schizophrenia and unipolar depression through
GWAS, show reduced hippocampal and subgenual cingulate gyrus activation during an
episodic memory task (Erk et al., 2010). Importantly, these findings have recently been
independently replicated (Erk et al., 2014) and suggest that the CACNA1C risk variant has
functional effects in the hippocampus and prefrontal cortex that may explain symptoms
shared across psychosis-affective disorders. This means that following further understanding
and specifics, CACNA1C could be a potential new drug target.
1.5.1 Impact of Genetic Variation on Gamma Frequency and GABA
Brain oscillations across all the main frequency bands have been proposed as potential
endophenotypes, as they are highly heritable and are altered in psychiatric disorders (van
Beijsterveldt et al., 1996, van Beijsterveldt and van Baal, 2002). For the context of this thesis,
studies have shown that gamma oscillations in both the auditory and visual domain could be
useful endophenotypes (Hall et al., 2011b, Hong et al., 2004, van Pelt et al., 2012).
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Essentially, these studies have shown that gamma oscillations present biologically relevant
and stable measures and that dysfunctions in these measures are present in both patients and
their relatives. A vital study has recently shown that the peak frequency of visual gamma
oscillations is highly heritable (van Pelt et al., 2012). This suggests that individual variation
in peak gamma frequency has a strong underlying genetic component and has been the main
driving factor to investigate the effect of genetic variation on visual peak gamma frequency in
this thesis. Coinciding with this, GABA concentration has also been proposed as a potential
endophenotype (Hasler and Northoff, 2011) and individual differences in GABA may also be
primarily genetically determined. Thus, another aim of this thesis was to use a candidate and
whole gene approach to explore if genetic variation in GABAergic genes could explain
individual differences in visual gamma peak frequency and occipital GABA levels in a large
group of healthy controls. In addition, the association between schizophrenia polygenic risk
scores and gamma peak frequency and GABA were investigated. Understanding which
genetic variants underlie individual differences in visual gamma frequency and GABA could
help explain more specifically which components of the biological pathway are involved in
these measures and the consequential behavioural differences they influence.
1.6 Outline of Thesis Chapters
This thesis uses structural MRI, MRS and MEG information, as well as genetic data to
answer several important questions explained above. Chapter 2 provides details on these
imaging methods and the data analysis used in this thesis. Chapter 3 is the first experimental
chapter and explores the relationship between visual gamma oscillations, occipital GABA
and V1 structural properties in a cohort of 100 healthy individuals. Specifically, individual
differences in occipital GABA, V1 thickness and surface area are used to explain individual
differences in visual gamma peak frequency. This cohort was part of a large genetic imaging
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study, named ‘100 Brains’, in which individuals were ‘GWASed’, giving us a wealth of
genetic data to relate to our imaging phenotypes. Hence, Chapter 4 looks at the effect of
genetic variants known to be involved in GABAergic pathways on occipital GABA and
visual gamma peak frequency. Chapter 5 investigates group differences between healthy
controls and SABP individuals in visual gamma oscillatory measures, occipital GABA and
V1 structural measures. Chapter 6 investigates individual differences in auditory peak gamma
responses and whether these can be explained by individual differences in the structural
properties of the auditory cortex. This chapter also determines if peak gamma responses
obtained in the auditory cortex share a relationship with visual peak gamma responses.
Lastly, Chapter 7 discusses the experimental findings of Chapters 3 to 6 and their
implications.
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Chapter 2 - Methods
This chapter describes the main principles behind the three imaging modalities MRI, MRS
and MEG. In addition, the analysis methods used in this thesis to obtain quantitative imaging
data from these imaging modalities are described.
2.1 Magnetic Resonance Imaging
The concept of Magnetic Resonance Imaging (MRI) originated over 35 years ago (Lauterbur,
1989, Mansfield and Maudsley, 1977) and since its discovery, this in vivo imaging technique
has been widely applied in the clinic for diagnosis and research purposes (Symms et al.,
2004). MRI can be divided into two fundamental types, known as structural MRI and
functional MRI. Structural MRI provides static anatomical information whereas functional
MRI provides physiological information based on cerebral blood flow. This section focuses
on the principles behind MRI and its application for acquiring structural MRI data.
An MRI image is essentially based on information about protons, which are highly abundant
in the human body. These protons have a positive electrical charge that is constantly moving
because they possess a spin. The moving electrical charge (electrical current) induces a
magnetic field, meaning that each proton has its own magnetic field. Normally, protons
within the body are randomly spinning (precessing) on their axis but when an individual is
placed in the magnetic field of the MRI scanner (an external magnetic field), the protons
align themselves to the field in a parallel or anti-parallel direction. This results in protons
precessing around the direction of the magnetic field, either pointing with or against the
external field. The speed at which the protons are precessing (precession frequency) is an
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important component that is calculated using the Larmor equation and is a product of the
strength of the external magnetic field (B0) and the gyromagnetic ratio (g) (Storey, 2006).
The parallel and anti-parallel alignments that protons take once placed in the MRI field have
different energy levels and more protons go to the lower energy level that is parallel to the
external magnetic field (Figure 2.1A). This results in the individual having a sum
magnetisation that is longitudinal to the external magnetic field (Figure 2.1B). However, as
this longitudinal magnetisation is in the same direction as the external magnetic field, its
strength cannot be measured directly and so magnetisation at an angle perpendicular to the
external magnetic field is required, known as transverse magnetisation. To induce transverse
magnetisation a radio frequency (RF) pulse that is at the same frequency as the precession
frequency of the protons is sent to the body. This has two resulting effects on the protons:
firstly, some protons gain energy and move into the higher energy level that is antiparallel to
the external field. This decreases longitudinal magnetisation. Secondly, the protons precess in
phase (in the same direction and at the same time) in the transverse plane, which establishes a
new transverse magnetisation (Figure 2.1C). A radiofrequency pulse that causes the
magnetisation to move 90⁰ (from longitudinal to transversal) is known as a 90⁰ RF pulse.
Importantly, it is this sum of transverse magnetisation that is detected by the receiver coil of
the MRI and forms the basis of the MRI signal.
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Figure 2.1 A) Shows the typical parallel and antiparallel alignment taken by protons once
they are placed in the external magnetic field. As more protons go to the parallel direction,
this results in bulk magnetisation in the longitudinal direction (B). Once the 90⁰RF pulse is
added, longitudinal magnetisation decreases and the protons are in phase, causing transversal
magnetisation (C). Image adapted from http://www.medscape.com/viewarticle/780917_3.
Once the RF pulse is switched off protons gradually lose their energy to the surrounding
tissue (lattice) and return to the parallel alignment, causing longitudinal magnetisation to go
back to its original strength. This longitudinal relaxation time is described by the time
constant T1, which is the time it takes for 63% of the original longitudinal magnetisation to
be reached. Importantly, T1 is affected by the composition of the lattice, so that surroundings
with high water content/liquids have a longer T1 compared to surroundings with a higher fat
content. This difference in T1 based on tissue composition arises because water molecules
have a high Larmor frequency, making it difficult for protons to transfer their energy to the
lattice. The loss of the RF pulse also causes protons to dephase, meaning that the transversal
magnetisation is lost (transversal relaxation). Transversal relaxation is described by the time
constant T2, when transversal magnetisation decreases to 37% of its original value. In
comparison to T1, T2 is primarily affected by variations in the magnetic fields of
A B C
32
neighbouring protons (spin-spin interactions). Tissues with a high amount of water
molecules/liquids have fast local magnetic fields and no large net differences in magnetic
fields, meaning that protons stay in phase for longer and thus have a long T2. In comparison,
tissues with larger fatty molecules have bigger magnetic fields causing differences in local
magnetic fields and results in a short T2. Therefore, a key aspect of T1 and T2 is that they
allow us to differentiate between tissues, based on their molecular content and surroundings.
This means that in the brain we can differentiate between white matter, grey matter and CSF
using T1 and T2 data. An image that contrasts between tissues based on T1 data is a T1-
weighted image whereas one that distinguishes between tissues based on T2 data is T2-
weighted.
As well as being affected by spin-spin interactions T2 can be affected by inhomogeneities in
the external magnetic field. The combination of these two inhomogeneities (T2* effects)
causes a gradual decrease in the transverse magnetic field and the corresponding signal is
known as free induction decay (FID). Thus, a typical FID signal initially has a large increase
in signal due to the transverse magnetic field and an associated decrease by T2* that shapes
the signal sent to the receiving coil of the MRI. To combat the loss of signal caused by the
inhomogeneity in the external magnetic field, a certain amount of time after the 90⁰ pulse
(TE/2), a 180⁰ pulse is applied to the protons. The pulse results in an increase in signal due to
rephasing of the protons and is called a spin echo.
Ultimately, MRI protocols use spin-echo sequences that consist of repeated 90⁰ and 180⁰ RF
pulses. During MRI acquisition, certain parameters of the sequence are modified in order to
produce the required signal and desired image. For example, changing the time in between
the 90⁰ pulse and the echo (TE) can increase or decrease the difference in signal due to
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differences in the T2 of tissues. Having a long TE means that differences in amplitude
between tissues can be detected as they will have had enough time to develop differences in
T2*. This long TE creates a good contrast between tissues and a more T2-weighted image.
However, the TE must not be too long otherwise the amplitude of the signal will be too low,
creating a ‘noisy’ image.
Figure 2.2: A plot showing that tissue B has a shorter T2 time than tissue A. Using a long TE
time allows this difference in T2 to be more distinct by allowing enough time for a larger
contrast in signal intensity to be measured. Image adapted from
http://www.medscape.com/viewarticle/780917_3.
In contrast, if a more T1-weighted image is required then the parameter TR (time to repeat
the 90⁰ pulses) is altered. Having a short TR means that differences in T1 between tissues can
be detected as both tissues will not have had enough time to fully recover to their original
longitudinal magnetisation.
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Figure 2.3: A plot showing the advantage of using a short TR for distinguishing between two
tissues that differ in T1 time. Image adapted from
http://www.medscape.com/viewarticle/780917_3.
Another concept of MRI image acquisition is the need of spatial information in order to
examine a particular slice and then locate where the signals are arising from within that slice.
To locate a particular slice a gradient magnetic field is applied via gradient coils. This
induces a linear gradient of Larmor frequencies across the individual’s body in the applied
direction. Next, a RF pulse with the same frequency as that of the Larmor frequency within
the slice of interest is applied. This results in an MRI signal only being created from this
specific section. The thickness of the slice can also be selected by varying the steepness of
the gradient field or the bandwidth of the RF pulse.
Subsequently, to determine where the signals are originating from within the slice of interest
two more gradient fields are applied, called a frequency encoding and phase encoding
gradient. The phase encoding gradient is applied first and this causes protons within a row or
column (depending on the selected gradient direction) to have a frequency gradient varying
from low to high. Once the gradient is turned off the protons return to the base frequency and
spin at the same rate but they are now out of phase with one another. Next, the frequency
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encoding gradient is applied orthogonally to the phase encoding gradient and induces a range
of Larmor frequencies within protons across columns or rows depending on the selected
gradient direction. Overall, the two types of gradient result in a range of signals that have a
unique characteristic based on their phase or frequency that can be localised in space. The
phase and frequency data is stored as a data matrix called K-space which is then converted
into an image using the Fourier transform (Gallagher et al., 2008). Thus, obtaining an MRI
image is a complex process that requires a combination of precisely timed RF pulses and
gradients to induce a set of characteristic signals that are interpreted mathematically to
construct a 2D or 3D image.
In this thesis optimised parameters using spin echo sequences, RF pulses and gradients as
described above are used to obtain T1-weighted images for three main purposes. One purpose
is to obtain structural properties of the primary visual cortex and auditory cortex including
surface area and thickness using FreeSurfer (Hinds et al., 2008). Secondly, the structural
image is used for locating a region of interest (occipital cortex) in which to measure GABA
levels using MRS. Thirdly, for co-registration purposes between MRI and MEG data, which
is detailed later in this methods chapter.
2.2 Magnetic Resonance Spectroscopy
The application of in vivo magnetic resonance spectroscopy (MRS) began in the early 1980s,
in parallel to the introduction of MRI (Bertholdo et al., 2013). MRS is based on similar
principles as MRI but instead of producing structural images provides physiological
information, by quantifying chemical metabolites. The particular usefulness of this
biochemical information has meant that MRS and MRI are commonly used in conjunction
with one another, such as for monitoring brain tumours and metabolic diseases. Importantly,
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MRS can detect subtle biochemical changes that may not be visible using structural MRI.
This has led to MRS being used in psychiatry research with the aim of further identifying
clinically relevant group differences in biochemical metabolites (Frangou and Williams,
1996, Stanley, 2002).
Proton MRS (1H-MRS) is the most commonly used technique as hydrogen has a high
magnetic sensitivity and is highly abundant in most metabolites. The main concept in MRS is
that of chemical shift, which relies on how protons act in their chemical environment within
the magnetic field of the MR scanner. As noted above, protons precess at a Larmor frequency
that is mainly dependent on the strength of the external magnetic field. Due to the relative
homogeneity of the external field the protons precess at relatively similar rates. However, the
protons do precess at slightly different rates due to differences in the surrounding local
magnetic fields that are produced by electrons. If the protons have a high electron density
around them, they resonate at a lower frequency as the electrons shield the proton from the
external magnetic field. This means that protons in different molecules and protons in the
same molecule but at different positions will have slightly different Larmor frequencies.
Essentially, it is the chemical structure of the molecule that determines the shift in frequency
and it is these chemical shifts that are plotted in a MRS spectra and allow us to identify and
quantify molecules. In a typical MRS plot, the horizontal axis shows the Larmor frequencies
(or chemical shift) in parts per million and the vertical axis shows the relative signal
amplitude in arbitrary units.
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Figure 2.4: A typical MRS spectrum showing the brain metabolites that can be detected and
their chemical shift frequencies. Image adapted from (Puts and Edden, 2012).
Although the human brain contains hundreds of metabolites, a typical MRS spectrum only
displays the amounts of certain brain metabolites (Figure 2.4). This is because MRS can only
detect a few of them as they need to be in at least milli-molar concentrations in order to be
detected. This means that many neurotransmitters cannot be detected. The major brain
metabolites that are detected are N-acetyl aspartate (NAA), creatine (Cr), choline (Cho),
myo-inositol (Myo), glutamate (Glu), glutamine (Gln) and GABA. Another feature of the
MR spectrum is that some metabolites have several peaks instead of one single peak. This is
due to the phenomenon of J-coupling or spin-spin coupling. J-coupling arises when protons
within a metabolite are found in different chemical groups, meaning that they have slightly
different local magnetic fields and resulting spin frequencies.
Typically, MRS data is collected following the acquisition of anatomical images so that a
region of interest can be selected. The spectrum can either be obtained from a single voxel
Frequency (ppm)
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(SVS) or multiple voxels, known as magnetic resonance spectroscopic imaging (MRSI).
Normally, a single voxel is used as this is a more robust technique that provides a better
signal to noise ratio. This means that placing the voxel of interest is a crucial step as only one
spectrum is obtained using SVS. To obtain 1H-MR SVS data, two types of pulse sequences
can be used: a Point Resolved Excitation Spin echo sequence (PRESS) or a stimulated echo
acquisition mode (STEAM) (Storey, 2006, van der Graaf, 2010). PRESS uses sequences of
one 90⁰ excitatory RF pulse followed by two 180⁰ refocusing pulses, with the spectral data
being obtained from the spin echo after the second 180⁰ pulse (see figure below). In contrast,
STEAM uses sequences of three consecutive 90⁰ RF pulses and the spectral data is obtained
from a stimulated echo. The stimulated echo has a lower amplitude than the spin echo,
meaning that the PRESS method has a better signal to noise ratio. For both methods, each
pulse is delivered across a different plane (x, y or z) so that spatial selectivity is acquired in
each direction (Figure 2.5)
Figure 2.5: Outline of the acquisition method for PRESS. The 90⁰-180⁰-180⁰ RF pulse is
delivered with each RF in a separate orthogonal direction to obtain a 3D voxel in the region
of interest. ADC denotes when the spectral data is acquired. Image taken from (Storey, 2006).
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To make sure that the acquired signal is specific to the voxel of interest, spoiler gradients are
added to dephase protons and reduce the signal from areas surrounding the region of interest.
In addition, the large water signal is suppressed to enable the smaller signals from
metabolites of interest to be detected. Lastly, the resulting signals are analysed by Fourier
transform to obtain the frequency data and plot the spectrum.
2.2.1 GABA Acquired MRS
Measuring in vivo GABA levels via MRS is more difficult than measuring conventional
metabolites such as NAA and Cr. Even so, studies measuring MRS GABA are steadily
increasing as more accurate and reliable methods are being developed (Puts and Edden,
2012). GABA is particularly difficult to measure due to three main reasons. Firstly, it is
found at a relatively low concentration of 1mM/mm³ in the human brain, compared to
concentrations of about 10mM/mm³ for NAA and 7mM/mm³ for Cr (Henriksen, 1995, Puts
and Edden, 2012). Secondly, the chemical structure of GABA means that it produces signals
between 1.8-3.1ppm, which are overlapped by the stronger signals originating from NAA, Cr
and Glx (glutamate and glutamine) (Figure 2.6). Lastly, J-coupling is present between spins
at 3ppm and 1.9ppm, causing a smaller signal and a broader frequency shift.
40
Figure 2.6: The chemical structure of GABA and its MR spectrum. GABA produces three
separate signals along the frequency spectrum due to its three methylene groups. The large Cr
signal at 3ppm overlays that of the GABA signal at 3ppm. Image taken from (Puts and
Edden, 2012).
To overcome problems of specificity and sensitivity of GABA measures, particular spectral
editing methods can be applied. The most common spectral editing method used for detecting
GABA uses a pulse sequence called MEGA-PRESS (Mescher et al., 1998, Mullins et al.,
2014). This method separates GABA signals at 3ppm from overlying Cr signals based on the
J coupling between signals at 3ppm and 1.9ppm. Two distinct spectra are measured. For
acquiring the first spectrum, a frequency-selective pulse that directly affects signals at
1.9ppm is applied (known as ‘ON’ spectrum). The pulse also has an indirect effect on signals
at 3ppm due to coupling. As signals from other metabolites at 3ppm are not coupled to those
at 1.9ppm the pulse only affects GABA signals at 3ppm. The second spectrum is collected
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using a normal PRESS sequence, without the editing pulse (known as ‘OFF’ spectrum) and is
subtracted from the ON spectrum. The resulting difference spectrum allows the residual
GABA signals at 3ppm to be quantified. This MEGA-PRESS technique has been used for
measuring GABA levels in a number of brain areas, including occipital, motor, temporal and
frontal regions (O'Gorman et al., 2011, Puts et al., 2011, Shaw et al., 2013). In the visual and
sensorimotor cortex, GABA measurements using MEGA-PRESS have been shown to be
highly repeatable and sensitive enough to detect inter-individual variation (Evans et al.,
2010). Therefore, experiments in Chapter 3, 4 and 5 of this thesis used the MEGA-PRESS
sequence to accurately measure GABA levels in a single voxel of the occipital cortex.
To quantify the GABA peak at 3ppm from the edited spectra, the CUBRIC Gannet analysis
pipeline was used (www.gabamrs.blogspot.co.uk). This fits the GABA peak with a single
Gaussian model to estimate the area under the peak. This raw GABA measure is an arbitrary
value that depends on several factors such as the distance between the coils and the head, and
the temperature of the scanner. To remove these factors, the GABA value is calculated
relative to a known concentration reference, such as Cr or water. Cr has the advantage of
being acquired during the MEGA-PRESS scan whereas the water measurement is normally
acquired at the end of the scan and so is more susceptible to motion effects. However, water
has a higher signal to noise ratio. Thus, both references are commonly used in experiments.
The benefit of using the Gannet pipeline is that GABA values are reported using both Cr and
water as references. One last factor that must be taken into consideration is that GABA
concentration differs depending on the tissue type; CSF has low GABA concentrations in
comparison to tissue. Similarly, water visibility in H20, grey matter and white matter also
differ. Thus, GABA estimates need to account for differences in voxel composition. In this
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thesis, MRS GABA values were corrected for tissue composition using  estimates of grey
matter, white matter and CSF from the FSL tool, FAST (Zhang et al., 2001).
Although the MRS-GABA methods described above have been dramatically improved since
being first implemented, several limitations must also be pointed out. For example, MRS
GABA spectra are acquired from relatively large voxels (3cm x 3cm x 3cm) due to GABA’s
low SNR. This means that MRS measures ‘bulk’ GABA concentration as it cannot
distinguish between different pools of GABA, such as vesicular, cytoplasmic or extracellular
GABA (Stagg et al., 2011b). Therefore, how MRS GABA levels relate to these individual
pools is still unknown. In addition, the GABA signal at 3ppm is also made up of signals from
macromolecules. This is because j-editing also picks up the macromolecule spins that are
coupled to spins at 1.7ppm. These macromolecules make up around 50% of the GABA signal
and so GABA is often described as GABA+. Even though these limitations are present, MRS
GABA levels have been shown to correlate with behaviourally relevant measures that are
functionally specific to the cortical region studied (Boy et al., 2010, Stagg et al., 2011a,
Sumner et al., 2010). These findings suggest that MRS is obtaining measures that are relevant
to the effects produced by the synaptic activity of GABA.
2.3 Magnetoencephalography
Magnetoencephalography (MEG) is also a relatively recent non-invasive imaging modality,
with the first magnetic signals being measured from the human brain in 1968 (Cohen, 1968).
The advantage of using MEG is that it measures direct neural activity with a high temporal
resolution. The neural activity arises from the summation of postsynaptic currents in the
dendrites of pyramidal cells and it is these postsynaptic currents that produce measurable
magnetic fields outside the brain (Okada, 1989). The magnetic fields are generated by
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pyramidal cells in layers 3, 4, 5 and 6 of the cortex and are extremely small. However, as
pyramidal cells are orientated in the same way, this allows the fields to summate in the same
direction. Even so, simultaneous activity from at least 100,000 cells needs to occur in order to
detect a measurable signal. As the magnetic fields are so small, the MEG system is also
placed in a magnetically shielded room to avoid the signals being contaminated with the
stronger environmental magnetic noise.
Special sensors called magnetometers and gradiometers are used to measure the amount of
magnetic field passing through their conducting coil, known as the magnetic flux.
Magnetometers measure the magnetic flux through a single coil whereas gradiometers
measure the difference in magnetic flux between at least two coils. Using this set up of two
coils means that gradiometers are efficient at suppressing environmental noise. As both coils
equally pick up environmental noise (as they are relatively at the same distance from the
noise) the unwanted noise is removed when the difference in magnetic flux is measured
between the two coils. Due to this efficient environmental suppression, MEG systems are
typically made up of gradiometers. Gradiometers can also be subdivided into axial and planar
based on their orientation with the scalp. Axial gradiometers are aligned orthogonally to the
scalp (one above the other), while planar gradiometers have two pick up coils in the same
plane (next to each other). Magnetic fields described in this thesis were obtained using a CTF
275-channel axial gradiometer system.
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Figure 2.7: Orientation of axial and planar gradiometers to measure the magnetic fields
produced by synchronised post synaptic currents in pyramidal cells. Image taken from
http://www.hindawi.com/journals/cin/2009/656092/fig3/.
Importantly, the magnetic flux induces electrical currents in the coils of the gradiometers
which are transferred to super conducting quantum interface device (SQUIDS) to further
amplify the signal (Vrba and Robinson, 2001). The signals are then digitised and analysed by
computer systems. Once these signals have been detected externally (in sensor-space), the
source producing the signals in the brain needs to be identified (in source-space) – this is
known as the inverse problem. Although the magnetic field generated by a known
configuration of sources within the head can easily be calculated – the so-called forward
problem - there is insufficient information in the external MEG measurements to uniquely
solve the inverse problem. As an infinite number of different sources could explain the
observed magnetic fields, the inverse problem is known as an ill-posed problem.  In order to
solve the inverse problem, different kinds of a prior information can be used and thus
different solutions (Barnes et al., 2006). Although several methods are available for solving
the inverse problem, two main methods known as equivalent current dipole (ECD) modelling
and beamforming will be described.
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ECD modelling is one of the most common and simple source estimation techniques. The
technique assumes that the magnetic fields measured by the MEG sensors can be explained
by a single dipole (small patch of activated cortex). An initial guess about the location,
orientation and amplitude of the dipole is made and then these parameters are adjusted until
the magnetic field generated by this simulated dipole best fits the measured magnetic fields.
If the single dipole does not fit the data well then multiple dipoles can be used, with each
dipole having their parameters needing adjusting. ECD modelling is typically used for
estimating the source of evoked responses. As this thesis is primarily focused on oscillatory
activity from induced responses, another technique called beamforming was used.
Beamforming does not manipulate parameters of the source (location, orientation and
amplitude) in order to explain the measured field. Instead, the technique estimates the output
of a source at a particular location in the voxel of the brain. This is known as spatial filtering,
in which the signal at a particular source is measured, while signals from other locations are
suppressed. The spatial filtering is achieved by selectively weighting how much each sensor
contributes to the overall beamformer output. These weights are estimated using an analysis
of the data covariance matrix (Hillebrand and Barnes, 2005).
Figure 2.8: Concept of beamforming in MEG. The signal at a particular location is calculated
by multiplying the signal from a particular MEG sensor (m1) by a weighting factor (w1). This
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means that only the signal from the location of interest will contribute to the beamformer
output while signals from other unwanted areas will be attenuated. Image taken from
(Hillebrand and Barnes, 2005).
Synthetic aperture magnetometry (SAM) is a novel beamforming approach that assumes the
signal is produced from several distinct dipoles and that these sources are uncorrelated in
time (Robinson and Vrba, 1999). A major advantage of using SAM is that it can be
performed on selected time windows and frequency bands of interest. Thus, at a particular
location of interest, responses to a stimulus can be identified at a specific moment in time and
across a particular frequency band. This has led to SAM being widely adopted in the MEG
community and has proven successful for analysing MEG data in sensory domains such as
the visual, auditory and motor cortex (Brookes et al., 2011, Fawcett et al., 2004, Gaetz et al.,
2009, Herdman et al., 2003). Due to the ease and efficiency of SAM this approach was used
in this thesis to obtain the time and frequency profiles of the evoked and induced activity
from the visual cortex.
Due to the latter assumption of SAM, in which sources are presumed uncorrelated in time, it
cannot accurately detect temporally correlated sources (such as bilateral auditory sources) as
the signals cancel each other out. This is why evoked responses which have very short
durations and are therefore more likely to be correlated in time are not usually localised using
SAM. Therefore, to measure the auditory evoked steady-state responses in this thesis, rather
than using a source space analysis, a sensor space approach was used. For sensor space
analysis, the sensor that elicited the strongest response following presentation of the auditory
response was selected and subsequent time-frequency analysis was performed on the data
acquired from this single sensor.
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It is usually desirable to map source-localised MEG activity onto the individual’s anatomical
MRI scan. This is done by placing three electromagnetic head coils at the nasion and left and
right preauricular points on the individual (fiducial markers). This enables the location of the
coils, and thus the location of the participant’s head, inside the dewar to be determined. The
locations of the fiducial points are then marked onto the MRI image to enable coregistration
between the MEG data and MRI image. Once SAM has been performed on the selected time
window and frequency band and has been coregistered with the structural brain scan, an
activity map across different voxels can be seen. From this map the voxel with the ‘peak
response’ across these parameters can be selected so that a ‘virtual sensor’ is placed at this
location.
2.3.1 Analysis of Induced, Evoked and Steady-State Activity
To view the response profile of the electrophysiological signal at the virtual sensor from
source space or the real sensor from sensor space, time-frequency analysis is performed. This
results in a time-frequency spectra in which amplitude changes (increases or decreases)
across the selected time and frequency domains can be viewed (Figure 2.9). Within the time-
frequency spectra, three main types of activity can be measured; evoked, induced and steady-
state responses. Evoked responses are phase-and time-locked to the stimulus. They are
detected by averaging the signal across a number of individual trials. This analysis produces
an event-related potential or event-related field potential (ERP/ERF). If desired, this average
response can be taken forward for time-frequency analysis of the evoked oscillatory response.
Induced responses are not phase locked to the stimulus and so time-frequency analysis needs
to be performed on a single trial basis. This is because averaging across trials would cancel
out the induced responses as they have essentially random phase on each trial. The time-
frequency representation of each individual trial is then averaged to reveal the induced
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oscillatory responses. Steady-state responses are produced following presentation of a
repeated stimulus, in which the frequency of the response is the same as that of the stimulus.
These responses are normally analysed in the same way as evoked responses by averaging
across trials as they are deemed to be phase locked to the repetitive stimulus.
Figure 2.9: Spectra acquired from a time-frequency analysis of evoked, induced and steady-
state responses. a) shows a continuous steady-state stimulus at a frequency of 20Hz and the
resulting continuous 20Hz response in a MEG recording and in a time-frequency spectra. b)
shows the phase locking in evoked and non-phase locking from induced responses in
individual trials and their amplitudes in the time-frequency spectra. Image taken from
(Uhlhaas and Singer, 2010).
Different components of the evoked, induced and steady-state response can be analysed. The
most common parameter studied for all three types is the amplitude of the response.
Experiments in this thesis looked at the amplitude of the induced and evoked response to a
visual stimulus (Chapter 3 and 5) and the amplitude of the steady-state potential in response
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to a repetitive auditory stimulus (Chapter 6). Another measure is the degree of phase locking,
known as the phase locking factor (PLF). PLF measures the variance of phase across single
trials and ranges from 0 (random distribution) to 1 (perfect phase locking). Lastly, the peak
frequency (the frequency at which the largest amplitude is recorded) can be analysed. This
thesis measures the peak frequency of the induced response following a visual stimulus and
the peak frequency of an auditory steady-state response (Chapter 3, 5 and 6). Given the
different profiles of evoked and induced activity they are thought to reflect different aspects
of information processing. Evoked responses are thought to reflect bottom up sensory
processing whereas induced oscillations may be involved in higher cognitive functions.
However, these presumptions must be interpreted with caution as many different measures
(such as those described above) within the response itself can be obtained.
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Chapter 3 - Investigating the Influence of GABA and the
Structural Properties of V1 on Inter-individual Variability in
Peak Gamma Frequency
3.1 Abstract
Background: Determining the factors driving individual variability in visual gamma peak
frequency will ultimately help us understand differences in visual perception in both health
and disease. Previous studies have indicated that the neurochemical MRS GABA measure
and the structural measures of the thickness and surface area of the primary visual cortex
(V1) may influence individual variability in visual gamma frequency. However, these
findings have not been replicated in larger independent studies. Hence, this study aims to
investigate the influence of these structural and neurochemical measures on visual gamma
peak frequency in a large homogenous cohort.
Methods: Visual gamma peak frequency, GABA+, V1 surface area and V1 thickness
measures were obtained from a homogenous group of 100 healthy individuals who
participated in a genetic imaging study, called ‘100 Brains’.
Results: Correlational analyses revealed no significant associations between any of the
variables studied (GABA+, V1 surface area, V1 thickness) with peak gamma frequency
(p=0.690, p=0.640,p=0.108, respectively).
Conclusion: These findings contradict previous studies that have found positive associations
between GABA+, V1 surface area and V1 thickness on peak gamma frequency. As these
variables are influenced by age, previous positive associations may have been driven by a
mutual influence of age. This is supported by other independent studies in which once the
effect of age is removed, the variables no longer correlate and further highlights the
importance of using large homogenous cohorts. Further investigation using large sample sizes
is needed to determine the factor(s) driving individual variability in visual gamma frequency.
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3.2 Introduction
The structural and neurochemical properties of the visual system are known to vary widely
across individuals (Dougherty et al., 2003, Puts and Edden, 2012). The exact significance of
this variation is unknown but emerging research suggests that inter-individual differences in
the visual system are functionally important and may shape our visual perception (Edden et
al., 2009, Kanai and Rees, 2011, Schwarzkopf et al., 2011, Song et al., 2013). For example,
Schwarzkopf et al. (2011) found that variation in the effective connectivity of the human
primary visual cortex determines variability in orientation perception (Schwarzkopf et al.,
2011). Thus, further understanding the factors that determine functional variation may help us
explain individual differences in the perception of our environment.
Investigating the factors underlying individual differences in gamma oscillations (30-100Hz)
has been of particular interest in the physiology research field. This is because these high
frequency oscillations are found in many cortical areas, have been implicated in sensory and
cognitive processing (Başar, 2013, Engel et al., 2001, Ward, 2003) and are altered in disease
(Başar and Güntekin, 2008, Uhlhaas and Singer, 2010). In the visual cortex, sustained
narrow-band gamma oscillations (30-80Hz) can be elicited using visual gratings (Adjamian et
al., 2004, Hoogenboom et al., 2006, Muthukumaraswamy et al., 2010, Swettenham et al.,
2009) and have been implicated in the encoding of stimulus features as they are modulated by
stimulus orientation (Koelewijn et al., 2011), size , contrast (Hall et al., 2005) and
eccentricity (van Pelt and Fries, 2013). Importantly, the two main parameters of the visual
gamma response, peak gamma frequency and peak gamma power show inter-individual
variation that is stable and repeatable over time (Adjamian et al., 2004, Hoogenboom et al.,
2006, Muthukumaraswamy et al., 2010, Swettenham et al., 2009). Although the majority of
studies have investigated the amplitude/power of visual gamma oscillations, peak frequency
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is an equally important measure and has been shown to be functionally important as it is
negatively correlated with orientation discrimination thresholds (Edden et al., 2009). The
exact factor/s driving the inter-individual variability in peak gamma frequency are unknown
but recent evidence suggests that these factors are under genetic control (van Pelt et al.,
2012).
Neurophysiological studies and computational models suggest that gamma oscillations are
generated via reciprocally connected interneuron and pyramidal cell assemblies (Buzsaki and
Wang, 2012, Traub et al., 1997, Whittington et al., 2011). In particular, the inhibitory drive
from parvalbumin containing fast-spiking basket cells in layers 2-6 appears to be vital for
generating cortical gamma oscillations (Cardin et al., 2009). In support of this, the visual
gamma measures peak power and peak frequency are modulated by the balance between this
inhibitory and excitatory network and are affected by parameters such as its
excitation/inhibition ratio, strength and time constants (Brunel and Wang, 2003). The
dependency of visual gamma parameters on the cortical excitatory and inhibitory balance led
to the investigation of the influence of the inhibitory neurotransmitter GABA on visual
gamma parameters using neuroimaging. This provided in vivo evidence for the primary
involvement of GABAergic transmission in gamma generation, as visual gamma peak
frequency measured using MEG was shown to positively correlate with MRS resting
occipital GABA+ (Muthukumaraswamy et al., 2009). This finding was explained as those
individuals with higher levels of GABA+ having increased inhibition, which decreases the
excitation/inhibition ratio, resulting in higher peak frequencies. Following this, the structural
parameters of V1, cortical thickness (Gaetz et al., 2012, Muthukumaraswamy et al., 2010)
and V1 surface area (Schwarzkopf et al., 2012) were also shown to positively correlate with
peak gamma frequency.
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The positive association between cortical thickness and gamma frequency can be explained
by the possible effect of thickness on the excitatory/inhibitory balance. Cortical thickness is
thought to reflect the density of neuronal and glial cells within the radial columns of the
cortex (Rakic, 1988). This density of neurons is determined during development and depends
on the number of neurogenic progenitors in these units that proliferate or generate neurons
(Pontious et al., 2008). Therefore, variability in cortical thickness may have downstream
effects on the number of neurons and hence the excitatory/inhibitory balance. For example, if
an individual has a thicker cortex, this may be due to a larger number of neurons and as V1
has a high number of GABAergic inhibitory neurons (Hendry et al., 1987) this could
potentially lead to increased GABA levels and hence a higher peak gamma frequency.
In comparison, the positive correlation between V1 surface area and visual gamma frequency
was proposed to be due to the homogeneity of factors such as the cytoarchitecture and
receptor density within the V1 radial columns (Schwarzkopf et al., 2012). Participants with a
larger V1 were proposed to have a more homogenous functional architecture, where the local
connections travel shorter distances, leading to local pools oscillating at similar frequencies
and hence a higher peak frequency. These differences in lateral connectivity could also alter
gamma frequency indirectly by affecting the GABAergic/glutamatergic balance of the cortex.
Overall, these studies suggest that variability in occipital GABA+, V1 cortical thickness and
V1 surface area may influence variability in visual gamma peak frequency. However, as
cortical thickness and surface area may not influence peak gamma directly but indirectly via
GABAergic transmission, the effect of these variables must be interpreted with caution as
they may be mutually correlated and not entirely independent. Furthermore, these
correlations have been demonstrated in small sample sizes and have failed to be replicated in
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independent studies (Perry et al., 2013, Shaw et al., 2013) or in a larger sample size (Cousijn
et al., 2014). Using a retrospective, pooled analysis of data from CUBRIC (n=46), Robson et
al. (2012) found cortical thickness and GABA+ to weakly positively correlate with peak
frequency. However, when age was accounted for these correlations were no longer
significant and age was left as the only determinate factor of peak frequency, explaining 13%
of the variance (Robson, 2012). As cortical thickness (Salat et al., 2004), surface area
(Hogstrom et al., 2013), GABA+ (Bigal et al., 2008) and peak gamma frequency (Gaetz et
al., 2012) are found to decrease with age it was suggested that previous correlations between
these measures may have been driven by their mutual relationship with age. Thus, age is an
important factor that should be taken into account when assessing the effect of these variables
on gamma measures.
However, a potential weakness of this pooled study was that not all MEG and MRS data was
collected using identical experimental/acquisition parameters. To further investigate the
relationship between visual gamma peak frequency, GABA+, thickness and surface area,
these measures were therefore obtained in a large homogeneous cohort of 100 healthy
individuals that were part of a large genetic imaging study called ‘100 Brains’. Identical
experimental protocols were used for each individual. The aim was to keep the sample
homogenous in order to reduce potential confounds such as age. This allowed us to determine
whether inter-individual differences in visual gamma peak frequency are influenced by inter-
individual differences in occipital GABA+, V1 cortical thickness and/or V1 surface area.
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3.3 Methods
3.3.1 Participants
100 healthy individuals with normal or corrected vision (with MRI/MEG compatible lenses)
took part in the study. As this study was part of a large genetic imaging project (called 100
Brains), variance from non-genetic factors needed to be minimised so a group homogenous in
age, ethnicity, education and handedness were required. This led to nine participants being
excluded; one due to not fully completing the study, another due to previously undocumented
medication, another due to left-handedness, four that were genetically identified as
population outliers (non-Caucasian) and two that were identified as age outliers. This meant
we had a homogenous group of 91 individuals (33 males and 58 females) aged between 19-
34 (mean 23.5, SD 3.4) that were healthy, right-handed, Caucasian and had all completed or
were currently completing a degree. Right-handedness was determined by the Edinburgh
Inventory (Oldfield, 1971). Mental well-being was screened using the 12-Item General
Health Questionnaire (GHQ-12), with additional questions including a history of excessive
drug or alcohol use and any regular medications. All participants gave written informed
consent to participate.
3.3.2 MEG Stimulus
The visual task was one of six MEG paradigms that all participants completed. The visual
stimulus consisted of a stationary, vertical, square-wave grating with maximum contrast, and
a spatial frequency of 3 cycles per degree. Stimuli were presented on a mean luminance
background with a red central fixation point (Figure 1), using a Mitsubishi Diamond Pro
2070 monitor (1,024 × 768 pixels and 100Hz frame rate).  Participants were instructed to
fixate on the central fixation point and to press a button once the grating disappeared. The
grating was presented for 1.5-2s and participants were given 0.75s for their button press
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response. If a response was late or no response was obtained a warning would be presented.
Following the response period, only the red fixation point was presented for 2s. The visual
session contained 100 trials and took ~10 minutes to complete.
Figure 1: The visual grating stimulus used in the study
3.3.3 MEG Acquisition
Whole-head MEG data was acquired on a CTF 275-channel radial gradiometer system. Three
of the 275 channels were turned off due to excessive sensor noise. An additional 29 reference
channels were recorded for noise cancellation purposes and the primary sensors were
analysed as third-order gradients (Vrba and Robinson, 2001). Three electromagnetic head
coils were placed onto participants at fixed distances from their anatomical landmarks (nasion
and pre-auriculars) and were localised relative to the MEG system before and after each
session to localise the head. Subjects were seated upright in the magnetically shielded room.
Each dataset was epoched offline -2 to 2s around stimulus onset. Individual trials were
visually inspected for data quality and those with large signal artefacts such as head
movements, muscle clenching and eye blinks were removed from further analysis. From the
91 datasets, on average 10.4% (SD 10.9, range 0-51%) of the 100 trials were removed.
Source localisation was calculated using synthetic aperture magnetometry (SAM) (Robinson
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and Vrba, 1999).  For each participant, a global covariance matrix was calculated for the
gamma band (30-70Hz) and beamformer weights were computed for the entire brain at 4mm
isotropic voxel resolution (Robinson and Vrba, 1999).
Student-t images to reveal source increases were calculated using a baseline period of -1.5s to
0s and a stimulation period of 0 to 1.5s. Using these images, for each participant, their
strongest increase in the gamma band was located and a virtual sensor was placed at this
location. To reveal the time-frequency response at this location, the virtual sensor was
repeatedly band-pass filtered between 1 and 100Hz at 0.5Hz frequency step intervals with an
8Hz bandpass, 3rd order Butterworth filter (Le Van Quyen et al., 2001). The Hilbert transform
was used to obtain the amplitude envelope at each frequency step, resulting in time-frequency
spectra. Spectra were computed as a percentage change from the mean baseline amplitude.
From these spectra the peak amplitude and peak frequency were extracted in the sustained
(0.3 to 1.5s) response (Swettenham et al., 2009).
3.3.4 MRI Acquisition
Magnetic Resonance (MR) data was acquired on a 3T General Electric HDx MRI scanner
with an 8-channel receive-only head coil. A high resolution T1-weighted anatomical image
(FSPGR) with 1-mm isotropic resolution (TE/TR/inversion time = 2.98/7.8/450msec, flip
angle =20⁰) was obtained for each participant. Using these anatomical images, the occipital
voxel (3cm x 3cm x 3cm) was placed in each subject (Figure 3A and 3B). The voxel was
placed bilaterally in the occipital cortex to include both hemispheres with the lower edge of
the voxel aligned to the superior border of the cerebellum and the anterior edge aligned with
the parieto-occipital sulcus. GABA spectra were acquired using a MEGA-PRESS sequence
(TE=68ms, TR=18s, 332 transients of 4096 datapoints and 16msec editing pulses applied at
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1.9 parts/million (ppm) (ON) and 7.5 ppm (OFF). In addition, 8 transients were acquired
without water suppression. The acquisition time for the T1 weighted scan took ~9 minutes
and the GABA spectrum acquisition took ~12 minutes. MEG and MRI/MRS data were
usually collected on different days.
GABA analysis was carried out with the in-house software Gannet, a batch-analysis tool for
GABA-edited MRS data (http://gabamrs.blogspot.co.uk/). The GABA peak at 3.0ppm in the
difference edited spectrum was fitted with a single Gaussian model. GABA values obtained
from the Gaussian model fit are described as GABA+, as the GABA signal at 3ppm is likely
to contain a co-edited macromolecular signal (Henry et al., 2001). GABA+ concentrations
were quantified using both creatine (GABA+/Cr) and water (GABA+/H20) as an internal
concentration reference. For the reported GABA+/H20 values, the ratio of GABA+ to water
was converted to institutional units (IU) by correcting for the voxel tissue fraction (grey
matter and white matter) and the effective visibility of water. Grey matter, white matter and
CSF fraction were determined using FAST (Zhang et al., 2001). Both creatine and water
were used as reference molecules to ensure the reliability of the findings and that they were
not due to using a particular reference molecule.
3.3.5 V1 Structural Properties
FreeSurfer was used to estimate the cortical thickness and surface area of V1 for each
participant from their 3D FSPGR scan. FreeSurfer is an automated technique and identifies
the calcarine sulcus and curvature heuristics to estimate the location of V1 and is a validated
technique (Hinds et al., 2008). As the visual stimulus was presented on the full visual field,
estimates of V1 surface area and thickness were calculated by averaging the right and left
hemisphere.
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3.3.6 Statistical Analysis
Correlations between GABA+ concentration, peak gamma frequency and V1 structural
parameters (surface area and thickness) were carried out using the Pearson correlation
coefficients (r) in SPSS 20.
3.4 Results
3.4.1 Visual Gamma Responses
Following presentation of the visual grating, all except one of the participants showed a clear
source increase in the visual gamma band (30-70Hz) that was localised to the primary visual
cortex (Figure 2 (A)). This participant was excluded from further analysis. Figure 2B displays
the grand-averaged time-frequency analysis of the virtual sensor at the group and individual
level. The time-frequency spectra reveal the typical response morphology that is obtained
using this type of visual stimulus (Swettenham et al., 2009). Initially, a transient broadband
gamma response (0-0.3s) occurs, followed by a sustained narrow gamma band response (0.3-
1.5s) that remains for the duration of the stimulus. In the lower frequency bands, there is an
early evoked response and a reduction of power in the alpha band. The main variable of
interest for this study, peak gamma frequency (30-70Hz) was extracted from the sustained
response (0.3-1.5s). Upon visual inspection of the time-frequency analysis, 13 of the 90
individuals displayed no clear gamma peak and were excluded from further analysis. Many of
these 13 participants were excluded because they displayed 2 peaks within the 30-70Hz range
and this made it difficult to distinguish a single peak. Thus, a total of 78 participants are
included in the data analyses. Peak gamma frequency in the 78 participants ranged from 41.5-
64.5Hz (mean 53.2 (SD=4.8)) which is consistent with previous studies
(Muthukumaraswamy et al., 2010). The variability in peak gamma frequency between
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individuals can be seen in Figure 2B and 2C; participant 1 has a low gamma band frequency
(48.5Hz) compared to participant 2 with a high gamma band frequency (61.5Hz).
Figure 2: (A) Source localisation maps for increases in the gamma band (30-70Hz) for the
group average (n=78) and 2 single participants. Images share the same scaling and units are
student t values. (B)  Grand-averaged time-frequency spectra for the group average and 2
individual participants. Spectra share the same scaling and units are % change from baseline.
(C) Power-frequency plots showing the peak gamma frequency obtained from the sustained
time window (0.3-1.5s).
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3.4.2 Occipital GABA+ Quantification
From the 91 participants, four participants were excluded; 2 had no data available, 1 had bad
quality spectra upon visual inspection and 1 was identified as an outlier (1 for GABA+/Cr
and 1 different participant for GABA+/H20). Thus, 87 participants are included in the data for
both GABA+/Cr and GABA+/H20 values. All 87 participants showed a clear resolved GABA
peak at 3ppm that was well modelled by a Gaussian fit. Figure 3C shows the edited MRS
spectra for 2 single participants.
Figure 3: (A+B) Representative occipital voxel locations from 1 participant in (A) the
horizontal plane and (B) the sagittal plane. (C) Representative edited MRS spectra for 2
single participants. The Gaussian-shaped GABA signal is visible at 3ppm and a co-edited Glx
(glutamate and glutamine) peak is visible at 3.75ppm.
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3.4.3 V1 Structural Parameters
FreeSurfer analysis of V1 calculated surface areas and cortical thickness for all participants.
One participant had a cortical thickness measure that was identified as an outlier, and so was
excluded from further analysis.
3.4.4 Descriptive Statistics
The descriptive statistics for the variables of interest are shown in Table 1. The variables
were normally distributed apart from age which was positively skewed (+1.03).
Table 1: Descriptive statistics for the main variables of interest
Number of
participants
Minimum-Maximum Mean SD
Sustained Peak Gamma
Frequency (0.3 to 1.5s) (Hz)
78 41.5-64.5 53.2 4.8
Age (years) 91 19-34 23.5 3.4
V1 Cortical Thickness (mm) 90 1.65-2.26 1.93 0.14
V1 Surface Area (cm2) 91 1697.5-3318.0 2406.6 360.3
Occipital GABA+/Cr 87 0.10-0.22 0.16 0.02
Occipital GABA+/H20 (IU) 87 1.18-2.44 1.75 0.24
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Figure 4: Sorted plots to show the distribution of the variables of interest.
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3.4.5 Correlational Analysis
Table 2: Correlations between peak gamma frequency and the structural measures: cortical
thickness and surface area and the neurochemical measure: GABA+.
Peak Gamma
Frequency
Age Cortical
Thickness
Surface
Area
GABA+/Cr GABA+/H20
(IU)
Peak Gamma
Frequency
1
Age n = 78
R = -0.115
p = 0.317
1
Cortical
Thickness
n = 78
R = -0.183
p = 0.108
n = 90
R = -0.014
p = 0.898
1
Surface Area n = 78
R = -0.054
p = 0.640
n = 91
R = -0.246
p = 0.019
1
GABA+/Cr n = 74
R = -0.047
p = 0.690
n = 87
R = -0.020
p = 0.857
1
GABA+/H20
(IU)
n=74
R=0.023
p=0.847
n=87
R=0.053
p=0.625
1
No significant correlations were found between peak gamma frequency and the structural
parameters of V1 (cortical thickness and surface area) or the neurochemical measure,
GABA+ (Table 2 and Figure 5A). To ensure that the lack of correlation between gamma
frequency and GABA+/Cr was not due to using creatine as a reference, a correlational
analysis was carried out using H20 as a reference but this also produced no significant
association (R=0.023, p=0.847). As age has previously been found to be a determining factor
of peak gamma frequency (Gaetz et al., 2012) correlational analysis was performed on these
two variables but no such correlation was found in this dataset (Figure 5B). Age also showed
no association with cortical thickness or GABA+ as previously reported but did negatively
correlate with surface area (Figure 5B). As age was negatively correlated with surface area a
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partial correlation between gamma frequency and surface area (accounting for age) was
performed, to ensure that a possible correlation between gamma frequency and surface area
was not masked by the age effects on surface area. Gamma frequency still showed no
association with V1 surface area (R=-0.86, p = 0.458). Peak gamma power (% change from
baseline) was also not associated with any of the four parameters tested (cortical thickness
R=-0.011, p =0.927; surface area R=-0.060, p=0.612; GABA+/Cr R=0.150, p=0.212;
GABA+/H20 R=0.063, p =0.599).
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Figure 5: Scatterplots with best fit linear regression lines to investigate associations between
(A) peak gamma frequency with V1 thickness, V1 area and GABA+ (B) Age and peak
gamma frequency and V1 area.
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3.5 Discussion
Aiming to build upon previous studies indicating that inter-individual variability in peak
gamma frequency is determined by variability in the structural parameters of V1
(Muthukumaraswamy et al., 2010, Schwarzkopf et al., 2012) and occipital GABA+
(Muthukumaraswamy et al., 2009), we investigated these associations in a large sample size
of 100 healthy individuals. No correlations were found between peak gamma frequency and
any of the three imaging parameters: V1 thickness, V1 surface area or GABA+ (using either
creatine or water as a reference). This null finding between peak gamma frequency and
GABA+ is contrary to Muthukumaraswamy et al. (2009), who found that in 12 healthy male
subjects, peak gamma frequency was positively correlated with GABA+ (R=0.68, p<0.02).
These opposing findings should not be due to differences in acquisition, as both used similar
stimuli and analysis methods to quantify gamma and GABA+. The only two main
methodological differences between the studies are the difference in size of the visual grating
and the difference in gender ratio of participants. A full field grating stimulus (4 quadrants)
was used in this study rather than a single quadrant grating in the lower left visual field.
However, this should not have affected the results as the size of the grating has not been
found to affect peak gamma frequency (Perry et al., 2013). In fact, using a full field stimulus
is more optimal as it produces a larger gamma response, which makes the peak gamma
frequency measure more easily identifiable and robust. In terms of possible gender effects,
this study had a gender ratio of 33 males: 58 females compared to all male participants.
However, partial correlations (accounting for gender) also revealed no associations between
gamma frequency and GABA+ or V1 structural measures. Thus, using the results from this
study with a larger sample size would suggest that with the current imaging methods, peak
gamma frequency and GABA+ do not correlate. This null finding is also supported by recent
studies in our group and others that have used larger sample sizes (Cousijn et al., 2014,
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Robson, 2012, Shaw et al., 2013). Together, these findings highlight the importance of using
large sample sizes and identical experimental parameters.
Given the experimental and modelling evidence supporting the dependence of gamma
frequency on inhibitory transmission (Sohal et al., 2009), the lack of correlation between
peak gamma frequency and GABA+ may depend on several factors. Firstly, the exact
inhibitory components that GABA+ measurements reflect are not clear. As MRS GABA+ is
quantified from a relatively large voxel size (3cm x 3cm x 3cm) the measure is likely to be
combining GABA from different pools, including cytoplasmic GABA, vesicular GABA and
free extracellular GABA (Stagg et al., 2011b). In addition, GABA+ typically contains a 50%
macromolecule contribution, making the measure less specific to GABA (Near et al., 2011).
Therefore, the resting MRS GABA+ quantification in this study is unlikely to reflect the
specific GABAergic activity that may be most relevant to the generation of gamma
oscillations such as that of parvalbumin cells. This lack of specificity may account for the
lack of replication between GABA+ and gamma frequency and may need to be improved
before consistent findings are reported.
Secondly, gamma frequency is determined not only by inhibitory transmission but by the
balance between excitatory and inhibitory transmission in a complex neuronal and glial
network (Buzsaki and Wang, 2012). However, measures of excitatory transmission through
MRS Glx (a combined measure of glutamate and glutamine) have failed to find an
association with gamma frequency or gamma power (Cousijn et al., 2014,
Muthukumaraswamy et al., 2009). Thus, individual measures of GABA+ and Glx may not be
reflecting the overall balance of the neural network and so measures that take into account
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both excitatory and inhibitory transmission may be more appropriate to investigate their
effect on gamma frequency.
The complex relationship between gamma band activity and GABA/glutamate is supported
by MEG pharmacological studies that modulate GABAergic and glutamatergic transmission.
Increasing endogenous GABA levels with tiagabine (blocks the GABA transporter 1 (GAT-
1)) does not affect gamma frequency or the power of the response (Muthukumaraswamy et
al., 2013). In contrast, decreasing the excitability but increasing the inhibition of the visual
cortex with alcohol (blocks the NMDAR and is a GABAAR agonist) decreases the peak
frequency of the response but increases the power of the response (Campbell et al., 2014).
Furthermore, propofol (a GABAAR agonist) had no effect on frequency but increased the
power of the response (Saxena et al., 2013). These findings suggest that in the visual cortex,
peak gamma frequency is more sensitive to modifications of specific components of the
GABAergic and glutamatergic network. Further pharmacological studies are needed in order
to identify the specific components of the GABAergic and glutamatergic system that
influence the generation and maintenance of gamma oscillations.
In addition, no correlation was found between peak gamma frequency and the structural
parameters of V1: thickness and surface area. This null finding between V1 surface area and
peak gamma frequency contradicts that of Schwarzkopf et al. (2012) who found a positive
correlation between peak gamma frequency and V1 surface area in a small cohort of 16
healthy participants (Spearman’s p: Rs=0.63, p= 0.011). A possible explanation for this
discrepancy could be due to the different methods used to delineate V1. In this study
FreeSurfer was used to estimate the whole surface area of V1 whereas Schwarzkopf et al.
(2012) determined the central surface area of V1 (includes about 50% of V1) using
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functional retinotopic mapping. Therefore, the two methods may not be representing the same
proportions of V1 surface area, accounting for the different results. In support of the null
finding in this study, other studies using the same FreeSurfer analysis to estimate V1 surface
area have found no associations between peak gamma frequency and V1 surface area
(Muthukumaraswamy et al., 2010, Perry et al., 2013). Further independent studies using
functional retinotopic mapping to define V1 will need to be conducted in order to verify the
findings of Schwarzkopf et al. (2012) and determine whether this functional method is more
applicable.
No relationship between peak gamma frequency and V1 thickness was found, inconsistent
with a previous study reporting a positive correlation between the two variables
(Muthukumaraswamy et al., 2010). However, this previously reported correlation was weak
(R=0.392, p =<0.05) and supporting the finding from this study, has failed to be replicated in
other studies (Perry et al., 2013).
Importantly, age did not correlate with peak gamma frequency, GABA+ or V1 thickness.
Although age was significantly negatively correlated with surface area, this association was
relatively weak. A moderately narrow age range was chosen for this study (19-34 years) in
order to reduce the effects of age on the variables of interest as they are affected by age and
thus the true relationship between the variables could be confounded by age. Interestingly, by
reducing possible age effects the findings of the lack of correlation between the three
variables surface area, thickness and GABA+ with gamma frequency coincide with the
overall conclusion of other studies. Using collective data from CUBRIC with an age range of
19-45 years, Robson et al. (2012) initially found GABA+ and V1 thickness to be associated
with peak gamma frequency. However, once age was accounted for, these associations no
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longer remained significant. Similarly, in a separate study, V1 thickness and peak frequency
have been found to correlate (R2=0.06,p=0.06) but after accounting for age, was no longer
associated (Gaetz et al., 2012). Therefore, previous correlations between GABA+ and gamma
frequency may have been driven by age rather than a true relationship with the two variables.
Overall, the structural and neurochemical measures investigated did not predict peak gamma
frequency. This finding is supported by recent studies (Cousijn et al., 2014, Shaw et al.,
2013). Even though none of the variables studied were found to influence peak gamma
frequency, the factors driving inter-individual variability in peak gamma frequency warrant
further investigation as they may help explain behavioural differences and differences in
health and disease. The recent finding that peak gamma frequency is strongly genetically
determined (van Pelt et al., 2012) suggests that factors which are genetically controlled (such
as structural and neurochemical parameters) present themselves as suitable factors to be
investigated.
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Chapter 4 - Effect of Genetic Variation in GAD1, the GABAAR
and Schizophrenia Polygenic Risk Scores on GABA+ and Gamma
Frequency
4.1 Abstract
Background: Combining genetic and neuroimaging information provides novel insights into
the link between genes, neurobiology and behaviour, in both healthy and disease states. The
neuroimaging measures occipital GABA+ and visual gamma peak frequency show inter-
individual variation that is behaviourally and clinically important but the factors driving this
variation are not clear. This study investigates the impact of genetic variants on GABA+ and
gamma frequency with the aim of further understanding the biological pathways involved in
these two measures and their implication in schizophrenia.
Methods: Neuroimaging data (occipital GABA+ and visual gamma frequency) and genome-
wide genotype data was obtained from a group of 100 healthy individuals who participated in
a large genetic imaging study. The effect of genetic variation on GABA+ and gamma
frequency was assessed in three ways: (1) testing the association between eight candidate
GAD1 SNPs with GABA+ and gamma frequency (2) testing the association between ten
candidate SNPs in genes encoding GABAAR subunits with GABA+ and gamma frequency
and (3) testing the association of schizophrenia polygenic risk scores with occipital GABA+
and gamma frequency.
Results: Three of the eight GAD1 SNPs (rs10432420, rs3749034 and rs2241165) showed an
association with occipital GABA+/Cr, in which individuals with the schizophrenia risk
associated SNP had lower GABA+/Cr levels. None of the eight GAD1 SNPs significantly
impacted gamma frequency and none of the GABAAR genes or polygenic risk scores showed
an association with either the GABA+ or gamma frequency measure.
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Conclusion: This study adds further support for the involvement of genetic variants within
GAD1 and in vivo GABA levels. Studies using larger sample sizes are needed to reinforce
these findings and to determine the genetic variants driving variability in visual gamma peak
frequency.
4.2 Introduction
Genetic imaging is an encouraging research field that studies how individual genetic
differences lead to differences in brain structure/function and behaviour (Linden, 2012). This
is providing novel insights into the biological mechanisms underlying neuroimaging
measures and how these are linked to behaviour and/or disease. Genetic imaging has been
widely applied in psychiatry, as psychiatric disorders have a strong genetic basis and the
neural mechanisms underlying these disorders are still poorly understood (Sullivan et al.,
2012). Most of these studies have employed a candidate approach, in which the impact of a
single genetic variant from a biologically relevant system is assessed (Meyer-Lindenberg,
2010b). While providing insights into the downstream effects of the genetic variant, the
usefulness of the single candidate approach for understanding psychiatric disorders as a
whole is not clear. This is because the combined effect from thousands of common genetic
variants, rather than from one single variant are thought to predispose individuals to
psychiatric disorders (Purcell et al., 2009). Thus, with the advent of efficient genome-wide
genotyping, the genome-wide association study (GWAS) approach is also being used. This
hypothesis-free method tests the impact of the entire genome on the neuroimaging measure
and has the potential for implicating new genetic variants and thus new biological pathways
(Potkin et al., 2009a). However, this method is limited by the need to correct for multiple
comparisons and so to reduce the problem of multiple testing but still incorporate the effects
of multiple genes, a new polygenic risk score approach has been devised (Purcell et al.,
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2009). The polygenic risk score reflects an aggregate measure of common variants that are
associated with the disorder of interest and tests for the effects of these risk alleles on the
imaging measure.
In the candidate gene, GWAS and polygenic risk score imaging approach, the structural or
functional brain imaging measure is used as an intermediate phenotype (endophenotype)
(Gottesman and Gould, 2003). The imaging phenotype is proposed to be closer to the
underlying biological etiology than the heterogeneous diagnosis of a psychiatric disorder.
This means that it should be easier to identify the genes underlying the disorder and the
method will have greater statistical power, so a smaller sample size is needed (Potkin et al.,
2009b).
The neuroimaging measures occipital GABA+ and visual gamma peak frequency are valid
endophenotypes in which to investigate how genetic variation influences their individual
variability. Visual gamma peak frequency is a stable and repeatable measure
(Muthukumaraswamy et al., 2010) that has recently been shown to be highly heritable via a
twin study (van Pelt et al., 2012) and visual gamma oscillations are often perturbed in
schizophrenia (Grützner et al., 2013, Sun et al., 2013, Tan et al., 2013). Similarly, occipital
MRS GABA+ is a measure that is repeatable over time (Near et al., 2014), under genetic
control (Hasler and Northoff, 2011) and altered in schizophrenia (Yoon et al., 2010). Thus,
assessing the impact of genetic variants on these two measures, will determine whether
genetic variants may be implicated in the downstream effects of individual variability in
GABA+ and gamma oscillatory activity, which may subsequently be important biomarkers
for schizophrenia. This study will also allow us to further disentangle the relationship
between these two neuroimaging measures by determining whether similar genetic variants
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produce similar effects on both. Three different approaches were used to test the impact of
genetic variation on individual differences in GABA+ and gamma peak frequency, two of
which are candidate gene approaches - investigating single nucleotide polymorphism (SNP)
and a gene-wide approach, and the third was a schizophrenia polygenic risk score approach.
The first approach assesses the impact of SNPs in glutamic acid decarboxylase 1 (GAD1) on
occipital GABA+ and visual gamma peak frequency. GAD1 is located on chromosome 2q31,
spans about 45kb and consists of 17 exons. Importantly, GAD1 encodes glutamic acid
decarboxylase 67 (GAD67), the major enzyme for synthesising cortical GABA by catalysing
glutamate to GABA. GABA can also be synthesised by the GAD65 enzyme (encoded by the
glutamic acid decarboxylase 2(GAD2) gene) but GAD2 is primarily activated in times of high
GABA demand (Martin et al., 1991). The importance of GAD1 in producing GABA has been
demonstrated via gene knockout studies, as GAD1 -/- mice have substantially reduced GABA
levels and die at birth (Asada et al., 1997). In contrast, GAD2 -/- mice showed no significant
difference in GABA levels and appeared healthy. Furthermore, genetic variation in GAD1 is
associated with in vivo MRS GABA+ levels (Marenco et al., 2010). The effect of GAD1
SNPs on MRS GABA+ levels may be mediated via its effect on transcriptional regulation, as
GAD1 SNPs have been associated with GAD1 mRNA levels (Straub et al., 2007).
Establishing the effect of genetic variation in GAD1 on GABA+ and gamma frequency is
clinically relevant, as GAD1 SNPs have been associated with schizophrenia (Addington et
al., 2005, Du et al., 2008, Lundorf et al., 2005, Straub et al., 2007) and reduced GAD1
mRNA expression from post-mortem brain tissue is one of the most consistent findings in
schizophrenia individuals (Hashimoto et al., 2008, Thompson et al., 2009). In conjunction,
the GAD1 mRNA deficits are especially pronounced in parvalbumin neurons (Curley et al.,
2011, Hashimoto et al., 2003), an interneuron cell-type that is specifically important for
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gamma activity (Sohal et al., 2009). Therefore, investigating the effects of genetic variations
within GAD1 is biologically valid for both GABA+ and gamma.
The second approach assesses the contribution of genetic variation in genes encoding
GABAA receptor (GABAAR) subunits on GABA+ and gamma frequency. GABAAR are the
major inhibitory receptors in the central nervous system (CNS) and mediate the fast
neurotransmission of GABA in the CNS. The receptors are ligand-gated chloride ion
channels and are made up of five subunits, each of which has several isoforms (α1–6, β1–3,
γ1–3, δ, ϵ, θ, and π) (Barnard et al., 1998, Olsen and Sieghart, 2008). Most receptors consist
of 2 α’s, 2 β’s and 1 γ subunit. The genes for these three main receptor subunit types (α, β and
γ) cluster in three chromosomal regions, on chromosome 4, 5 and 15. Variants from these
three subunit genes (GABRG1, GABRA2, GABRA4, GABRB1, GABRB2, GABRA1, GABRG2,
GABRB3, GABRA5 and GABRG3) have been chosen for this analysis. Differences in the
subunit composition affect the functional properties and pharmacology of the receptor (Olsen
and Sieghart, 2009). Therefore, SNPs in these subunits may also alter the functionality and
pharmacology of the receptor, leading to changes in GABA and gamma activity. Variation in
the function of the GABAAR is particularly relevant in the context of gamma oscillations as
gamma activity relies on the fast activation and kinetics of the GABAAR (Buzsaki and Wang,
2012, Whittington et al., 2011, Whittington et al., 1997). In addition, modulation of the
GABAAR via alcohol (an agonist of the GABAAR) decreases visual gamma peak frequency
(Campbell et al., 2014). In terms of clinical relevance, alterations in the expression of a range
of GABAAR subunits have been implicated in schizophrenia (Benham et al., 2014). Several
SNPs in the α and β subunit of the GABAAR have been associated with schizophrenia (Lo et
al., 2004, Petryshen et al., 2005) and these SNPs were hypothesised to be functionally
relevant in predisposing to schizophrenia as they affect GABAAR mRNA expression levels.
77
Whether variation in GABAAR subunit SNPs/genes consequently leads to alterations on in
vivo GABA levels and gamma oscillations has yet to be investigated.
Lastly, the third approach determines whether schizophrenia polygenic risk scores predict
GABA+ and gamma frequency. Schizophrenia polygenic risk scores were chosen as
GABAergic dysfunction is a well-known feature of schizophrenia (Gonzalez-Burgos et al.,
2010) and the polygenic score may reflect alterations in the GABAergic pathways. The
polygenic risk score approach is a relatively new concept but of the few reported studies, this
approach is providing promising results. For example, Walton et al. (2013) reported a
positive relationship between schizophrenia risk score and left DLPFC inefficiency during
working memory processing (Walton et al., 2013). In addition, Whally et al. (2012) found
bipolar affective disorder risk score to be associated with increased activation in limbic
regions during an executive processing task (Whalley et al., 2012).
Therefore, the aim of this study was to use three promising genetic imaging approaches to
provide novel insights into the link between genetic variants, variability in GABA+ and
gamma frequency and schizophrenia.
4.3 Methods:
4.3.1 Participants
The imaging and genetic data in this study was obtained from the homogenous group of 91
healthy participants (described in Chapter 3) that took part in the ‘100 Brains’ study. The 91
subjects consisted of 33 males and 58 females and were aged between 19-34 years (mean
23.5, SD 3.4). All subjects were healthy, Caucasian, right-handed and had completed or were
completing a university bachelor’s degree. All individuals were of Caucasian ethnicity
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because ethnic matching is vital in genetic imaging (Hariri and Weinberger, 2003). Out of the
91 participants, following imaging quality control procedures, GABA+ data was available for
87 participants and gamma frequency data for 78 participants (Chapter 3). Genetic data was
available for 87 of the 91 participants as one subject did not provide a saliva sample and three
were excluded due to low genotyping completeness.
4.3.2 Gamma Frequency and GABA+ Acquisition
Details of gamma frequency and GABA+ acquisition are provided in Chapter 3. Briefly,
participants viewed an optimised high-contrast square-wave grating to induce visual gamma
oscillations in the occipital cortex. Gamma band oscillations were localised to the visual
cortex using synthetic aperture magnetometry (SAM) (Robinson and Vrba, 1999) and a
virtual sensor was placed at the location of peak gamma activity. Time-frequency analysis
was performed using the Hilbert transform to create time- frequency spectra. From the
resulting spectra, the induced peak gamma frequency over the sustained time window (0-
1.5s) was obtained for each individual.
GABA+ was quantified in a 3cm x 3cm x 3cm voxel optimally placed in the occipital cortex.
GABA spectra were acquired using a MEGA-PRESS sequence and GABA+ was quantified
using GANNET (http://gabamrs.blogspot.co.uk/). The GABA peak at 3.0ppm in the
difference edited spectrum was fitted with a single Gaussian model. To reduce multiple
testing, analyses were conducted using GABA+ concentrations quantified using creatine as
an internal concentration reference as creatine has been shown to be more repeatable than
using water as the internal reference (Bogner et al., 2010). However, to ensure the reliability
of any significant findings for GABA+/creatine were not due to using creatine as a reference,
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post-hoc analysis using water as an internal reference (GABA+/H20 (IU)) was subsequently
tested.
4.3.3 Genotyping
Genomic DNA was obtained from saliva using Oragene OG-500 saliva kits. Genotyping was
performed using custom Illumina HumanCoreExome-24 BeadChip genotyping arrays which
contain 570,038 genetic variants (Illumina, Inc., San Diego, CA). Standard genotype quality
control (QC) procedures were implemented using PLINK v1.07 (Purcell et al., 2007).
Individuals were excluded for ambiguous sex, cryptic relatedness up to third degree relatives
ascertained using identity by descent, genotyping completeness less than 97%, and non-
European ethnicity admixture detected as outliers in iterative EIGENSTRAT analyses of an
LD-pruned dataset (Price et al., 2006). SNPs were excluded where the minor allele frequency
was less than 1%, if the call rate was less than 98% or if the χ2-test for Hardy-Weinberg
Equilibrium had a p-value less than 1 e-04. Individuals genotypes were imputed using the
pre-phasing/imputation stepwise approach implemented in IMPUTE2/SHAPEIT (Delaneau et
al., 2012, Howie et al., 2011) and 1000 Genomes (1000 Genomes haplotypes Phase I
integrated variant set release, December 2013) as the reference dataset. Details of the
subsequent acquisition and analysis for the three genetic approaches are detailed below.
4.3.4 Candidate SNP Approach
Following standard quality control of the genetic data, four GAD1 SNPs that were genotyped
using the Illumina chip remained for analysis: rs2241165, rs3828275, rs701492, rs16858988.
In addition, the genotypes for four GAD1 SNPs (rs1043240, rs1978340, rs3749034,
rs769390) that have previously been shown to impact GABA+ (Marenco et al., 2010) and/or
are associated with schizophrenia (Addington et al., 2005, Lundorf et al., 2005, Straub et al.,
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2007) were available through imputation with high quality scores (imputation quality more
than 0.9). Genotype imputation predicts the genotype for SNPs that are not directly
genotyped by using genetic data from those that are directly genotyped on the chip (Marchini
and Howie, 2010). Thus, a total of eight GAD1 SNPs were analysed. Although two pairs of
SNPs (rs2241165 and rs3749034; rs769390 and rs701492) were in strong linkage
disequilibrium (LD) (r2 >0.8), all SNPS were kept for analysis. The effect of these eight SNPs
on gene expression in the primary visual cortex was assessed using the brain eQTL Almanac
(Braineac) (Ramasamy et al., 2014). Braineac is a web-based resource that contains data from
134 healthy Caucasian post-mortem brains to determine whether a gene or SNP is operating
as an expression quantitative trait loci (eQTL), meaning altering the mRNA levels of the
gene. Detailed information for the eight SNPs is provided in Table 1.
Table 1. Summary of the Genotyped and Imputed GAD1 SNPs
dbSNP ID Base Position
on chromosome
21
Location
within
gene
Allele
(major/minor)
Schizophrenia
Risk
Associated
Allele
Effect of Risk
Associated
allele on mRNA
expression2
rs10432420 171660312 5’flanking G/A G G increased
expression
rs1978340 171670121 5’flanking G/A A A increased
expression
rs3749034 171673475 5’UTR G/A G G increased
expression
rs2241165 171678379 Intron 2 A/G A A increased
expression
rs3828275 171682740 Intron 3 G/A N/A A lowered
expression
rs769390 171693455 Intron 6 A/C C C increased
expression
rs701492 171702480 Intron 9 G/A N/A A increased
expression
rs16858988 171702960 Intron 10 G/A N/A A increased
expression
1Position According to National Center for Biotechnology Information (NCBI, September,
2014). 2For the three SNPs which have not been associated with schizophrenia the effect of
the minor allele on mRNA expression is reported.
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The effect of genetic variation in GAD1 on GABA+ and gamma frequency was tested with
linear regression analyses using an additive genetic model and a recessive genetic model
(post-hoc analysis) in PLINK (Table 2). The additive model assumes that for each copy of the
minor allele there is a uniform, linear increased impact on the phenotype. The recessive
model assumes that two copies of the minor allele are needed to alter the phenotype, so
individuals homozygous for the minor allele are compared to individuals homozygous for the
major allele and heterozygotes. A recessive model was performed for three SNPs post-hoc as
figures displaying GABA+ levels according to genotype group suggested a recessive effect
(Figure 1) and previous studies have shown GAD1 SNPs to have recessive effects (Marenco
et al., 2010). As age, gender and V1 structural parameters were not found to affect gamma
frequency in this dataset (Chapter 3) we did not need to co-vary for these variables. In
addition age, gender and GM fraction are not associated with GABA+ in this dataset and so
were not added as covariates in the linear regression analyses.
4.3.5 Aggregate SNP (gene-level) Approach
SNPs from the GABAAR subunit genes lying in clusters on chromosomes 4, 5 and 15 that
had been genotyped on the chip, in the 87 individuals were extracted for analysis. Genotype
data was available for 187 SNPs, which grouped onto ten GABAAR subunit genes (Table 3).
SNPs from all ten genes were included as all ten GABAAR subunit genes are highly
expressed in the occipital cortex. To assess the impact of these set of SNPs from the
GABAAR subunit gene on GABA+ and gamma frequency, a gene-based approach was
performed using a sequence kernel association test (SKAT) within the SKAT package (Wu et
al., 2010, Wu et al., 2011) in R (R Development Core Team, 2013). SKAT is a flexible test
for the joint effects of multiple SNPs in a region (gene) on a phenotype (Wu et al., 2011).
The test uses a multiple regression model to regress the phenotype on genetic variants in a
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region and on covariates. This allows for different variants to have different directions and
magnitude of effects, including no effects.
4.3.6 Polygenic Scoring Approach
Five individual polygenic schizophrenia risk scores were computed using the score function
in PLINK (Purcell et al., 2007). SNPs to include in the score were selected from the
Psychiatric GWAS Consortium (PGC2) database for schizophrenia (https://pgc.unc.edu/),
with a statistical threshold of P ≤0.5, P ≤0.3, P ≤0.1, P ≤0.01 and P ≤0.0001. The PGC2
schizophrenia database contains genome-wide genetic data for 36, 989 schizophrenia subjects
and 113,075 controls (Consortium, 2014). The polygenic score was calculated as the sum of
the number of susceptibility alleles weighted by the logarithm of the corresponding odds
ratios (ORs) from the schizophrenia case-controls study performed by PGC2. Linear
regressions were performed in SPSS by regressing the polygenic risk score against the
phenotypes GABA+ and gamma frequency.
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4.4 Results
4.4.1 Impact of Variation in GAD1 SNPs
Using the additive genetic model, variation in one SNP (rs2241165) was significantly
associated with GABA+/Cr levels (p=0.024) and two SNPs (rs10432420 and rs3749034)
showed a trend towards significance (p=0.057 and p=0.067, respectively, Table 2). Plotting
GABA levels by genotype group for these three SNPs suggested a recessive effect of the
minor allele on GABA+/Cr (Figure 1) and so post-hoc analysis with the recessive model was
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performed for these three SNPs. Rs10432420 was associated with GABA+/Cr under a
recessive model (p=1.58*10-4). Only the association between rs10432420 and GABA+/Cr
using the recessive model remained significant after correcting for multiple comparisons
(p<0.05). To ensure the findings were not due to using creatine as a reference, the effect of
genotype on GABA+/H20 values was also assessed. This revealed a similar direction of effect
of these three GAD1 SNPs on GABA+/H20 but was not significant using either the additive
or recessive model. Figure 1 shows the direction of effect on GABA+/Cr and GABA+/H20 by
genetic variation in these three GAD1 SNPs. None of the SNPs had a significant effect on
gamma frequency with the additive model (p>0.05, Table 2).
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Table 2: Effect of Variation in GAD1 SNPs on GABA+ and Gamma Frequency
Beta is the regression coefficient. Beta values are standardised to enable comparison across SNPs and across GABA+ and gamma frequency. SE
is the standard error of the Beta. P values are uncorrected for multiple comparisons (bold = p<0.05).
GABA+/Creatine GABA+/H20 Gamma Frequency
Additive Model Recessive Model Additive Model Recessive Model Additive Model
GAD1 SNP N Beta
(SE)
P Beta
(SE)
P Beta
(SE)
P Beta
(SE)
P N Beta
(SE)
P
rs10432420 80 0.214
(0.111)
0.057 0.410
(0.103)
1.58*10-4 0.103
(0.113)
0.366 0.172
(0.112)
0.129 73 -0.079
(0.118)
0.504
rs1978340 76 -0.039
(0.116)
0.738 70 0.037
(0.121)
0.760
rs3749034 82 0.203
(0.110)
0.067 0.255
(0.108)
0.021 0.114
(0.111)
0.309 0.075
(0.112)
0.505 76 -0.085
(0.116)
0.465
rs2241165 83 0.248
(0.108)
0.024 0.245
(0.108)
0.025 0.117
(0.110)
0.291 0.073
(0.111)
0.510 76 -0.086
(0.116)
0.460
rs3828275 83 -0.096
(0.111)
0.388 76 0.052
(0.116)
0.657
rs769390 78 -0.105
(0.114)
0.359 72 0.005
(0.120)
0.966
rs701492 83 -0.035
(0.111)
0.753 76 0.079
(0.116)
0.498
rs16858988 83 -0.050
(0.111)
0.651 76 -0.022
(0.116)
0.852
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Figure 1: Effect of GAD1 genotype on GABA+/Cr and GABA+/H20 for (A) rs10423420 (B)
rs3749034 and (C) rs2241165. Black lines represent the genotype group mean and standard
error of the mean.
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All three GAD1 SNPs show the same direction of effect on GABA+/Cr, in which individuals
with the schizophrenia risk associated allele, (G for rs10423420 and rs379034 and A for
rs2241165) have decreased levels of GABA+/Cr. Post-hoc analysis reveals a recessive effect
of the minor allele as individuals homozygous and heterozygous for the major allele (the risk
associated allele) have decreased levels of GABA+/Cr in comparison to the group
homozygous for the minor allele. For rs2241165, the A:A and G:A groups have decreased
levels of GABA+/Cr in comparison to the G:G genotype, for rs1043240, the G:G and A:G
groups have decreased GABA+/Cr in comparison to the A:A group and for rs3749034, the
G:G and A:G group have decreased levels of GABA+/Cr in comparison to the A:A
genotype. Although non-significant, a similar pattern can be seen for GABA+/H20, in which
individuals with the risk associated allele have lower GABA+/H20 levels.
4.4.2 Impact of Variation in GABAAR Subunit Genes
None of the 10 GABAAR subunit genes had a significant association with GABA+/Cr or
gamma frequency.
Table 3. Effect of GABAAR Subunit Genes on GABA+ and Gamma Frequency
Gene Chromosome GABAA
Receptor
Subunit
Number of
SNPs
GABA+/Cr
n=83
Gamma
Frequency
n=76
P P
GABRG1 4 γ1, gamma-1 5 0.578 0.468
GABRA2 4 α2, alpha-2 9 0.890 0.110
GABRA4 4 α4, alpha-4 5 0.465 0.407
GABRB1 4 β1, beta-1 30 0.446 0.349
GABRB2 5 β2, beta-2 14 0.323 0.606
GABRA1 5 α1, alpha-1 3 0.683 0.638
GABRG2 5 γ2, gamma-2 8 0.227 0.862
GABRB3 15 β3, beta-3 44 0.800 0.221
GABRA5 15 α5, alpha-5 5 0.626 0.096
GABRG3 15 γ3, gamma-3 64 0.477 0.984
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4.4.3 Impact of Schizophrenia Polygenic Risk Score
Schizophrenia polygenic risk score using any of the five training p-value thresholds was not
significantly associated with GABA+/Cr or gamma frequency.
Table 4 Effect of schizophrenia polygenic risk score on GABA+/Cr and gamma frequency.
Training SNP
threshold level1
Number of SNPs
included in
Schizophrenia
Risk Score
GABA+/Cr Gamma Frequency
R2 P R2 P
P ≤ 0.0001 914 0.004 0.579 0.021 0.209
P ≤ 0.01 6032 0.000 0.979 0.047 0.059
P ≤ 0.1 22263 0.007 0.467 0.036 0.099
P ≤ 0.3 43488 0.004 0.573 0.033 0.115
P ≤ 0.5 59226 0.003 0.626 0.028 0.146
1 Training SNP threshold level obtained from the PGC2 schizophrenia study.
4.5 Discussion
Three different genetic imaging approaches consisting of a candidate SNP approach with
GAD1 SNPs, a candidate gene-based approach with GABAAR genes and a schizophrenia
polygenic risk score approach were used to assess the influence of genetic variation on
occipital GABA+ and visual gamma peak frequency. The candidate SNP approach revealed
an association between three of the eight GAD1 SNPs and occipital GABA+/Cr (Table 2). As
all three SNPs are in strong or moderate LD with one another (r²>0.5), they may be reflecting
a common effect. Using the additive model, rs2241165 reached nominal statistical
significance (p=0.024) and rs10432420 and rs3749034 showed a strong trend towards
nominal significance (p=0.057 and p=0.067). Post-hoc analysis revealed that the minor A
allele for two of these SNPs (rs10432420 and rs3749034) may have recessive effects as the
recessive model increased the significance of the two SNPs from a strong trend to statistical
significance (p<0.05). This is in contrast to a previous study which found a recessive effect
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for the major G allele (associated with risk for schizophrenia) of rs3749034 on cortical
thickness in the left parahippocampal gyrus (PHG) (Brauns et al., 2013). The difference in
the A minor allele having recessive effects in this study rather than the G major allele in
Brauns et al. (2013) could be due to a number of differences between the two studies. Firstly,
the recessive effect was found in different imaging measures (GABA+/Cr vs cortical
thickness) and in different cortical areas (occipital vs PHG). Thus, major and minor alleles
may have opposing effects depending on the imaging measure or the region in which they are
obtained. Secondly, the differential findings could be due to the low number of individuals in
the homozygous minor A allele group in this study (n=3) leading to unreliable results.
To test the robustness of these GAD1 findings and ensure their specificity to GABA rather
than using creatine as a reference, the impact of these three significant SNPs on GABA+/H20
was also tested and although were not found to be significant, did reveal a similar pattern
(Figure 1). This discrepancy in results between using creatine and water as a reference
reflects the inherent ‘noise’ present in the GABA+ measure and highlights the small effects
of single genetic variants. However, as the effect of the three GAD1 SNPs show a similar
pattern with both measures, the results are still highly viable and require further investigation.
Encouragingly, the direction of effect of the risk associated alleles was as expected and was
present in all three SNPs. Individuals with the schizophrenia risk associated allele
(homozygous and heterozygous) had decreased GABA+/Cr levels in comparison to those
homozygous for the minor allele. This finding compliments the theory of decreased
GABAergic function in schizophrenia, due to findings of decreased GAD1 mRNA
(Thompson Ray et al., 2011), decreased GAD67 protein (Curley et al., 2011) and decreased
GABA levels (Yoon et al., 2010) in clinical schizophrenia populations. However, this clear
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directional effect of schizophrenia risk alleles leading to reduced GAD1 mRNA, GAD67
protein and GABA was not present in this study as the three significant risk associated alleles
reported here are associated with increased GAD1 mRNA expression in the occipital cortex
(Table 1). A pharmacological study supports this uncertain directional relationship between
these components as inhibition of GABA transaminase (enzyme that metabolises GABA)
increases cortical GABA levels but decreases GAD67 protein (Mason et al., 2001). The
reason for this dissociation between GAD67 protein and GABA could be due to GAD1
mRNA expression being activity regulated (Benson et al., 1994) and if GABA metabolism is
reduced (increases GABA) this could lead to decreased GAD1 expression and GAD67
protein. Conversely, as possible in this study if GAD1 mRNA and GAD67 protein is
increased, this could lead to decreased GABA levels. To add to this issue, this study was
performed in healthy individuals and thus the discrepancy between these variables could be
due to differences between healthy and schizophrenia individuals. Furthermore, measures
obtained from chronic schizophrenia patients can often be confounded by other factors such
as medication, difference in lifestyle and an increased prevalence of smoking, which may
lead to findings that are not directly specific to schizophrenia itself (Meyer-Lindenberg,
2010a, Tomelleri et al., 2009).
In contrast to our findings, the only other study to investigate genetic variation in GAD1 on
GABA+, reported two GAD1 schizophrenia risk associated SNPs to be associated with
increased MRS GABA levels in the anterior cingulate cortex of healthy individuals (Marenco
et al., 2010). This directional effect in the anterior cingulate cortex was unexpected and was
described as being due to a compensatory change following reduced GABA production. The
compensatory change was hypothesised to be due to excessive production of GABA by the
GAD65 enzyme (encoded by GAD2) or decreased catabolism by GABA transaminase. These
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are valid theories to explain the unexpected association between risk alleles and increased
GABA levels and highlight the fact that GABA levels do not solely depend on the activity of
GAD1 but a number of regulatory systems. The two significant GAD1 SNPs (rs1978340 and
rs769390) reported in Marenco et al. (2010) were also tested in this study and were not found
to be associated with occipital GABA levels. These contrasting findings, in terms of the
direction of effect and the difference in significant SNPs may be due to the difference in
cortical regions studied. SNP effects may be regional specific and compensatory mechanisms
may be more prevalent in certain cortical areas. Overall, these findings suggest a complex
interaction between the GAD1 gene, mRNA, protein, GABA and schizophrenia. However,
both this study and that of Marenco et al. (2010) do support the involvement of genetic
variation in GAD1 influencing the functional MRS GABA measure, which is clinically
important. Further studies will need to be performed in both healthy individuals and those
with schizophrenia to disentangle the complex links between these biological mechanisms.
Although the exact mechanisms by which the risk associated alleles alter occipital GABA+
levels are unknown, a strong hypothesis would be through their effect on gene expression as
all three SNPs were associated with changes in gene expression (Table 2). Supporting this,
the three SNPs with the strongest effect on gene expression also had the strongest effect on
GABA+ levels, suggesting a link between gene expression and the functional GABA+
measure. Importantly, these three GAD1 SNPs are not located in protein coding regions but
are in the regulatory elements of the gene. Therefore, they do not affect the amino acid
sequence of the protein but play an important role at the transcriptional and translational level
to control gene expression (Veyrieras et al., 2008). Rs10432420 is located in the 5’ flanking
region, a region that is not transcribed into mRNA but is important in the transcription
process as it contains the promoter, other enhancers and protein binding sites. Rs3749034 lies
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in the 5’ untranslated region (5’UTR) of GAD1, an area that is transcribed into mRNA and
may affect the efficiency of the transcription and translation process (Mignone et al., 2002).
Specifically, the risk associated G allele of rs3749034 causes the loss of two putative
transcription factor binding sites (the ATP1A1 regulatory element binding factor 6 and the
myoblast determining factor) which may disrupt GABAergic transmission (Addington et al.,
2005, Cherlyn et al., 2010). Rs2241165 is located in intron 2 and although introns are
removed during the transcription process to form mature mRNA, they can affect the initial
transcription of the gene, polyadenylation of the pre-mRNA and the decay of mRNA (Le Hir
et al., 2003, Nott et al., 2003). Therefore, these SNPs may affect gene expression through
their effect at various genetic stages including transcription, mRNA splicing,
polyadenylation, mRNA export, translational efficiency and mRNA decay. This finding of
regulatory elements affecting GABA+ reveals that these SNPs are functionally important and
is in keeping with the growing evidence that regulatory sequences play an important part in
psychiatric disorders (Cooper, 2010, Hindorff et al., 2009).
In comparison to the finding of an association between GAD1 SNPs and GABA+, no effect
of these SNPs was found on visual gamma peak frequency (Table 2). This suggests that
variation in GAD1 does not play a major role in determining peak gamma frequency.  As the
relationship between GAD1 and gamma may be weaker than that between GAD1 and GABA,
a larger sample size is needed to further explore this. The lack of association also adds further
evidence that in vivo GABA concentration estimates and gamma peak frequency are not as
strongly associated as previously thought (Chapter 3). However, there is still strong
experimental evidence for a prominent role of GABAergic function in the generation of
gamma oscillations (Buzsaki and Wang, 2012, Cardin et al., 2009, Chen et al., 2014). It may
be that genetic variants that influence the function of other components of the GABAergic
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system such as GAT-1, VGAT, GABAAR, GABABR or those involved in excitatory
neurotransmission have a stronger impact on gamma frequency.
The candidate gene approach which tested the effect of ten individual GABAAR subunit
genes by aggregating multiple SNPs found no significant relationship with either GABA+/Cr
or gamma frequency (Table 3). Even though no gene reached statistical significance an
interesting finding is that the two genes GABRA2 and GABRA5, which are closest to reaching
significance with gamma frequency have been strongly implicated in schizophrenia (Benham
et al., 2014). In addition, several SNPs in GABRA2 have been associated with alcohol
dependence and the frequency of beta oscillations (Edenberg et al., 2004). Alcohol is a
positive allosteric modulator of the GABAAR and has shown to decrease visual gamma peak
frequency (Campbell et al., 2014). Therefore, a common pathway linking variation in
GABRA2, alcohol and beta/gamma oscillations could be present. The significant effect of
these GABRA2 SNPs on alcohol dependence and beta oscillations was found by testing single
SNPs in comparison to the multiple SNP (gene) test used in this study. This highlights a
limitation of the whole gene measure test, as the gene as a whole may not exert significant
effects on GABA+ or gamma frequency, but the potential effects of single SNPs are masked.
Thus, investigation of genetic variants in GABAAR subunits, particularly on gamma
oscillatory measures warrants further investigation with larger sample sizes and using both a
candidate SNP and candidate gene approaches.
The schizophrenia polygenic risk score was also not associated with GABA+/Cr and gamma
frequency. As the polygenic risk score pools the effects of multiple variants with small
effects from different genes and thus different proteins and biological pathways this measure
may not be specific enough to biological pathways involved in GABA and visual gamma.
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Converging genetic evidence implicates common SNPs involved in the neuronal calcium
pathway to predispose individuals to schizophrenia (Ripke et al., 2013). Calcium is a
versatile intracellular signal that regulates many different cellular processes and is a vital
component of GABAergic signalling (Berridge et al., 2003, Higley, 2014). Even so, the
polygenic risk score may still not be specific enough to GABA and gamma and the functional
imaging measures of GABA+ and gamma frequency may not be sensitive enough to detect
effects of these genetic variants. Other studies that have found a functional influence of
polygenic risk scores use a more global imaging measure such as working memory (Walton
et al., 2013). Working memory may be a more appropriate schizophrenia endophenotype as it
is a core deficit of schizophrenia and may be under control by a large number of different
genes, including those involved in calcium signalling.
Overall, this study had several methodological strengths and limitations. The main strength
being that the study was conducted in a homogenous population in terms of age, ethnicity,
handedness, well-being and education. This greatly increased the likelihood of associations
between genetic variation and GABA+ or gamma frequency being specific to the genetic
variation and not other confounding variables. In addition, the imaging measures GABA+
and gamma frequency are highly repeatable (Muthukumaraswamy et al., 2010, Near et al.,
2014), which also provides confidence that significant genetic associations with GABA+ and
gamma frequency are reliable and replicable. The main limitation of this study is the sample
size, which although is large in terms of neuroimaging studies, is small in terms of genetic
studies. This meant that when individuals were grouped based on genotype, some genotype
groups had very small numbers, which questions the reliability of the findings. In particular,
the recessive effect of the three GAD1 SNPs (rs10432420, rs3749034 and rs2241165) on
GABA+/Cr are open to doubt as the homozygous minor allele group in all three SNPs only
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had three individuals (Figure 1). The study was also conducted in healthy controls which
although limits the effects of medication, means the results may not be directly translatable to
a schizophrenia population.
To conclude, this study provides strong evidence for three candidate GAD1 SNPs impacting
occipital GABA+ levels in a homogenous group of healthy Caucasian individuals. This adds
to the growing evidence that genetic variation in GAD1 is associated with downstream
functional effects on structural and neurochemical imaging measures (Brauns et al., 2013,
Marenco et al., 2010). In addition, GAD1 SNPs have been associated with schizophrenia
(Addington et al., 2005, Straub et al., 2007), in which altered GABAergic function has been
strongly implicated (Gonzalez-Burgos et al., 2011, Stan and Lewis, 2012). Thus, GAD1 SNPs
may play an important role in leading to the altered GABA levels observed in schizophrenia
patients, which may consequently lead to altered behaviour. In contrast, none of the three
genetic methods revealed an influence of genetic variation on gamma frequency. However,
this may be due to the sample size being too small to detect genetic effects as large sample
sizes are needed in genetic studies (Abbott, 2008). As visual gamma peak frequency has been
reported to be under strong genetic control (van Pelt et al., 2012), the genetic components
determining this measure require further investigation in a larger sample size. Ultimately, by
identifying the effects of genetic variants on clinically relevant biological measures this will
increase our understanding of the specific biological pathways affected in disease and may
lead to novel targeted treatment strategies.
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Chapter 5 - Visual Gamma Oscillations and Occipital GABA in
Schizoaffective Bipolar Disorder
This Chapter has been published as a peer-reviewed journal article: Brealy, J. A., et al.
(2014). Increased visual gamma power in schizoaffective bipolar disorder. Psychological
Medicine, 1–12.
5.1 Abstract
Background: EEG and MEG studies have identified alterations in gamma-band (30-80 Hz)
cortical activity in schizophrenia and mood disorders. MRS studies have also reported group
differences between psychiatric disorders and healthy controls for in vivo GABA levels.
These findings are consistent with neural models of disturbed glutamate and GABA neuron
influence over cortical pyramidal cells. Genetic evidence suggests specific deficits in GABAA
receptor (GABAAR) function in schizoaffective bipolar disorder (SABP), a clinical syndrome
with features of both bipolar disorder and schizophrenia. This study investigated gamma
oscillations and in vivo GABA+ levels in this under-researched disorder.
Methods: MEG was used to measure induced gamma and evoked responses to a visual
grating stimulus, known to be a potent inducer of primary visual gamma oscillations. MRS
was used to measure in vivo GABA+ levels from an occipital voxel. The GABA+ and gamma
band activity measurements were acquired from 15 individuals with remitted SABP, defined
using Research Diagnostic Criteria, and 22 age and sex matched healthy controls.
Results: Individuals with SABP demonstrated increased sustained visual cortical power in the
gamma band (t(35)=-2.56, p=0.015) compared with controls. There were no group
differences in baseline gamma power, transient or sustained gamma frequency, alpha band
responses or pattern onset visual evoked responses. There was also no group difference in
occipital GABA+ levels.
Conclusions: Gamma power is increased in remitted SABP, which reflects an abnormality in
the cortical inhibitory-excitatory balance. Although an interaction between gamma power and
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medication can not be ruled out, there were no group differences in baseline measures.
Further work is needed in other clinical populations and at risk relatives. Pharmaco-
magnetoencephalography studies will help to elucidate the specific GABA and glutamate
pathways affected.
5.2 Introduction
Schizoaffective bipolar disorder (SABP) is a mental illness characterised by manic and
depressive episodes typical of bipolar disorder and psychotic symptoms observed in
schizophrenia. SABP individuals have a distinctly poor prognosis compared with the wider
bipolar phenotype (Harrow et al., 2000). A genome-wide association study provided strong
genetic evidence for a selective influence of GABA-A receptor dysfunction in this
subpopulation of bipolar individuals (Craddock et al., 2010), which was recently
independently replicated (Breuer et al., 2011). Although these SNPs do not alter protein
sequence, they may affect the expression levels of GABA-A receptor subunits, which could
consequently affect the duration of inhibitory postsynaptic current onto pyramidal cells.
These genetic findings in SABP add to the increasing evidence of an abnormal glutamatergic/
GABAergic cortical balance in psychiatric disorders. Neuropathological evidence (Costa et
al., 2004, Lewis et al., 2012) suggests that there is a cortical GABA deficit in both bipolar
disorder and schizophrenia. Decreased levels of glutamic acid decarboxylase (GAD) 67
mRNA are consistently found in parvalbumin-positive interneurons, in multiple cortical
regions in schizophrenia and mood disorders (Gonzalez-Burgos et al., 2010, Hashimoto et
al., 2003, Thompson et al., 2009). Complementing this, decreased MRS GABA levels have
been reported in the occipital cortex (Bhagwagar et al., 2007, Yoon et al., 2010) and anterior
cingulate (Rowland et al., 2013) of schizophrenia and bipolar individuals. However, the
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findings are inconsistent, as no group differences (Tayoshi et al., 2010) and increases (Brady
et al., 2013, Kegeles et al., 2012, Ongür et al., 2010) have also been found across various
cortical regions. Glutamate dysfunction, particularly involving the N-methyl-D-aspartate
receptor (NMDAR) has also been implicated (Kirov et al., 2012, Martucci et al., 2006),
supported by alterations in MRS glutamate levels (Rowland et al., 2013).It is possible that
these glutamatergic and GABAergic abnormalities are present in the SABP phenotype, which
manifests features of both disorders.
Converging evidence from both computational and animal models demonstrates that high
frequency (30-80 Hz) cortical gamma oscillations depend on the excitatory-inhibitory activity
generated between reciprocally connected glutamatergic and GABA interneuron cell
assemblies (Bartos et al., 2007, Buzsaki and Wang, 2012). Thus, one might expect gamma
oscillations to be similarly perturbed in psychiatric disorder. Indeed, alterations in evoked and
induced gamma band measures have been found in response to a variety of tasks in
schizophrenia and bipolar disorder (Ethridge et al., 2012, Hall et al., 2011a, Liu et al., 2012,
Mulert et al., 2011, O'Donnell et al., 2004, Spencer et al., 2009, Sun et al., 2013, Tan et al.,
2013). The majority of studies find a decrease in gamma oscillatory measures, including
gamma power, frequency and phase locking. However, no differences (Uhlhaas et al., 2006)
and increases (Riečanský et al., 2010) in gamma measures have also been reported.
Methods have been developed to induce gamma oscillations in the primary visual cortex of
healthy individuals in response to visual gratings with a high degree of repeatability
(Hoogenboom et al., 2006, Muthukumaraswamy et al., 2010). However, the link between
GABA and gamma is unclear, depending on whether you look at disease, pharmaco-MEG or
modelling. Positive correlations have been demonstrated between induced gamma frequency
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and occipital MRS GABA measures (Muthukumaraswamy et al., 2009) although this was not
replicated in a larger cohort (Cousijn et al., 2014). If gamma oscillations are modulated by
GABA, if a GABA deficit is present in SABP (as is implicated in clinical studies of
schizophrenia and bipolar disorder) then MRS GABA-gamma studies would predict that a
GABA deficit would decrease gamma frequency. Pharmaco-MEG drug studies (alcohol and
propofol) would suggest that enhancing GABA will boost gamma power, (Campbell et al.,
2014, Saxena et al., 2013) so a GABA deficit may well lead to a reduction in gamma power.
Conversely, computational models of an NMDAR hypofunction (which may be relevant to
the aetiology of SABP) (Spencer, 2009) would predict an increase in gamma power.
Therefore, in this study the oscillatory measures gamma power and frequency in the visual
cortex and GABA levels in the occipital voxel were obtained from SABP individuals and
healthy controls to shed light on these contradictions.
5.3 Methods
5.3.1 Participants
Fifteen SABP individuals and 24 healthy control (HC) individuals participated in the study.
The study was approved by the National Research Ethics Service (England and Wales) and
the School of Psychology ethics committee, Cardiff University. Informed consent was
obtained from all participants. SABP participants were recruited from local genetic
epidemiology studies at the MRC Centre for Neuropsychiatric Genetics & Genomics, Cardiff
University, part of the Wellcome Trust Case Control Consortium (http://www.wtccc.org.uk).
They had previously been diagnosed according to the research diagnostic criteria (RDC)
(Spitzer et al., 1978). HC were recruited from Cardiff University staff and the local
community. HC had no history of axis I psychiatric disorder, determined by the MINI
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(Sheehan et al., 1998) and General Hospital Questionnaire (GHQ) and no history of
psychiatric disorder in first-degree relatives using the RDC family history method
(Andreasen et al., 1977). Exclusion criteria included dyslexia, contra-indications to MRI,
organic brain disease, drug or alcohol dependence (determined by the MINI) and self-
reported cognitive problems or memory problems, determined by systematic interview.
SABP subjects completed the MINI, to screen for current affective or psychotic episodes, and
measures of current affective and psychotic symptoms: the Scale for the Assessment of
Positive Symptoms (SAPS)(Andreasen, 1984) , the Scale for the Assessment of Negative
Symptoms (SANS)(Andreasen, 1983) the Young Mania Rating Scale (YMRS) (Young et al.,
1978) and the Calgary Depression Scale (CDS) (Addington et al., 1990). In addition, a record
was made of currently prescribed medications.
5.3.2 MEG Acquisition and Analysis
Participants were presented with a slightly modified version of an established visual
paradigm (Muthukumaraswamy et al., 2009) consisting of a vertical, stationary, maximum-
contrast, 3 cycles per degree, sine-wave grating presented on a mean luminance background
(Figure 1). The stimulus was presented in the lower left visual field, subtended 4° both
horizontally and vertically, with the centre of the image located 2.8° along a 45° angle,
extending left-inferiorly from a small red fixation point. Visual stimuli were presented on a
Mitsubishi Diamond Pro 2070 monitor (1,024 × 768 pixels and 100Hz frame rate). The
duration of each stimulus was 0.8–2.3s (mean duration 1.55s) followed by 1.5s of the fixation
point only. Participants were instructed to maintain fixation for the entire experiment and to
maintain attention, were instructed to press a response key at the termination of each
stimulation period. One hundred and fifty identical visual stimuli were presented in each
recording session and each recording session took approximately 8 minutes.
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Figure 1: Visual stimulus used in this study
Whole head MEG recordings were made using a 275-channel whole head MEG system in a
magnetically shielded room. Twenty nine reference channels were also recorded for noise-
cancellation purposes and the primary sensors were analysed as synthetic third-order
gradiometers (Vrba and Robinson, 2001). Three of the 275 channels were turned off due to
excessive sensor noise. Before MEG recording, participants were fitted with three fiduciary
markers in the form of electromagnetic head coils at the two pre-auricular points and nasion,
and were localised relative to the MEG system immediately before and after the recording
session. Previously, high resolution anatomical images had been acquired for each individual
with a T1-weighted 3D FSPGR sequence (TR/TE/TI = 7.8/3.0/450ms, flip angle=20° FOV =
256*192*172mm, 1mm isotropic resolution, 8min acquisition time). After MEG recording
these fiduciary markers were used to enable MEG and MRI co-registration. Two healthy
controls did not participate in the MEG section of the study, so MEG analysis was conducted
in 15 SABP individuals and 22 healthy controls. One SABP subject and 3 controls did not
participate in the MR section of the study, so for MRI co-registration, a structural scan from a
matching subject in age and gender was used.
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Offline, each dataset was epoched from -0.8 to 0.8s around stimulus onset and each trial
visually inspected for data quality. Trials containing gross artefacts, such as head movements
and muscle clenching were excluded from further analysis. For the 15 SABP MEG datasets,
on average 15.9% (SD 16.9, range 0-50.7%) of the 150 trials were removed and for the 22
healthy control datasets, on average 14.1% (SD 13.6, range 0-565) of the 150 trials were
removed. Three source localisations were performed on each dataset using synthetic aperture
magnetometry (SAM) (Robinson and Vrba, 1999) for gamma (30 - 70 Hz), alpha (8 – 13Hz)
and evoked responses (SAMerf) (Robinson, 2004). Correspondingly, three global covariance
matrices were calculated for each dataset, one for gamma, one for alpha and one for SAMerf
(0 - 100 Hz). Based on these covariance matrices, using the beamformer algorithm (Robinson
and Vrba, 1999) , three sets of beamformer weights were computed for the entire brain at
4mm isotropic voxel resolution.
For gamma-band SAM image reconstruction virtual sensors were constructed for each
beamformer voxel and student t images of source power changes computed using a baseline
period of -0.8 to 0s and an active period of 0 to 0.8s, while for alpha-band SAM image
reconstruction a baseline period of -0.8 to -0.25s and an active period of 0.25 to 0.8s was
used.  The 0 to 0.25s active time window was excluded for the alpha-band SAM image
reconstruction to avoid contamination of the evoked response into the alpha-band source
image.
For each participant, using their source reconstruction image, the voxel with the strongest
power increase in the contralateral occipital lobe was located for gamma and the voxel with
the strongest source power decrease located for alpha. Time-frequency analyses of these
virtual electrodes were conducted with the Hilbert transform between 1 and 100Hz, at 0.5 Hz
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frequency step intervals and time-frequency spectra were computed as a percentage change
from the pre-stimulus baselines (-0.8 to -0s) for each frequency band. From these spectra, the
peak frequency and amplitude at that frequency for transient gamma amplitude increases (30
- 70 Hz, 0 to 0.3 s), sustained gamma amplitude increases (30 - 70 Hz, 0.3 to 0.8 s) and alpha
amplitude decreases (8-13 Hz, 0.25 to 0.8s) were quantified by collapsing across the time
dimension and finding the maximal (or minimal for alpha) frequency. From these spectra, the
time course of gamma (30–70 Hz) was extracted and submitted to non-parametric
permutation tests using 5000 permutations (Nichols and Holmes, 2002). Permuted t statistics
were corrected for multiple comparisons using cluster-based techniques (Maris and
Oostenveld, 2007). The width of the spectral peak was estimated by the full width half
maximum (FWHM) of the gamma peak.
Previous studies have reported differences in baseline (pre-stimulus) gamma power between
schizophrenia patients and controls (Spencer, 2012). Hence, pre-stimulus amplitudes were
examined by recomputing time-frequency spectra with no baseline correction across
frequency bands (0-105Hz) in the pre-stimulus period (-0.8 to 0s).
For SAMerf, the computed evoked response was passed through the 0 -100 Hz beamformer
weights to generate SAMerf images (Robinson, 2004) at 10 ms intervals from 50 – 150 ms.
The image window (usually 70–80 ms or 80–90 ms) with the maximal response in visual
cortex was identified and the maximal voxel selected as the peak location for further analysis.
For this, the evoked field was computed for this virtual sensor (-0.2 to 0 s baseline) and the
peak amplitude and latency of the M80 and M150 responses quantified.
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5.3.3 MRS Acquisition and Analysis
MR spectra were acquired on a GE Signa HDx 3T MRI scanner using the body coil for RF
transmission and an eight-channel head coil for signal reception. MR spectra were acquired
from a 3.0 x 3.0 x 3.0 cm3 voxel in the visual cortex.  The occipital voxel was orientated so
that the inferior border was aligned in sagittal view with the superior border of the cerebellum
and was located bilaterally to include an equal volume of both hemispheres. The posterior
and superior limits of the voxel were defined by the sagittal sinus. Spectra were acquired with
a MEGA-PRESS sequence (Mescher et al., 1998) over an 8 minute period with the following
parameters: TE = 68 ms, TR =1.8s, 256 transients of 4096 datapoints, and 16 ms editing
pulses applied at 1.9 ppm (ON) and 7.5 ppm (OFF). GABA was quantified with GANNET
(www.gabamrs.blogspot.co.uk/). The GABA peak at 3.0 ppm in the difference-edited
spectrum was fitted with a single Gaussian model and GABA levels were quantified using
both creatine and water as an internal concentration reference. For GABA+/H20 values, the
ratio of GABA+ to water was converted to institutional units (IU) by correcting for the voxel
tissue fraction (grey matter and white matter) and the effective visibility of water. Grey
matter, white matter and CSF fraction were determined using FAST (Zhang et al., 2001). MR
spectra were not acquired from one SABP individual and three controls. Thus, GABA+ data
was analysed in 14 SABP individuals and 21 healthy controls.
5.3.4 GABA+ and Gamma Frequency
Correlational analysis between age-corrected GABA+/Cr concentration and sustained peak
gamma frequency were carried out using the Pearson correlation coefficients (r) in SPSS 20.
Age corrected values were used as the age range in this sample was large (21-61 years) and
age has been shown to influence GABA levels and gamma frequency (Gaetz et al., 2012, Gao
et al., 2013).
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5.3.5 V1 Structural Properties
V1 structural properties were estimated in each individual in order to identify whether any
group differences in GABA+ and gamma measures were influenced by structural group
differences. FreeSurfer was used to estimate the cortical thickness and surface area of V1 for
each participant from their 3D FSPGR scan (Hinds et al., 2008). As the visual stimulus was
presented on the left visual field, estimates of V1 surface area and thickness were calculated
for the right hemisphere. As MRI data was not acquired from one SABP and three controls,
V1 thickness and V1 surface area data was available for 14 SABP and 21 healthy controls.
Acknowledgements for data collection
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5.4 Results
5.4.1 Participant Demographic and Clinical Characteristics
Demographic and clinical characteristics for SABP and HC groups are summarized in Table
1. The SABP and HC subjects did not differ significantly by age (46.8 years (SD=9.8) versus
41.6 years (SD=10.8), t(37)=-1.52, p=0.138) and had similar female to male gender ratios.
SAPS and SANS symptom scores and YMRS and CDS scores were available in 13 SABP
individuals; SABP had sub-syndromal levels of depression and manic symptoms as measured
with the YMRS and CDS. They also had low negative and positive symptoms as measured
using the SAPS and SANS. All of the SABP patients were taking a range of medications: 14
were taking antipsychotics (Quetiapine, Aripiprazole, Olanzapine, Clozapine, Sulpiride), 7
were taking antidepressants (Citalopram, Mirtazapine, Vilazodone, Venlafaxine, Effexor), 9
were taking anticonvulsants (Depakote, Sodium Valproate, Epilim, Lamotrigine, Tegretol), 5
were taking lithium and 4 were taking benzodiazepines (Diazepam, Lorazepam, Oxazepam).
SABP individuals had slightly longer key pressing response times compared to healthy
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individuals (317 ms (SD 54) versus 283ms (SD 47), t=-2.056, p=0.047) but there were no
group differences in the number of key presses missed (7.3 (SD 7.0) versus 4.5 (SD 4.1), t=-
1.544, p=0.132).
Table 1. Demographic and Clinical Characteristics of SABP and HC groups
SABP HC t value (df) p value
Age 46 (9.8) 41 (10.8) -1.52 (37) 0.138
Gender (F : M) 9:6 14:10
YMRS 1.8 (2.2)
CDS 3.8 (4.1)
SAPS 1.4 (1.9)
SANS 1.3 (2.0)
Mean values are shown (with standard deviations)
5.4.2 MEG Oscillatory Measures
Figure 2A shows the grand-averaged source localisation of gamma oscillations (30-70Hz) for
SABP and HC. Figure 2B shows the resulting grand-average time-frequency spectra for
SABP and HC. For both groups, the time-frequency spectra showed the characteristic
responses following this type of visual stimulus (Muthukumaraswamy et al., 2010): there was
an initial transient increase in gamma power (0-0.3s), followed by a sustained increase in
gamma power (0.3-0.8s). The lower frequency band (8-13 Hz) included the early (<0.3s)
visual evoked response, followed by a sustained suppression of alpha amplitude.
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Figure 2 (A) Grand-averaged source localisation of gamma oscillations (30-70Hz) for SABP
and HC individuals. Units are t statistics. (B) Grand-averaged time-frequency spectrograms
showing source-level oscillatory power changes following visual stimulation with a circular
grating patch (stimulus onset at time = 0s) for SABP and HC individuals. Spectrograms are
displayed as percentage change from the pre-stimulus baseline.
For group comparisons, the grand-averaged time frequency spectra demonstrate a greater
increase in sustained gamma power (30-70Hz) in the SABP group compared to the HC
group. These increases in gamma power in the SABP group follow a much broader gamma
band response compared to the HC (20.9 (SD 7.4) versus 15.6 (SD 7.2), t(35)=-
2.170,p=0.037,95% confidence intervals of the difference = -10.253 to -0.341), calculated
using FWHM of the gamma peak. In order to further investigate this group difference in the
sustained gamma band response, power-frequency plots were generated for the transient (0-
0.3s) and sustained gamma time windows (0.3-0.8s) (Figure 3A and B). As expected from
Figure 2, in the sustained gamma time window, SABP individuals showed a significantly
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higher increase of 18% in gamma power (30-70Hz) compared to a 9% increase in controls
(t(35)=-2.56, p=0.015, 95% confidence intervals of the difference=-15.3 to -1.7).
Figure 3. Grand-averaged power-frequency spectrograms, showing power changes across a
broad frequency range (0-105Hz) in (B) the transient (0-0.3s) and (A) sustained response
(0.3-0.8s) time window following visual stimulation. Coloured areas represent standard error
of the mean. Frequency bands with significant differences in power between SABP and HC
group are shown with a black bar (*p<0.05, **p<0.01, corrected for multiple comparisons
across frequency bands (see text)). (C) Mean pre-stimulus baseline activity (-0.8 to 0s) in
SABP and HC subjects, with an integrated and enlarged graph across 30-70Hz.
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To detect the specific frequencies within the gamma frequency band at which there was
increased gamma power Permuted t statistics were used with cluster based techniques. The
power-frequency plot for sustained responses (Figure 3A) shows 2 significant clusters of
increased power in the SABP group compared to HC, one at lower gamma frequencies (26.5-
42.5Hz, p<0.01, corrected) and one at higher gamma frequencies (60.5-70Hz, p<0.05,
corrected) (Figure 3A). At the lower gamma frequency range (26.5-42.5Hz), SABP
individuals showed a 19.5% mean increase in gamma power compared to a 7.4% increase in
HC. At the higher gamma frequency range (60.5Hz-70Hz), SABP individuals had a mean
increase of 8.9% in gamma power compared to 3.2% in HC. There was no significant
difference between groups in transient responses (p>0.05) (Figure 3B).
Whether the observed increase in sustained gamma power in the SABP group was due to an
initial baseline (pre-stimulus) difference in the power-frequency spectrum was investigated
(Figure 3C). No group differences in mean pre-stimulus (-0.8 to 0s) values were seen across
the 30-70Hz frequency range (t(35)=-0.126, p=0.901, 95% confidence intervals of the
difference = -0.113 to 0.100).
In order to explore if the significant difference in gamma power observed in the group
comparison was consistent across the group or was influenced by only a minority of
individuals,  n=15 HC individuals who were age-and-sex-matched to the n=15 SABP
individuals on a pair-wise basis were selected and the gamma power values were chartered
for these pairs. Sustained gamma power was higher in the SABP individual than the HC
individual in all but one of these pair-wise comparisons (see Figure 4A). A similar plot was
made for peak sustained gamma frequency (Figure 4B). This paired age matching also
ensures that small differences in age between the two groups are not affecting our results, as
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although age has not been found to affect gamma power, peak gamma frequency decreases
with age (Muthukumaraswamy et al., 2010).
Figure 4: A histogram demonstrating individual pair-wise comparisons in (n=15) SABP and
(n=15) controls for (A) mean gamma power values (30-70Hz) and (B) sustained peak gamma
frequency.
The effect of medication on our finding of increased gamma power in SABP was also
investigated. For the 14 patients on antipsychotics, we converted antipsychotic dosage to
chlorpromazine equivalent levels (Janssen et al., 2004, Woods, 2003). Chlorpromazine
dosage did not correlate with gamma power (r=0.168, p=0.565). The potential effect of other
medications on gamma power was investigated by group comparisons within the SABP
patients, comparing those on the medication and those not on the medication. No significant
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difference was found between the two groups of SABP patients for benzodiazepines
(p=0.868), antidepressants (p=0.278) or lithium (p=0.789). Anticonvulsants were found to
significantly reduce gamma power (p=0.01),with patients on anticonvulsants having a mean
increase in gamma power of 11%, compared to a mean increase of 27% for those not
medicated on anticonvulsants.
There were no group differences in transient or sustained peak gamma frequency (Figure 5A
and B, p = 0.106, p = 0.280), or alpha power (Figure 5C, p = 0.900). There were also no
group differences in the amplitude or latency of the M80 or M150 pattern onset evoked
responses. (Figure 5D; M80 amplitude: p = 0.928, M80 latency: p = 0.072, M150 amplitude:
p= 0.899, M150 latency: p = 0.143).
Figure 5: (A)-(C) Bar charts showing no significant group differences in (A) peak transient
gamma frequency (0-0.3s), (B) peak sustained gamma frequency (0.3-0.8) and (C) alpha
power (8-13Hz). Error bars represent standard errors of the mean. (D) A graph of the time
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course of source level evoked responses in SABP and HC, showing no significant group
differences.
5.4.3 MRS GABA+ Measures
The GABA+/Cr value for one SABP individual was identified as an outlier and excluded
from further analysis. The edited MRS spectra from the occipital voxel for the remaining 13
SABP and 21 healthy individuals are shown in figure 6. All individuals show a clear GABA
peak at 3ppm.
Figure 6: Edited MRS spectra for (A) 13 SABP and (B) 21 healthy controls.
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For the 13 SABP and 21 control subjects, GABA+/Cr values ranged from 0.118 to 0.191
(mean 0.150 (SD 0.022) and 0.102 to 0.175 (mean 0.145 (SD 0.018)) respectively (Figure
7A). No group difference in occipital GABA+/Cr levels was found (p=0.441) and the lack of
a consistent directional group difference is also shown with 13 age and gender matched
pairings (Figure 7B). No group difference in GABA+ levels was also found when using
GABA+/H20 values (p=0.456).
Figure 7: (A) Group comparison for GABA+/Cr values. Black lines represent the genotype
group mean and standard error of the mean. (B) Histogram to compare 13 SABP individuals
with an age and gender matched healthy control.
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5.4.4 GABA and Gamma Frequency
There was a significant correlation between age-corrected values for GABA+/Cr and
sustained peak gamma frequency in the control sample (n=19; R=0.457, p=0.049) but not in
the SABP sample (R=-0.212, p=0.486) or the combined sample (R=0.106 p=0.564).
5.4.5 V1 Structural Properties
For the 14 SABP and 21 healthy controls, V1 thickness ranged from 1.58mm to 2.21mm
(mean 1.91(SD 0.19)) and from 1.62mm to 2.11mm (mean 1.81 (SD 0.12)) respectively. For
V1 surface area, one control was excluded as they were identified as an outlier. For the
remaining 14 SABP and 20 healthy controls V1 surface area ranged from 1814cm² to
3283cm² (mean 2381 (SD 427)) and from 1905cm² to 2939cm² (mean 2325 (SD 338))
respectively. No group difference was found for either V1 thickness (p=0.102) or surface area
(p=0.671).
5.5 Discussion
This study demonstrates a large increase of 18% in induced gamma power in SABP
individuals compared to a 9% increase in controls, in response to a visual grating stimulus
designed to maximally elicit gamma responses in the visual cortex. This was present in all but
one of the pair-wise comparisons. Importantly, this increase in gamma power was not due to
group differences in baseline (pre-stimulus) gamma power and could not be explained by
group differences in V1 structural parameters. No group differences were found for other
MEG measures, in either transient or sustained peak gamma frequency, alpha power or
components of the evoked response. This dissociation between induced and evoked responses
is not surprising, since previous studies have identified these measures as independent
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oscillatory parameters which may be generated via different cell populations in the visual
cortex (Jia et al., 2013, Spaak et al., 2012).
For the MRS GABA+ measure, no group differences were found using either creatine or
water as a reference molecule. Given that schizophrenia and bipolar disorder are associated
with decreased GABAergic function (Lewis et al., 2012) and that gamma frequency and
occipital GABA has previously been reported to be decreased in schizophrenia (Ferrarelli et
al., 2012, Yoon et al., 2010), one might expect decreased gamma frequency and decreased
GABA+ levels. A possible explanation for the lack of group difference in this study could be
due to the relatively low sample size used. As GABA+ and gamma frequency measures show
relatively high inter-individual variability, larger sample sizes may be needed to identify clear
group differences. Gamma frequency has also previously been found to positively correlate
with MRS GABA levels (Muthukumaraswamy et al., 2009). This significant positive
correlation was replicated in this study but only when using the healthy control sample and
only just reached statistical significance (p=0.049). Therefore, this finding would need to be
replicated in a large sample size as recent studies using larger sample sizes have not found a
significant relationship between GABA+ and gamma frequency (Cousijn et al., 2014,
Robson, 2012).
In contrast to the significant finding of increased visual gamma power in SABP in this study,
the majority of electrophysiological studies report reductions in gamma band responses in
schizophrenia and bipolar patients during a range of cognitive and visual tasks. Many of these
studies have employed evoked gamma band responses, which are phase-locked to stimuli:
reduced evoked gamma power and synchrony have been observed in response to click train
stimuli in chronic schizophrenia (Kwon et al., 1999) and reduced gamma phase locking in
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visual and auditory oddball tasks were observed in both bipolar disorder and schizophrenia
(Hall et al., 2011a, Spencer et al., 2008a). Early visual processing deficits have also been
found in schizophrenia patients, as measured by the visual backward-masking task (Wynn et
al., 2005). Reductions in frontal gamma power have been reported in schizophrenia
individuals during more complex cognitive tasks such as working memory (Haenschel and
Linden, 2011) and mental arithmetic (Kissler et al., 2000). Fewer studies have focused on
induced gamma oscillations. Both intact (Uhlhaas et al., 2006) and impaired induced visual
gamma oscillations (Grützner et al., 2013) have been found in response to Mooney faces
(Sun et al., 2013).
Overall, several factors may explain the observed inconsistency in gamma deficits between
these results and other studies. Firstly, induced gamma responses were investigated, which
reflect intrinsic cortical network activity as opposed to evoked responses, which reflect
driven cortical activity. Secondly, this study was in SABP individuals rather than
schizophrenia patients. SABP individuals have previously been included in the schizophrenia
cohort rather than as a separate cohort, which assumes a common pathophysiology. An
auditory steady state response observed greater gamma amplitudes and phase locking factors
in the 40Hz steady state responses to auditory stimuli in the right hemisphere of individuals
with schizoaffective disorder but not schizophrenia when compared to controls (Reite et al.,
2010) . This suggests schizoaffective disorder may be an independent phenotype and differs
in pathophysiology to schizophrenia. Thirdly, gamma responses were measured in the visual
cortex rather than the auditory or prefrontal cortices. In the context of psychiatric disorders,
primary abnormalities in cortical glutamate function are unlikely to be confined to the
occipital cortex, but occipital measures could represent sensitive indices of more generalized
pathology. Fourthly, a simple visual stimulus was used as opposed to more complex
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cognitive or emotional stimuli. The advantage of using this stimulus is that responses are
highly repeatable within individuals and thus represent a stable measure. Responses can also
be manipulated pharmacologically in healthy individuals, providing us with a strong basis to
probe GABAergic and glutamatergic function in the visual cortex of SABP individuals.
Although the time window (0.5sec) over which induced sustained gamma measures are
assessed is also relatively short, previous studies have investigated induced gamma power
over much shorter time windows (Grützner et al., 2013, Uhlhaas et al., 2006). Finally, it is
also possible that gamma power across psychotic disorders may be increased or decreased
depending on the preponderance of positive versus negative symptoms in the illness history.
The power of gamma responses to Gestalt tasks have been shown to positively correlate with
positive symptoms, such as delusions and hallucinations, in the occipital region (Spencer et
al., 2004), and when averaged across all channels (Uhlhaas et al., 2006), while gamma power
has been shown to negatively correlate with the negative symptom disorganisation (Grützner
et al., 2013). However, as the patients in this study were remitted and had low SAPS and
SANS scores, the influence of symptoms on gamma measures cannot be fully investigated.
The finding of increased gamma power in SABP supports the NMDAR hypofunction
hypothesis for the aetiology of schizophrenia. Computer modelling evidence suggests gamma
power may be increased by NMDAR antagonism (Spencer, 2009). In the cortical circuit
model, reducing the NMDAR input by 20-100% to fast-spiking interneurons was found to
increase gamma power. This increase in gamma power has been explained by reduced
NMDA facilitation of fast spiking GABA interneurons which, in turn, disinhibits AMPA
neurons, leading to an overall increase in cortical excitability. Preclinical work also supports
this hypothesis, demonstrating increased gamma power in response to the N-methyl-D-
aspartate (NMDA) antagonist MK-801(Arai and Kessler, 2007, Wood et al., 2012) and
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decreased cortical gamma power in response to the α-amino-3-hydroxy-5-methyl-4-
isoxazolepropionic acid (AMPA) receptor antagonist SYM 2206 (Oke et al., 2010). The
anaesthetic ketamine is thought to act in a similar way, and recent in vivo evidence suggests
that it increases glutamate release in the prefrontal cortex of healthy volunteers (Stone et al.,
2012). Thus, increases in gamma power may be mediated by NMDA receptor blockade,
which reduces the activity of cortical GABAergic interneurons and, in consequence,
increases the excitability of pyramidal cells (Homayoun and Moghaddam, 2007).
However, recent pharmacoimaging work argues against a GABA deficit mediating the effect
of increased gamma responses observed in SABP. The GABAAR agonist propofol increased
rather than decreased gamma power in healthy volunteers (Saxena et al., 2013). Furthermore,
the GABA transporter tiagabine, which increases synaptic availability of GABA, had no
effect on gamma frequency or power, but suppressed the pattern onset (80ms) evoked
response (Muthukumaraswamy et al., 2013). It is possible, therefore, that the observed
increase in gamma power reflects a primarily glutamatergic pathology. This is supported by
the non-significant group differences for the GABAergic measures, gamma frequency and
GABA+. The effects of NMDA antagonists (such as ketamine) and AMPA antagonists (such
as perampanel) on visual gamma power need to be investigated in vivo.
This study had some limitations. In the context of psychiatric disorders, primary
abnormalities in cortical GABAergic/glutamatergic function are unlikely to be confined to
the occipital cortex. However, occipital measures could represent particularly sensitive
indices of more generalized pathology. The putative advantage of using a low level visual
stimulus, as opposed to more complex cognitive or emotional stimuli, is that the paradigm is
tapping in to a stable and sensitive index of neurotransmitter function. While the stimuli are
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simple, any abnormalities that might be discovered in mental disorder would have
implications for the integration of higher level perceptual and cognitive processes seen in
these disorders that are harder to detect using current MEG methods.
Medication will always be a potential confound when studying patients with schizoaffective
disorder or psychosis in general. All the participants were taking medication, which could
have affected gamma measures independent of any trait disturbance, and medication could
have mitigated against any illness-related disturbance in this remitted group. In an auditory
steady-state stimulation paradigm, patients with schizophrenia taking atypical antipsychotics
showed enhanced gamma power at 40 Hz stimulation compared with patients taking
conventional antipsychotics (Hong et al., 2004), although there was considerable overlap. All
but one of the participants was taking atypical antipsychotics. However, preclinical work
suggests that atypical and conventional antipsychotics reduce spontaneous gamma power
(Jones et al., 2012), or suppress gamma power responses to acetylcholine and physostigmine
(Schulz et al., 2012). Hence, we might expect antipsychotics to reduce rather than explain the
observed group differences. Other clinical evidence suggests that both medicated and
unmedicated patients with first episode psychosis have similarly impaired gamma power
during cognitive control in first-episode schizophrenia (Minzenberg et al., 2010).
From the results in this study, no effect was found for chlorpromazine dosage,
benzodiazepines, antidepressants or lithium on gamma power. However, patients on
anticonvulsants were found to have significantly lower gamma power compared to those not
on the medication. These findings coincide with a recent study, showing that the
anticonvulsant sodium valproate significantly decreases visual gamma power (Perry et al.,
2014). This implies that anticonvulsants may in fact be normalising gamma power and that
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increases in gamma power could be less detectable in patients on this type of medication.
Nicotine may also be a confounding factor. Nicotine has been shown to enhance auditory
evoked gamma activity (Featherstone et al., 2012) but the effect of nicotine on induced
oscillations in the visual cortex is unknown. Although nicotine use may be affecting our
measures, as 14 of the 15 patients showed increased gamma power in comparison to their age
and gender matched control it is unlikely that this can be attributed to increased nicotine
intake across all SABP individuals.
In conclusion, this study demonstrates that remitted SABP is characterised by an increase in
gamma power induced by a simple visual stimulus. This may be an index of a more
generalised non-state-dependent dysfunction of glutamatergic and/or GABAergic activity.
Further work is needed to explore these deficits in unmedicated SABP and their relatives.
This will help determine if inconsistencies between the findings in this study and other
clinical population studies can be explained by the visual stimulus and/or the SABP cohort.
Pharmaco-MEG studies are required to examine the relative effects of glutamate and GABA
receptor agonists and antagonists on induced gamma power in healthy and psychiatric
populations. This may ultimately help us to understand specific mechanisms underlying the
generation of gamma oscillations and improve the treatment of major mental disorders.
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Chapter 6 – Individual Differences in Auditory Chirp Gamma
Responses: Relationship with Auditory Structural Properties and
Visual Gamma Responses
6.1 Abstract
Background: Auditory steady-state responses are increasingly being used to examine
neurophysiological function in neuropsychiatric disorders. A recent study has shown that
inter-individual variability is present in the peak frequency and peak power of the low and
high gamma band auditory steady-state response (ASSR). However, whether the individual
variation in these gamma ASSR measures is repeatable over time has not been reported. In
addition, the factor(s) underlying the variation are unknown. A possible factor influencing the
variation could be differences in the structural properties of the auditory cortex, as this may
have downstream effects on cellular components, which are involved in the generation of the
ASSR.  As inter-individual variability is also present in the visual gamma response, whether
this response shows a relationship with the variability in the gamma ASSR is also of interest.
Thus, this study investigates (1) the repeatability of the gamma ASSR measures (2) the
influence of auditory structural properties on the peak frequency and peak power of the
gamma ASSR and (3) the relationship between the auditory gamma steady-state response
with the induced visual gamma response.
Methods: An auditory click-chirp stimulus was developed and the individual repeatability of
four ASSR measures was tested in two subjects (peak frequency in the low gamma (30-50Hz)
and high gamma range (70-100Hz) and peak power in the low gamma (30-50Hz) and high
gamma range (70-100Hz)). Using ASSR data from 11 healthy subjects, correlational analysis
was performed to firstly assess the impact of auditory structural properties on the ASSR and
secondly, to determine if visual gamma responses were correlated with gamma ASSRs.
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Results: The morphology of the ASSR and the individual variability in the four ASSR
measures was highly repeatable. The thickness and surface area of Heschl’s gyrus (HG) was
not associated with any of the four ASSR measures. Similarly, the peak frequency and peak
power of the visual gamma response showed no relationship with the peak frequency and
peak power of the low and high gamma auditory response.
Conclusions: These results demonstrate that peak frequency and peak power from the low
(30-50Hz) and high auditory gamma responses (70-100Hz) are reproducible over time. The
findings suggest that the structural parameters of the HG do not influence the ASSR and that
the gamma ASSR has no relationship with the gamma visual response. However, these
analyses need to be conducted in a large sample size to reliably verify these findings. Further
understanding the factors underlying individual differences in the auditory domain and how
these compare to other sensory domains will ultimately improve our understanding of sensory
perception.
6.2 Introduction
The auditory steady-state response (ASSR) is an oscillatory response in which neurons
entrain to the frequency and phase of a repeated auditory stimulus. Thus, the ASSR is a
useful clinical probe for assessing the integrity of neural networks that are needed for
generating auditory oscillations. ASSRs were originally obtained using sequences of clicks
(click train) (Galambos et al., 1981) but can also be acquired using amplitude-modulated
tones (Picton et al., 1987). As with many oscillatory responses, the amplitude/power of the
ASSR varies across individuals (Ross et al., 2000). However, an interesting feature of the
ASSR is that humans show two main peak increases in amplitude which are present in the
gamma frequency band; the largest being around 40Hz (Galambos et al., 1981) and a second
smaller peak around 80Hz (Lins et al., 1995). Similarly, rats show two peak ASSRs but at
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slightly different frequencies within the gamma range (Pérez-Alcázar et al., 2008). The
reason for this maximal response at 40Hz in humans is still unclear but has been hypothesised
to be due to the preferential working frequency of the auditory system (Pastor et al., 2002).
Using MEG, the 40Hz response has primarily been localised to the primary auditory cortex
(Herdman et al., 2003) and the 80Hz response has been mainly localised subcortically (Bish
et al., 2004, Herdman et al., 2002).
Obtaining the ASSR to multiple stimulus frequencies can be a time consuming process if
different frequencies are individually tested. However, a new technique using an auditory
stimulus that increases linearly in frequency from 1-120Hz (chirp) has shown that the ASSR
can be measured continuously over a range of frequencies (Artieda et al., 2004), greatly
reducing the time needed to test the full spectrum. In addition, this stimulus has revealed that
individuals exhibit variability in their peak frequency within the two main gamma
components at 40Hz and 80Hz. Within the lower gamma component, individuals peaked in
power from 43-50Hz and for the higher gamma component individuals peaked between 80-
120Hz. This variability in peak frequency had not previously been demonstrated, as other
studies use click trains or amplitude-modulated tones only at one particular frequency, the
most common being 40Hz. Importantly, this variability has been shown to be functionally
relevant, as lower peak frequencies in the 30-60Hz range have been associated with cognitive
impairment in multiple sclerosis patients (Arrondo et al., 2009).
Intriguingly, this individual variability in the peak response frequency is also found in other
primary sensory cortices, including the visual cortex in response to a visual grating
(Adjamian et al., 2004, Hoogenboom et al., 2006, Muthukumaraswamy et al., 2010) and in
the motor cortex following finger movements (Cheyne and Ferrari, 2013, Gaetz et al., 2011,
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Muthukumaraswamy, 2010). Importantly, these studies have indicated that the cortical
balance between inhibitory (GABA) and excitatory (glutamate) neurotransmission in the
visual and motor cortex plays a significant role in determining their respective peak gamma
response frequency (Gaetz et al., 2011, Muthukumaraswamy et al., 2009). So far, no studies
have investigated the potential factor(s) underlying individual variability in the peak gamma
frequency of the ASSR. Due to the relatively consistent laminar structure and cell types
found across these three primary sensory domains, the auditory peak response frequency
may also share similar factors as the visual and motor domains in driving their individual
gamma frequency variability (Cunningham et al., 2004). Recent evidence supports
GABAergic and glutamatergic function as determining factors of the auditory peak response
frequency, as the 40Hz ASSR can be selectively manipulated via pharmacological
modulation with a GABAAR antagonist (muscimol) and an NMDAR antagonist (ketamine) in
both rats and human individuals (Plourde et al., 1997, Vohs et al., 2010, Vohs et al., 2012). If
consistent neurochemical similarities are present across sensory systems, this may lead to
functional relationships across the modalities, such as individuals with a high peak gamma
frequency in the visual domain may also have a high peak gamma frequency in the auditory
domain.
Structural properties of the visual cortex have also been implicated in influencing its peak
gamma response frequency (Gaetz et al., 2012, Muthukumaraswamy et al., 2010) and thus,
this may also be the case in the auditory domain. Different structural divisions of the auditory
cortex such as Heschl’s gyrus (HG), the primary auditory cortex (A1) and the superior
temporal cortex (STG) are known to vary widely in cortical thickness, volume and gyral
morphology across individuals (Abdul-Kareem and Sluming, 2008, Kang et al., 2012,
Rademacher et al., 2001). These variations may reflect differences in cell types (GABAergic
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interneurons) or cell densities, which are particularly relevant factors for generating and
maintaining sensory gamma oscillations (Cardin et al., 2009). Thus, differences in structural
properties could lead to downstream effects on functional gamma oscillatory activity. In
agreement with structural properties of the auditory cortex influencing the ASSR, a recent
study has shown that the power of the 40Hz steady-state response positively correlates with
the cortical thickness of the superior temporal gyrus (Edgar et al., 2013). Whether these
findings are also applicable to the peak gamma frequency of the ASSR has not been explored.
Further understanding the factors underlying the individual variability in the ASSR is also
important clinically, as several psychiatric populations, including schizophrenia (Kwon et al.,
1999, Spencer et al., 2008b), bipolar disorder (O'Donnell et al., 2004, Oda et al., 2012) and
schizoaffective disorder (Brenner et al., 2003) have been found to have a reduced 40Hz
ASSR. As GABAergic and glutamatergic dysfunction has been strongly implicated in the
pathophysiology of psychiatric populations, the ASSR abnormalities may be reflecting
neurophysiological changes in neurotransmission of inhibitory and excitatory systems.
Similarly, reduced grey matter volume in the STG and Heschl’s gyrus (Kasai et al., 2003,
Vita et al., 2012), is one of the most consistent cortical changes observed in schizophrenia,
and so these structural changes may also be responsible for the ASSR abnormalities.
Therefore, by linking structural, neurochemical and functional information from the auditory
cortex, this will help unravel the specific systems disrupted in clinical disorders and how
these may lead to particular symptoms.
Hence, this study developed an auditory click-chirp stimulus to investigate the relationship
between inter-subject variability in auditory peak gamma frequency and peak gamma power
with auditory cortical thickness and surface area. Peak gamma frequencies and power of the
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ASSR were measured from individuals by driving the auditory cortex from 10-120Hz using a
click train stimulus. All individuals had previously participated in the ‘100 Brains’ imaging
project. This enabled us to determine: (1) whether the peak gamma frequency or peak gamma
power in the ASSR was determined by the thickness and/or area of Heschl’s gyrus
(transverse temporal plane) and (2) whether peak gamma frequencies and power in the
auditory domain were correlated with peak gamma frequency or power obtained in the visual
domain.
6.3 Methods
6.3.1 Participants
15 healthy individuals (9 females and 6 males, all right handed) aged between 20-29 years
(mean 24.1 years (SD=3.0)) and with normal hearing participated in the study. All
participants had no history of neurological or neuropsychiatric disease and had previously
participated in the ‘100 Brains’ study (Chapter 3). All participants provided written informed
consent.
6.3.2 Auditory Stimulus
The auditory stimulus was based upon a previously described chirp stimulus (Artieda et al.,
2004). However, rather than using a tone modulated in amplitude at increasing frequencies, a
chirp using click trains that linearly increased in frequency was developed. This is because
click trains have been shown to elicit larger ASSRs in comparison to amplitude-modulated
tones (McFadden et al., 2014). Auditory stimuli consisted of trains of 1-millisecond clicking
sounds that either increased in frequency from 10-120Hz (chirp, Figure 1) or decreased in
frequency from 120-10Hz. 120Hz was chosen as the maximum stimulation frequency as the
power of the ASSR is considerably weaker beyond 120Hz (Pérez-Alcázar et al., 2008). Each
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chirp lasted for 1.62s followed by a 0.5s baseline period. A total of 525 chirps (500
increasing chirps and 25 decreasing chirps that were randomly ordered) were delivered
binaurally through insert ear (etymotic) phones at 70dB above the participant’s sound
threshold level (Ross et al., 2000). Subjects were instructed to listen to the chirps and in order
to help maintain their attention, were asked to count how many of the chirps decreased in
frequency. These 25 decreasing chirps were not used for further analysis and hence were
solely presented for attention purposes. Each testing session lasted approximately 18.5
minutes. To assess the repeatability of the ASSR measures, 2 of the 15 participants repeated
the testing session three times in one day at 1hr intervals. These three repeat sessions for the 2
participants were performed eight weeks after their initial participation.
Figure 1: Auditory stimulus represented in terms of (A) click train stimulus and (B) a time-
frequency figure to show the linear increase from 10-120Hz over the 1.62s stimulus period.
6.3.3 MEG Acquisition and Analysis
Whole head MEG data was acquired using a 275-channel CTF radial gradiometer system.
Four of the channels were turned off due to excessive sensor noise. In addition, 29 reference
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channels were recorded for noise-cancellation purposes and the primary sensors were
analysed as synthetic third-order gradiometers (Vrba and Robinson, 2001). Three fiducial
markers (1 nasal and 2 pre-auricular points) were placed on the participant using
electromagnetic head coils and were localised relative to the MEG before and at the end of
the recording session.
Offline, data sets were epoched -0.2s before stimulus onset and 1.9s after stimulus onset.
Trials were visually inspected and those with large artefacts such as muscle clenching and
head movement were excluded. For the 15 MEG datasets, on average 4.8% (SD 3.9, range 0-
13.4%) of the 500 trials were removed. The MEG data from the axial gradiometers was
converted to a planar gradient configuration (gradient tangential to the scalp) using the
Fieldtrip toolbox (Oostenveld et al., 2011). This conversion was performed as the power of
the signal is typically largest directly above the source, which can be optimally measured
using a planar gradient configuration (Bastiaansen and Knösche, 2000). Frequency analysis
was performed using the Hilbert transform from 1 to 120Hz in 1Hz steps for the horizontal
and vertical components of the planar gradients. Next, the two planar directions were
combined to give the local maximal under the sensors.
To calculate relative changes from baseline, activity from the baseline period of -0.2 to 0s
was compared to the active period of 0 to 1.9s. For each participant, the temporal sensor with
the maximum response in the gamma band (30-50Hz) over the 0.35 to 0.70s time window
was located for both the left and right hemisphere individually. From these maximal temporal
sensors, peak frequency and peak power values in the low gamma (30-50Hz) and the high
gamma (70-100Hz) band were extracted. These two gamma band ranges were chosen as all
participants showed two peaks of activity within these values. This sensor-space method was
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chosen over the source-space synthetic aperture magnetometry (SAM) approach, as SAM
cannot accurately detect temporally correlated sources, such as bilateral auditory sources.
This is due to an assumption of SAM that sources are uncorrelated in time and so for
temporally correlated sources, the reconstructed source power is attenuated resulting in a
reduction in the source power (Brookes et al., 2007).
Visual gamma peak frequency and peak power for these 15 participants had previously been
obtained from the ‘100 Brains’ study (Chapter 3).
6.3.4 MRI Acquisition and Analysis
T1-weighted anatomical images (FSPGR) with 1-mm isotropic resolution had previously been
obtained from the ‘100 Brains’ study (Chapter 3). From these 3D FSPGR scans, estimates for
the thickness and surface area of Heschl’s gyrus were obtained using an Atlas in Freesurfer
template space, using Version 4.4 of the FreeSurfer package
(http://surfer.nmr.mgh.harvard.edu/).
6.4 Results
6.4.1 Auditory Chirp Gamma Responses
The auditory click-chirp evoked clear sources of increased gamma activity in both the left
and right temporal sensors in 11 of the 15 participants. Thus, 11 participants were included
for further analysis. Figure 2A shows topographic maps with the location of increases in
gamma activity (30-50Hz) for the group average (n=11) and 2 single participants. Increases
in activity from baseline were stronger in the right than left hemisphere for 10 of the 11
subjects.
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Figure 2: (A) Topographic maps showing the increased gamma activity (30-50Hz) over the
left and right temporal sensors in response to the auditory click-chirp. (B) Time-frequency
spectra showing the click-chirp response from the left and right maximal temporal sensor for
the group average and 2 representative participants.
The time-frequency spectra from the left and right temporal sensor across individuals show a
similar morphology. Characteristic components are similar to those previously reported using
a ‘chirp’ stimulus with an amplitude-modulated tone rather than a click train (Artieda et al.,
2004). The ASSR starts at about 30Hz and continues linearly increasing in frequency in
accordance with the frequency of stimulation until the end of the stimulus at 120Hz. The
largest increase in power occurred in the 30-50Hz frequency band from 0.35 to 0.7s. A
second, smaller, increase in power occurred in the 70-100Hz frequency band from 0.9 to 1.5s.
In the low frequency band there is an early evoked response (M100 and P200) and an offset
response at 1.7s.
130
As the responses showed a similar morphology in both the left and right temporal sensor but
were reliably stronger in the right sensor, the peak gamma frequency and peak gamma power
in the low gamma and high gamma band were extracted from the right sensor for each
individual. Peak gamma frequencies in the 30-50Hz band ranged from 37 to 43Hz (mean
40.36Hz (SD= 2.11)) and ranged in power (% change from baseline) from 22 to 169 (mean
77 (SD=43), see figure 3A). Peak gamma frequencies in the 70-100Hz band had a larger
range in peak frequency, from 70-84Hz (mean 78.45 (SD=4.48)) and ranged in power from 6
to 71 (mean 30 (SD =23), see figure 3B). The peak response from the low gamma frequency
(30-50Hz) was not significantly correlated with the peak from the high gamma frequency
(70-100Hz) (R=0.393, p=0.232), suggesting that the two responses are independent and that
the high gamma response is not simply a harmonic of the low gamma response.
Figure 3: Peak gamma frequency and peak power in (A) the 30-50Hz gamma band and (B)
the 70-100Hz gamma band for all 11 participants.
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6.4.2 Repeatability of Chirp Gamma Responses
The ASSR showed a stable morphology that was repeatable across time (Figure 4).
Figure 4: Time-frequency spectra from the maximal right temporal sensor of 2 participants
that were scanned in the initial study (session 1) and then scanned 8 weeks later, three times
in one day at 1hr intervals (session 1, 2 and 3).
The peak frequency and peak power obtained from these 2 individuals across the four
sessions is displayed below and show that the 30-50Hz peak frequency measure has the
strongest reliability across the sessions.
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Figure 5: Plots displaying the reliability of the four gamma measures from the low gamma
band (A) and the high gamma band (B) of 2 individuals, across the four different sessions.
To statistically assess the repeatability of the measures of interest (30-50Hz peak frequency,
30-50Hz peak power, 70-100Hz peak frequency and 70-100Hz peak power) the intraclass
correlation coefficients (ICC) with two-way random effects and absolute agreement were
calculated. The 30-50Hz peak frequency measure had a strong ICC (single measures ICC=
0.973; average measures ICC=0.993), as did the 30-50Hz peak power (single measures ICC=
0.743; average measures ICC=0.920). The 70-100Hz peak frequency measure also had a
weaker ICC (single measures ICC= 0.453; average measures ICC=0.768) and the 70-100Hz
peak power had a strong ICC (single measures ICC= 0.933; average measures ICC=0.982).
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6.4.3 Auditory Structural Properties
From the 11 participants that produced clear ASSRs, the thickness of the right HG ranged
from 2.41mm to 2.89mm (mean 2.67 (SD 0.13)) and the surface area of the right HG ranged
from 298cm2 to 394cm2 (mean 339 (SD 34)).
Figure 6: Histogram showing the thickness and surface of the right HG for the 11
participants.
6.4.4 Visual Gamma Responses
From the 11 participants, visual gamma peak frequency ranged from 36.5Hz to 58.5Hz (mean
50.5 (SD 5.5)) and visual gamma peak power (% change from baseline) ranged from 26.59%
to 89.75% (mean 52.76 (SD 17.61)).
Figure 7: Histogram showing the peak visual gamma frequency and peak visual power for the
11 participants.
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6.4.5 Correlational Analysis
Table 1: Correlations between ASSR gamma responses with auditory structural properties
and visual gamma responses
Age Right HG
Thickness
Right HG
Surface Area
Visual Gamma
Peak Frequency
Visual Gamma
Peak Power
30 to 50Hz ASSR
Peak Frequency
R=0.502
P=0.115
R=0.155
P=0.649
R=0.163
P=0.633
R=-0.294
P=0.380
R=0.205
P=0.546
30 to 50Hz ASSR
Peak Power
R=0.391
P=0.234
R=0.305
P=0.362
R=310
P=0.354
R=0.096
P=0.778
R=0.270
P=0.423
70 to 100Hz ASSR
Peak Frequency
R=0.376
P=0.254
R=-0.511
P=0.109
R=-0.426
P=0.191
R=0.008
P=0.981
R=0.411
P=0.209
70 to 100Hz ASSR
Peak Power
R=0.110
P=0.748
R=0.259
P=0.441
R=0.473
P=0.142
R=-0.168
P=0.622
R=-0.178
P=0.601
Firstly, correlational analysis between age and the four ASSR measures was performed as age
has previously been found to negatively correlate with the 30-50Hz peak frequency of the
ASSR (Purcell et al., 2004). Age was not significantly associated with any of the four
auditory measures and so was not included for further analysis. None of the four ASSR
measurements (30-50Hz peak frequency, 30-50Hz peak power, 70-100Hz peak frequency
and 70-100Hz peak power) were significantly associated with either the structural properties
of the right HG (thickness or surface area) or visual gamma responses (visual gamma peak
frequency or visual gamma peak power).
6.5 Discussion
This study has developed an auditory click-chirp stimulus that reliably produces a continuous
ASSR over a broad range of frequencies. This allows for both low and high gamma
frequency ASSRs to be simultaneously measured. This is highly beneficial for clinical
investigations as both low and high gamma oscillations have been found to be altered in
schizophrenia and bipolar disorder (Grützner et al., 2013, Hamm et al., 2011, Oda et al.,
2012). Another advantage of this stimulus is that it provides further information about the
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ASSR, as in addition to measuring individual differences in the power of the ASSR,
individual differences in peak frequency can also be measured.
Essentially, the click-chirp revealed two main increases in gamma power, one being in the
30-50Hz range and another in the 70-100Hz range (Figure 2B and Figure 4), that were
maximal in the temporal sensors of the right and left hemisphere (Figure 2). These findings
coincide with previous studies that have shown the ASSR produces maximal responses in the
30-50Hz and 80-120Hz range (Alegre et al., 2008, Artieda et al., 2004) and have been
localised to the auditory cortex (Herdman et al., 2003, Pantev et al., 1996, Pastor et al.,
2002). The high gamma response (70-100Hz) was also weaker in power than the low gamma
response (30-50Hz) across all individuals. Although the ASSR produces the largest response
at 40Hz (Galambos et al., 1981), the significantly weaker high gamma response may be due
to the source of this component being more subcortical, which MEG is less able to detect.
This is supported by studies which have shown both brainstem/cerebellar and cortical
(temporal lobe) sources to be active during the ASSR (Pastor et al., 2002, Pastor et al., 2008,
Ribary et al., 1991), but stronger activation is visible in cortical areas for lower frequencies
(<50Hz) and above 50Hz, stronger activity is present in the brainstem (Herdman et al., 2002,
Mauer and Döring, 1999). As MEG is not sensitive enough to reliably measure deeper
sources, the source of the 80Hz response was not investigated in this study. Further
investigation into the primary source of the 80Hz response with this chirp stimulus would
need to be verified using other imaging techniques with a higher spatial resolution, such as
fMRI.
Interestingly, the power of the low and high gamma components was stronger in the right
temporal sensor than the left temporal sensor in 10 of the 11 participants. This finding
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coincides with other MEG studies that have found a right hemisphere dominance following
binaural stimulation with 40Hz amplitude-modulated tones (Ross et al., 2005), and click
trains at 20, 30, 40 and 80Hz (Oda et al., 2012). The reason for this right hemisphere
dominance has been hypothesised to be due to the right hemisphere’s sharper tuning to
spectral processing in comparison to the left hemisphere which is more specialised for
temporal processing (Liégeois-Chauvel et al., 2001, Ross et al., 2005). However, these
findings and implications must be interpreted with caution as a recent EEG study has shown
larger ASSRs in the left temporal hemisphere in response to 40Hz click trains (McFadden et
al., 2014).
Importantly, the chirp revealed that individuals differed in their peak power for both the low
and high gamma response and also in their peak frequency within these two responses
(Figure 3). The ICC values suggest these inter-individual differences present in all four
measures were relatively repeatable within individuals, particularly for participant 2 (Figure 4
and 5). For participant 1, the repeatability was less consistent for the power of the 30-50Hz
and 70-100Hz response across sessions. Due to the relatively long length of the recording
session, this lower reliability in power may be due to fatigue and decreased attention (Alegre
et al., 2008). Even with the lower reliability for the power of the response, all four measures
are statistically consistent and thus suitable for correlational analysis with auditory structural
and visual oscillatory measures.
None of the four right temporal ASSR measures were significantly associated with the
thickness or surface area of the right HG. So far, only one other study has investigated the
effect of auditory structural properties on the ASSR (Edgar et al., 2013). This study reported
a positive correlation between the power of the 40Hz response and the thickness of the left
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superior temporal gyrus (STG), using a sample size of 29 healthy controls. Several factors
may explain this discrepancy in findings between that of Edgar et al. (2013) and this study.
Firstly, this study investigated the impact of thickness from Heschl’s gyrus rather than the
STG, as Heschl’s gyrus contains the primary auditory cortex, which is thought to be the main
generator of the 40Hz ASSR (Herdman et al., 2003). Secondly, the positive correlation was
specific to the left STG as it was not found in the right STG,  and this study investigated
correlations in the right HG as these produced the stronger, more reliable findings. Lastly, the
sample size in this study was much smaller (n=11 vs n=29), which greatly reduces the power
to detect reliable relationships between variables. The power to detect a correlation of
moderate effect size between pairs of relevant variables with a sample size of 11 is 25%.
Therefore, further investigating this relationship in a larger sample size is required to
determine whether the properties of auditory structures such as the STG and Heschl’s gyrus
influence individual differences in the peak power or peak frequency of the low and high
gamma ASSRs.
In addition, no association was found between the peak frequency of the ASSR (30-50Hz and
70-100Hz) and the peak gamma frequency (30-70Hz) obtained from the visual cortex in
response to a high-contrast grating. Similarly, the peak power of the ASSR (30-50Hz and 70-
100Hz) was not associated with the peak power of the visual gamma response. These
findings are not surprising, seeing as the auditory gamma activity represents a steady-state
response and the visual gamma activity represents an induced response, which may have
different neural sources and functional processes (Krishnan et al., 2005a). In the visual
system, a static grating is able to induce an oscillatory gamma response within the primary
visual cortex, the frequency of which appears to be a stable trait marker within an individual
and hence represents a characteristic ‘resonance’ of the visual system. In the auditory
domain, no reliable analogue of a static visual stimulus has been found that induces auditory
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gamma. However, by using an evoked design that uses varying frequency of stimulation, as
with the chirp used here, the assumption is that the peak stimulus response frequency also
represents a similar ‘resonance’ within the individual’s auditory system. The lack of
association between these visual and auditory oscillatory resonant frequencies suggests
differences in neural circuitry between the two sensory domains, in agreement with recent
evidence (Linden and Schreiner, 2003, Read et al., 2002, Smith and Populin, 2001). As
sensory gamma oscillations depend on the balance between GABAergic and glutamatergic
neurotransmission via reciprocally connected parvalbumin expressing interneurons and
excitatory pyramidal cells (Whittington et al., 2011) there may be specific differences in the
number, type or the strength of connectivity in these neurons.
Although no relationship was found between individual variation in gamma power and
frequency with auditory structural properties, this study provides a platform for future studies
to investigate the factors underlying individual differences in the ASSR. As in other sensory
domains, identifying the factors underling individual variability in the ASSR is behaviourally
and clinically important (Cheyne and Ferrari, 2013, Kanai and Rees, 2011). Supporting this,
in healthy individuals the power of the 40Hz ASSR has been shown to positively correlate
with speech recognition (Manju et al., 2014) and  in MS patients the frequency of the ASSR
(30-50Hz) has been associated with verbal memory and attention-executive functioning tests
(Arrondo et al., 2009). In psychiatric populations, the power of the 80Hz ASSR negatively
correlates with scores from the Hamilton Depression Rating Scale and global hallucinatory
experiences (Oda et al., 2012, Tsuchimoto et al., 2011). In addition, the power of the 40Hz
ASSR has been found to be reduced in adults with autism spectrum disorder (ASD) and
parents of children with ASD, with the power of the 40Hz response being negatively
correlated with the Social Responsiveness Scale (SRS) (Rojas et al., 2008, Rojas et al.,
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2011). Thus, the altered 40Hz ASSR found across different disorders may be indicating a
widespread alteration in biological mechanisms, which consequently lead to various
symptoms and altered behaviours.
Given that cortical gamma oscillations depend on GABAergic and glutamatergic function
(Bartos et al., 2007, Buzsaki and Wang, 2012), determining the effect of in vivo GABA and
Glx (glutamate and glutamine) measures from the auditory cortex on the peak frequency and
power of the ASSR would be of particular interest. The dependency of the 40Hz ASSR on
GABAergic and glutamatergic function has been supported by several studies via
pharmacological manipulation (Plourde et al., 1997, Sivarao et al., 2013, Vohs et al., 2010).
In conjunction, abnormal excitatory/inhibitory cortical balance is well documented in
psychiatric populations and schizophrenia and bipolar individuals demonstrate altered ASSRs
(O'Donnell et al., 2013, Oda et al., 2012, Spencer, 2012, Tsuchimoto et al., 2011). Therefore,
this stimulus may be of particular use to identify particular biological pathways in the
auditory system that may lead to an altered ASSR, which may consequently lead to
differences in auditory perception.
In addition, although the power and frequency of the gamma oscillations did not correlate
across the auditory and visual cortex further understanding the similarities and differences
between these two sensory modalities is clinically important. In psychiatric patients,
decreased gamma power is found in both the visual and auditory cortex (Grützner et al.,
2013, Oda et al., 2012, Rass et al., 2010). As increasing GABAergic function increases the
power of the gamma ASSR (Vohs et al., 2010) and the power of visual gamma oscillations
(Campbell et al., 2014, Saxena et al., 2013) this suggests these patients have a widespread
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deficit in cortical GABAergic function.  However, further work is needed to determine the
precise GABAergic pathways affected and whether these are modality specific.
Overall, this study shows that a click-chirp stimulus provides a powerful tool in which to
probe the factors underlying individual variability of the ASSR. Identifying these factors will
(1) enable comparisons across other sensory modalities, (2) increase our understanding of the
biological substrates that lead to altered oscillatory activity and (3) how these substrates may
consequently influence perception in both health and disease.
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Chapter 7 - General Discussion
This thesis used a combination of structural and functional neuroimaging measures, as well as
genetic data, to increase our understanding of individual variation in genes and brain
structure/function in the visual and auditory system of healthy individuals and psychiatric
disorders. Specifically, four main experimental questions were investigated: firstly, (Chapter
3) whether differences in the structural and neurochemical properties of the visual cortex
explain individual variation in visual gamma frequency; secondly, (Chapter 4) whether
genetic variation influences individual variation in resting occipital GABA+ levels or visual
gamma frequency; thirdly, (Chapter 5) to determine if occipital GABA+, V1 structure or
visual gamma oscillations are altered in SABP and lastly, (Chapter 6) to determine if
individual differences in auditory steady-state gamma oscillations can be explained by
individual differences in the structure of the auditory cortex.
7.1 Summary of Experimental Results
Previously, positive correlations between the structural parameters of V1 (thickness and
surface area) and MRS GABA+ levels with visual gamma peak frequency have been reported
(Gaetz et al., 2012, Muthukumaraswamy et al., 2009, Muthukumaraswamy et al., 2010,
Robson, 2012, Schwarzkopf et al., 2012). However, these studies used small sample sizes or
slightly different stimulus parameters across participants. Thus, Chapter 3 investigated the
relationship between these imaging variables using identical stimulus parameters in a large
cohort of 100 healthy individuals that were homogenous in terms of age, ethnicity, education
and handedness. Using this large homogenous cohort, neither the structural properties of the
visual cortex (thickness or surface area) nor resting occipital GABA+ levels were found to be
associated with visual gamma peak frequency.
142
Genetic variation may be another factor influencing downstream individual variation in both
gamma peak frequency and cortical GABA levels (Hasler and Northoff, 2011, Marenco et
al., 2010, van Pelt et al., 2012). Hence, Chapter 4 looked at the influence of genetic variation
on individual variation in visual gamma frequency and occipital GABA+, using a candidate-
SNP, a candidate-gene approach and a polygenic schizophrenia risk score approach. The
GAD1 candidate approach, revealed an association between three out of eight GAD1 SNPs on
occipital GABA+ levels. Specifically, the minor allele from all three SNPs was found to have
a recessive effect, so that those individuals who were homozygous for the minor allele had
increased levels of GABA+/Cr in comparison to those who were homozygous or
heterozygous for the major allele. In contrast, none of the eight GAD1 SNPs influenced visual
gamma peak frequency. Genetic variation in the GABAAR subunit or polygenic
schizophrenia risk scores were also not significantly associated with occipital GABA+ or
visual gamma peak frequency.
Altered GABAergic and gamma oscillatory activity has been widely implicated in the
pathophysiology of schizophrenia and bipolar disorder, via a wealth of genetic, pathological
and physiological studies (Bhagwagar et al., 2007, Gonzalez-Burgos et al., 2010, Hashimoto
et al., 2003, Lewis et al., 2012). However, some reports have identified no differences or
opposing directions of effect within the same clinically defined psychiatric population (Ongür
et al., 2010, Riečanský et al., 2010, Tan et al., 2013, Tayoshi et al., 2010, Yoon et al., 2010).
Therefore, Chapter 5 investigated visual gamma oscillations and occipital GABA+ in SABP
individuals to further understand the neurochemical and neurophysiological changes present
in psychiatric populations. SABP individuals were found to have increased visual gamma
power compared to healthy individuals, both at the group level and individually, as 14 of the
15 SABP individuals tested had increased power relative to their matched control. No group
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differences were found for other MEG visual measures (baseline gamma power, transient or
sustained gamma frequency, alpha band responses and visual evoked responses) or MRS
occipital GABA+ levels.
Although differences in structural and neurochemical measures have been identified as
potential factors influencing individual variation in peak gamma response frequency in both
the visual and motor cortex (Gaetz et al., 2011, Gaetz et al., 2012, Muthukumaraswamy et
al., 2009, Muthukumaraswamy et al., 2010, Schwarzkopf et al., 2012), these relationships
have not been studied in the auditory domain. Determining the factors underlying the peak
response frequency in the auditory domain is equally important as the visual and motor
domain. Chapter 6 found neither the thickness nor surface area of the right HG to be
associated with the peak gamma frequency or power of the low (30-50Hz) or high (70-
100Hz) gamma ASSR in the right auditory cortex. Also, the peak response frequency in the
auditory cortex was not associated with the peak response frequency in the visual cortex,
suggesting these oscillatory responses are regionally specific.
7.2 Interpretation of Results and Future Directions
7.2.1 Occipital GABA, V1 Structural Properties and Visual Gamma Frequency
The lack of association between occipital GABA+ and visual gamma peak frequency opposes
preclinical evidence supporting the strong dependence of gamma oscillatory activity on
GABAergic circuitry (Buzsaki and Wang, 2012, Cardin et al., 2009) and the initial finding of
a positive correlation between the two neuroimaging measures (Muthukumaraswamy et al.,
2009). However, the null finding does agree with more recent research using larger sample
sizes that no relationship exists between MRS measured GABA+ and MEG measured gamma
frequency (Cousijn et al., 2014, Shaw et al., 2013). The lack of consistency between this
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study and more recent studies with the initial report shows how important it is for the
scientific community to use large sample sizes and replication, in order to increase the
likelihood that findings reflect a true association (Button et al., 2013).
Despite the lack of association between GABA+ and gamma frequency found in this study,
substantial computational and experimental studies indicate that GABAergic transmission,
via mutually connected interneurons and pyramidal cells is vital in the generation of gamma
oscillations (Brunel and Wang, 2003, Traub et al., 1997, Traub et al., 1996). In addition,
positive correlations between MRS GABA and gamma frequency have been reported in other
brain areas, including the primary motor cortex (Gaetz et al., 2011) and the left DLPFC
(Chen et al., 2014). Thus, these two imaging studies suggest that MRS GABA and gamma
frequency are associated and that a common GABAergic mechanism in regulating gamma
frequency is present across cortical regions. However, these two imaging studies have two
main limitations that question the reliability of a true association between gamma frequency
and GABA: small sample sizes (n=9 and n=16, respectively) and relatively large age ranges
(22.7-42.7 and 21-49 years, respectively). Small sample sizes are a well-known problem in
neuroimaging studies and can increase the likelihood of false positive findings. Also, gamma
frequency and GABA levels change with age (Gaetz et al., 2011, Gaetz et al., 2012, Gao et
al., 2013, Muthukumaraswamy et al., 2010) and previous correlations between these two
measures have been proposed to be due to their mutual relationship with age (Gaetz et al.,
2012, Robson, 2012). Thus, before a reliable and strong association between in vivo GABA
and gamma frequency across cortical regions can be confirmed using neuroimaging
techniques, these findings need to be verified in studies with larger participant numbers and
with reduced confounding variables such as age.
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A crucial reason for the lack of a consistent association between GABA+ and gamma
frequency across imaging studies may be due to the MRS GABA+ measure not consistently
reflecting the inhibitory activity that is most relevant for gamma frequency. In the neocortex,
the inhibitory activity from interneurons expressing the calcium binding protein parvalbumin
(PV), plays a particularly important role in the generation of gamma oscillations (Cardin et
al., 2009, Sohal et al., 2009) because of their fast-spiking characteristics (Bartos et al., 2007).
These PV-expressing interneurons are the largest subclass of inhibitory interneurons,
accounting for 40% of GABAergic neurons (Xu et al., 2010), but whether their
activity/function is accurately represented by MRS GABA+ measures is unclear. MRS
GABA+ could also not be specific enough to functional GABA, as the GABA+ measure is
obtained from a large volume which may not all represent functional GABA, and up to 40%
of the GABA+ MRS signal is from macromolecules (Harris et al., 2014). In addition,
computational and pharmacological studies have revealed that gamma frequency relies on a
complex local network, controlled by the excitatory/ inhibitory balance (Brunel and Wang,
2003) and the kinetics of inhibitory postsynaptic potentials (IPSPs) (Bartos et al., 2007). For
example, Whittington et al. (1995 and 2000) has shown that increasing the decay time of
GABAAR mediated IPSPs either by computer simulation or application of GABAAR
modulating drugs leads to a decrease in oscillation frequency (Whittington et al., 1995,
Whittington et al., 2000). Thus, even if GABA+ measures are accurately reflecting the
activity of PV-expressing interneurons, due to the combination of factors controlling gamma
frequency, accurate and consistent associations between GABA+ and gamma frequency may
be difficult to obtain.
The use of small sample sizes and confounding factors such as age used in previous studies
may also be accountable for unreliable relationships being previously reported between V1
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structural measures and visual gamma frequency (Gaetz et al., 2012, Muthukumaraswamy et
al., 2010, Schwarzkopf et al., 2012). Given that the study in this thesis used a large and
homogenous sample but still found no association between either V1 thickness or surface
area with gamma frequency, this would suggest that no association exists between these
measures. However, a lack of dependency of gamma frequency on the structural measures of
V1 would be surprising. Given that MR-measures of structural differences are thought to
reflect differences in the number and type of interneurons/pyramidal cells (Rakic, 1988) and
possibly their dendritic connectivity density, these cortical circuitry changes would strongly
affect the excitatory and inhibitory neurotransmission, and thus gamma frequency. This is
supported by computational studies showing that varying the strength of excitatory input to
interconnected interneurons and pyramidal cells alters gamma frequency (Jia et al., 2013,
Spencer, 2009). Therefore, as discussed with the GABA+ measure, the structural measures of
V1 may in fact be strongly influencing individual variation in gamma frequency, but the
structural measures lack the relevant specificity and their precise dependency on underlying
neuronal structure is unknown (Eriksson et al., 2009). Finally, the V1 structural measures
obtained in this thesis are a global representation of V1 structure (including all 6 cortical
layers), whereas only cortical layers 2, 3 and 4 are most relevant to gamma-band oscillations
(Xing et al., 2012). Thus, structural measures encompassing only layers 2, 3 and 4 may be
more useful.
Even with the complexity of factors involved in gamma oscillatory activity, understanding
the underlying mechanisms driving individual variation in frequency remains important as
this will reveal more about the functional role of these oscillations. A potential factor driving
inter-individual in visual peak response frequency that warrants investigation is the effective
connectivity of V1. Recently, inter-individual differences in the cortical effective
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connectivity of V1 (estimated using fMRI and dynamic causal modelling (DCM)) was shown
to positively correlate with individual variability in the tilt illusion (Song et al., 2013) and
orientation perception has been shown to be predicted by GABA and peak gamma frequency
(Edden et al., 2009, Yoon et al., 2010). Thus, effective connectivity of V1 may be driving
individual variation in gamma frequency, which consequently leads to alterations in visual
perception, such as orientation perception. Overall, these studies show how important it is for
future studies to combine different imaging modalities with preclinical and behavioural data
as significant insights into the behavioural consequences of biological variation are revealed.
7.2.2 Effect of Genetic Variation on Occipital GABA and Visual Gamma Frequency
Encouragingly, Chapter 4 revealed a significant association between three GAD1 SNPs and
in vivo occipital GABA+ levels. These findings build upon previous genetic imaging
evidence that individual variation in GAD1 influences individual variation of in vivo cortical
GABA levels (Marenco et al., 2010). In addition, the association implies that cortical MRS
GABA measures are influenced at a genetic level and reflect a downstream biologically
relevant GABAergic measure. The findings from this thesis are important from a clinical
perspective, as the GAD1 alleles (minor alleles) that were linked with decreased GABA
levels have been associated with increased risk for schizophrenia, bipolar disorder and panic
disorder (Addington et al., 2005, Du et al., 2008, Lundorf et al., 2005, Straub et al., 2007,
Weber et al., 2012). Decreased MRS GABA levels have been reported in a range of cortical
regions, including the occipital cortex,(Goddard et al., 2001, Yoon et al., 2010) anterior
cingulate (Rowland et al., 2013) and prefrontal cortex (Long et al., 2013, Marsman et al.,
2014) across major psychiatric disorders. Therefore, the findings from this thesis provide an
important link between GABA pathophysiology and common genetic variation, by
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suggesting that lowered GABA levels observed in disorders such as schizophrenia are the
biological consequence of GAD1 schizophrenia risk-associated alleles.
As many reports have also discovered lowered GAD1 mRNA expression (Hashimoto et al.,
2008, Thompson et al., 2009, Thompson Ray et al., 2011, Volk et al., 2012) and lowered
GAD67 protein levels (Curley et al., 2011, Guidotti et al., 2000) across various brain regions
(particularly in the DLPFC but also in the visual cortex), this leads to a strong assumption
that GAD1 risk alleles lead to decreased GABA levels via lowered mRNA expression and
less translation of the corresponding GAD67 protein. However, this clear directional
relationship between gene expression level, protein level and neurotransmitter level was not
present in this study, as the three GAD1 risk associated alleles that were associated with
lowered occipital GABA+ levels, were associated with increased GAD1 mRNA expression in
the occipital cortex (Ramasamy et al., 2014). Other studies have also reported an inconsistent
directional relationship across gene expression, protein and neurotransmitter levels. Dracheva
et al. (2004) found elevated levels of GAD1 mRNA in the DLPFC and occipital cortex of
elderly schizophrenia patients but the corresponding GAD67 protein levels were unchanged
(Dracheva et al., 2004). This shows a clear need for a further understanding of the molecular
mechanisms of action of GAD1 variants on mRNA and subsequent protein levels.
Understanding whether these molecular mechanisms of action of GAD1 variants are similar
across different GAD1 variants, across different cortical regions and in different types of
schizophrenia populations (chronic vs recently diagnosis) will also allow other key questions
to be answered. For example, a major difference between this study and that of Marenco et al.
(2010) is the directional effect of GAD1 risk associated alleles on resting GABA+ levels; this
thesis found schizophrenia risk-associated alleles were related to decreased occipital GABA
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levels, whereas Marenco et al, (2010) found the risk associated alleles were related to
increased ACC GABA levels. As the latter findings were found in the ACC rather than the
occipital cortex, these opposing directional effects could be due to regional specificity of
genetic variants. This is supported by post-mortem and imaging studies, showing that GAD1
mRNA expression and in vivo GABA levels are differentially modulated across brain regions
and so are likely to have different functional effects (Boy et al., 2010, Fong et al., 2005, Puts
et al., 2011, Ramasamy et al., 2014). A further example is that although the majority of
studies report a general deficit in GABAergic measures for schizophrenia individuals,
elevated levels of GABA have been reported in the anterior cingulate, parieto-occipital
cortices and PFC (Kegeles et al., 2012, Ongür et al., 2010). Understanding the mechanisms
of genetic variation could help explain these type of discrepancies across studies, such as
whether they are due to individuals having different GAD1 variants that lead to opposing
effects or other factors such as medication.
The findings from Chapter 4 provide crucial support for the usefulness of candidate SNP
studies and strong evidence for GAD1 variants influencing cortical GABA levels. However,
the major limitation of small sample groups (when individuals are grouped based on
genotype) must be acknowledged. As the majority of single genetic variants have small effect
sizes on downstream functional measures the small genotype groups in this study may have
led to an overestimation of GAD1 effects on GABA. The relatively small sample size may
also be a contributing factor as to why the GAD1 variants were not found to influence peak
gamma frequency. GAD1 variation would be expected to influence the GABAergic function
of PV interneurons and thus gamma frequency but as gamma frequency is likely to reflect a
more downstream and less direct measure of GABAergic activity compared to MRS GABA,
larger sample sizes may be needed to detect this effect. Therefore, future studies must address
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that despite the time and expense required, genetic imaging studies require large sample sizes
(in hundreds or thousands)  in order for obtaining reliable results and to enable the detection
of small effect sizes.
Another key issue that future genetic imaging studies must acknowledge is that both
biological and clinically defined psychiatric phenotypes are most likely to be influenced by
multiple genetic factors, which they themselves are affected by environmental elements
(Consortium, 2014, Purcell et al., 2009). For example, in this study the levels of occipital
GABA+ are likely to be influenced by a complex network of components that regulate
GABAergic circuitry/activity such as GABAA receptors, GABA transporters, or
developmental growth factors  (BDNF and neuregulin 1 (NRG1)-ErbB4 signalling) (Fazzari
et al., 2010, Marenco et al., 2011, Subburaju and Benes, 2012). Therefore, the corresponding
genes regulating these components also merit investigation into their effect on cortical GABA
and gamma frequency. Although the effect of other components and multiple SNPs on
GABA+ and gamma frequency were taken into account in this thesis by using GABAAR
subunit genes and schizophrenia polygenic risk scores, neither of these approaches revealed
significant associations of genetic variation with GABA+ or gamma frequency. These null
findings could reflect a true lack of effect but would need to be verified in a large
independent sample. Given the dependence of GABA and gamma on GABAAR function, the
surprising lack of association raises the important issue of specificity when incorporating the
effect of multiple SNPs/genes on imaging measures. Only certain SNPs/genes may be
significantly involved in biological/clinical phenotypes and including multiple variants may
be incorporating ‘noise’ into the analysis, masking the true effect of particular SNPs.
Therefore, a major challenge for future imaging studies is to balance specificity and
sensitivity, to ensure that enough genetic variation is included but that it is still specific
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enough in regards to the imaging measure. Despite these caveats, it is clear that through this
study and others, combining genetic and imaging data is truly advantageous in helping us
bridge the gap between genes, neurobiology and behaviour (Linden, 2012, Meyer-
Lindenberg, 2010b, Muñoz et al., 2009).
7.2.3 GABA and Gamma in SABP
Chapter 5 revealed that SABP individuals had a significant increase in visual gamma power
in comparison to their age and gender matched healthy control. These findings were not as
expected, as the majority of other studies have reported that schizophrenia/SABP subjects
have decreased gamma power in a range of cortical regions (Cho et al., 2006, Kwon et al.,
1999, Minzenberg et al., 2010, Wynn et al., 2005), including the occipital cortex (Grützner et
al., 2013). As discussed in Chapter 5, several reasons may account for this discrepancy with
other literature: (1) this study looked at induced responses rather than early evoked responses;
(2) the visual stimulus is less cognitively demanding compared to stimuli (working memory)
used in other studies and (3) the clinical population only included SABP individuals rather
than schizophrenia subjects or a combination of schizophrenia and SABP subjects.
Importantly, increased visual gamma power in SABP subjects indicates that an underlying
pathophysiology is present in this clinical population. As no group differences were present
for MRS GABA and gamma frequency measures, this suggests the prime pathophysiology
does not involve GABAergic transmission, which agrees with previous studies showing no
relationship between MRS occipital GABA and visual gamma power (Cousijn et al., 2014,
Muthukumaraswamy et al., 2009). Instead, substantial evidence points towards a key
alteration in glutamatergic function, in which NMDA receptor hypofunction reduces the firing
rate of PV interneurons, resulting in the disinhibition of pyramidal neurons and a subsequent
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increase in pyramidal neuronal activity (Homayoun and Moghaddam, 2007). This proposed
mechanism of action is supported by in vitro and in vivo rat studies that have shown NMDAR
blockade via application of MK-801 or ketamine (NMDAR antagonists) leads to a decrease
in the firing rate of interneurons but an increase in the firing rate of pyramidal neurons and
increased gamma power (Anver et al., 2011, Hakami et al., 2009, Hiyoshi et al., 2014,
Homayoun and Moghaddam, 2007). In addition, genetic ablation of the NMDAR in PV
interneurons of mice leads to increased gamma power (Carlén et al., 2012). This hypothesis
of increased gamma power due to NMDAR hypofunction is also translatable to humans, as
sub-anaesthetic doses of ketamine increase gamma responses to auditory stimuli (Hong et al.,
2010) and increases glutamatergic transmission in the anterior cingulate cortex of healthy
individuals (Stone et al., 2012).
A possible dysfunction of the NMDAR in SABP subjects is highly plausible, as this adheres
to the NMDAR hypofunction hypothesis of schizophrenia (Gilmour et al., 2012, Moghaddam
and Javitt, 2012). This hypothesis originated from the observation that administration of
NMDAR antagonists to schizophrenia individuals exacerbates their psychotic and cognitive
symptoms (Lahti et al., 1995, LUBY et al., 1959), while in healthy individuals NMDAR
antagonists induce the psychotic, negative and cognitive symptoms associated with
schizophrenia (DAVIES and BEECH, 1960, Krystal et al., 1994, Rowland et al., 2005).
Further evidence has now added to the involvement of the NMDAR in the etiology and
pathogenesis of schizophrenia, via genetic (Kirov et al., 2012, Martucci et al., 2006), post-
mortem (Law and Deakin, 2001) and imaging studies (Pilowsky et al., 2006, Rowland et al.,
2013). Therefore, the findings from this thesis and other literatures point towards a main
dysfunction in the NMDAR in SABP, which leads to increased gamma power.
153
The finding of no group difference in MRS GABA levels or gamma frequency was not as
expected, due to the substantial evidence showing that a general deficit in GABAergic
function is found in schizophrenia, bipolar disorder and SABP individuals (Curley et al.,
2011, Ferrarelli et al., 2012, Hashimoto et al., 2003, Lewis et al., 2012, Yoon et al., 2010).
Based on the assumption that a reduction in GABAergic activity is secondary to the NMDAR
hypofunction, alterations in GABA or gamma frequency may be less prominent and so larger
sample sizes may be needed to detect these differences. Interestingly, a crucial mechanistic
link between NMDAR dysfunction and diminished GABAergic function has been identified,
which may explain how both altered glutamatergic and GABAergic function are found in
psychiatric disorders. Behrens et al. (2007) have shown that in primary neuronal cultures,
prolonged exposure to ketamine causes the activation of NADPH oxidase (an enzyme that
generates the toxic reactive oxygen species superoxide) and subsequent toxic levels of free
radicals lead to a down regulation of GAD67 enzyme in PV expressing interneurons (Behrens
et al., 2007). Therefore, it may be that psychiatric populations including SABP have
alterations in both inhibitory and excitatory transmission, partly due to this intracellular
mechanism that link the two together.
Understanding how these alterations in visual gamma parameters (power or frequency) may
translate into functional differences is important, as this may explain why clinical populations
experience certain dysfunctions in visual processing/perception (discrimination of
orientation, motion and object size (Butler et al., 2008, Chen, 2011, Tadin et al., 2006, Yoon
et al., 2010)). As patients in this thesis were remitted and had low symptom scores, any
possible relationship between increased gamma power and visual symptoms or broader
symptom measures (SAPS or SANS) could not be investigated. Other studies have found
associations of visual gamma power with the positive (hallucinations and delusions) (Spencer
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et al., 2004, Uhlhaas et al., 2006) and negative symptoms (disorganisation) (Grützner et al.,
2013) of schizophrenia, which supports a general role of gamma band oscillations in visual
processing. However, exactly what role gamma band oscillations play in visual
processing/perception is still under considerable debate (Fries, 2009, Mazaheri and Van
Diepen, 2014, Ray and Maunsell, 2010). In terms of narrowband gamma oscillations obtained
in this thesis, it is clear that the parameters (power and frequency) depend on the size, (Perry
et al., 2013), contrast, (Hall et al., 2005) orientation (Koelewijn et al., 2011), and motion
(Swettenham et al., 2009) of the grating stimuli, and so imply these oscillations have a role in
encoding stimulus properties. However, whether these oscillations are essential for all types
of visual processing is not clear as a recent study has shown that narrow gamma band
oscillations are not elicited by all types of visual stimuli (Hermes et al., 2014). Therefore, a
challenge for future studies is to determine the exact role of gamma band oscillations in
visual perception and what particular visual deficits arise when abnormalities are present.
In order to advance our understanding of the role of gamma band oscillations in clinical
populations, it is essential that centres work together in obtaining data by using the same
experimental procedures, so that data across centres can be combined. This will greatly
reduce inconsistencies across studies which may arise from using small sample sizes or
different experimental techniques which lead to different types of participant responses. More
studies also need to focus on comparing different patients populations (i.e. schizophrenia,
SABP and bipolar disorder) and compare medicated vs unmedicated populations. This may
ultimately reveal whether similarities or differences are present in the pathophysiology of
these clinically defined populations and will help the development of more targeted treatment
strategies.
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7.2.4 A1 Structural Properties and Auditory Gamma Oscillations
Chapter 7 showed the development of an auditory click-chirp stimulus that has the advantage
of measuring the auditory steady-state response (ASSR) across a broad frequency range,
while still efficiently detecting the two largest responses at 40Hz and 80Hz. This provides a
richer representation of the ASSR in comparison to other studies that typically only measure
the ASSR to 40Hz or 80Hz stimulation independently (Oda et al., 2012, Pastor et al., 2002,
Ross et al., 2005, Spencer et al., 2009). Interestingly, the ASSR showed inter-individual
variability in the peak frequency and peak power of the response in the gamma band, as is
found in the visual domain in response to a static visual grating (Hoogenboom et al., 2006,
Muthukumaraswamy et al., 2010). The similarity of these gamma response parameters (peak
frequency and power) between the visual and auditory system would suggest that similar
variables may be driving these oscillatory responses and that they may be analogous in
representing the ‘resonance’ of their respective sensory domain. If similar factors are driving
the variability in peak frequency and power in both sensory domains, then investigating the
influence of GABA/glutamate levels and structural parameters on the ASSR is of great
interest, as these measures have been implicated in visual peak frequency and visual peak
power (Gaetz et al., 2012, Muthukumaraswamy et al., 2009, Schwarzkopf et al., 2012,
Spencer, 2009).
In this thesis, no correlational relationship was found between the structural parameters of the
right HG (thickness or surface area) with the peak frequency or peak power of the ASSR
(within either 30-50Hz or 70-100Hz range) from the right hemisphere. Only one other study
has reported an association between an auditory structural measure and the ASSR, in which
the power of the 40Hz response was positively correlated with the thickness of the left STG
(Edgar et al., 2013). A similar association may not have been found in this thesis because: (1)
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associations were tested in the HG rather than the STG, and although both are auditory
structures they have different morphologies (Abdul-Kareem and Sluming, 2008, Taylor et al.,
2005); (2) positive associations detected by Edgar et al. (2013) were in the left STG but not in
the right STG, and this thesis only tested associations in the right HG due to their stronger
reliability; (3) a small sample was used in this thesis. Thus, it is possible that variability in
auditory structural properties may play a role in determining the variability in peak frequency
and/or power of the gamma ASSR but this will need to be explored by other studies.
Future studies should also investigate the influence of GABAergic/glutamatergic circuitry in
the auditory cortex on individual variability in the peak frequency and power of the ASSR, as
inhibitory/excitatory transmission plays a key role in the generation of synchronous ASSRs in
the gamma frequency range (Lewis et al., 2005). Vohs et al. (2010 and 2012) has shown that
enhancing GABAergic activity via application of the GABAAR agonist muscimol increases
the power of the 40 Hz ASSR in sham rats but decreases the power in the neonatal ventral
hippocampal lesion (NVHL) rat model of schizophrenia (Vohs et al., 2010, Vohs et al.,
2012). This suggests a GABAAR dysfunction is present in the NVHL schizophrenia model,
which could be responsible for the decreased power of the 40Hz ASSR in the NVHL rats
compared to sham rats. These findings can also be applied to human schizophrenia
populations, by implying that the widely reported reduction in the 40Hz ASSR of
schizophrenia (Brenner et al., 2003, Krishnan et al., 2005b, Kwon et al., 1999) and their
relatives (Hong et al., 2004) is due to alterations in inhibitory function. This agrees with the
few studies that have investigated cellular inhibitory function in auditory areas of
schizophrenia individuals, in which decreased GAD1 mRNA and a reduced density of GAT1-
immunoreactive axon cartridges are found (Impagnatiello et al., 1998, Konopaske et al.,
2006).
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Glutamatergic function has also been shown to influence the power of the gamma ASSR, as
ketamine increases the power of the 40Hz ASSR in humans (Plourde et al., 1997). As
abnormal increases in the power of the auditory 40Hz response are also observed in
schizoaffective bipolar individuals (Reite et al., 2010), this may be driven by an NMDAR
hypofunction in the auditory cortex, which has also been hypothesised in the visual cortex
(Chapter 5). Therefore, evidence exists for both GABAergic and glutamatergic function
playing a role in the power of the 40Hz ASSR. However, it is not clear whether these
neurochemical factors also influence the variability in the power of the high gamma ASSR
(70-100Hz) or the peak frequency of the low (30-50Hz) or high gamma (70-100Hz) ASSR,
which can be studied using the click-chirp stimulus. As has been done in the visual system,
the impact of GABA and glutamate levels on the peak frequency and power of the gamma
ASSR can be assessed using MRS and by pharmaco-MEG. This will ultimately provide
information into the specific cellular pathways that generate the different ASSR components
which can then be applied to understanding the factors underlying ASSR abnormalities in
clinical populations.
In addition, it would be interesting to study whether individual differences in ASSR gamma
parameters lead to differences in behavioural measures of auditory perception. So far, other
studies have found the power of the 40Hz ASSR to positively correlate with speech
recognition ability (Manju et al., 2014) and with the auditory hallucinations symptom rating
of the SAPS (Spencer et al., 2009). Thus, a high 40Hz ASSR up to a certain threshold may be
advantageous for auditory perception, but responses above this threshold may predispose
individuals to experiencing auditory hallucinations. In particular, it would be interesting to
see if auditory peak gamma frequency and power play a role in encoding auditory stimulus
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parameters (discriminating the pitch of a sound), similar to the hypothesised encoding role
(contrast, motion and size) of gamma oscillations described in the visual domain.
Lastly, it is clear that similarities exist between gamma oscillations in the auditory and visual
domain, such as in their microcircuitry and neurochemical systems. Despite this, no
correlational relationship was found between gamma peak frequency or power responses in
the auditory domain with those in the visual domain. These findings suggest that these
oscillatory responses are regionally specific and functionally tuned. This agrees with
evidence showing that MRS GABA levels are region-specific in the motor and visual cortex
(Boy et al., 2010).
Overall, it is clear that the exact biological determinants of gamma ASSRs needs further
investigation in human individuals and can be studied using the click-chirp described in this
thesis. As most studies have focused on identifying ASSR abnormalities in schizophrenia,
more research on the ASSR in other clinical populations such as bipolar disorder needs to be
conducted.  This will not only allow similarities and differences in oscillatory activity to be
identified across psychiatric disorders but will provide further insights into the biological
pathways within these disorders, with the aim of improving current treatment.
7.3 Conclusion
To conclude, this thesis has shown the clear advantage of combining different brain imaging
modalities (MEG and MRS) and genetic information to provide a more detailed insight into
the biological mechanisms underpinning visual and auditory processing in healthy and
disease states. For example, Chapter 4 has reinforced that genetic variation in GAD1 is
associated with variation in occipital MRS GABA levels and that lower occipital GABA
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function in schizophrenia individuals may be partly due to the effect of specific GAD1
variants. The association between GAD1 and MRS GABA levels also reinforces the
usefulness of MRS as a biological marker, as variability in MRS occipital GABA levels was
sensitive to variation at the genetic level by GAD1.
Chapter 3 and 4 both show the importance of using large homogenous sample sizes, whether
this is for producing reliable and strong associations between imaging measures or for
statistical power in order to detect the small effect sizes of genes on imaging measures.
Similarly, although Chapter 5 did not reveal the expected directional group difference in
gamma measures between SABP and healthy individuals, these findings highlight how
researchers need to work together in order to identify whether these differences between
studies reflect true differences across patient populations, (SABP vs schizophrenia)
differences between cortical regions studied or are solely due to the use of different stimuli.
Lastly, as in Chapter 5 and 6, it is important that researchers transfer their knowledge from
their particular research area and apply it to less well researched areas such as from the visual
to the auditory system or in SABP individuals rather than solely schizophrenia individuals.
This will ultimately provide a more fruitful picture of the function and dysfunction of systems
across different brain areas and in different clinical populations.
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